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ABSTRACT 
 
The poly(diethylaminoethyl methacrylate) (PDEAEM) - Pluronic F127 - PDEAEM  
pentablock copolymer (PB) gene delivery vector system has been found to possess 
an inherent selectivity in transfecting cancer cells over non-cancer cells in vitro, 
without attaching any targeting ligands.  In order to understand the mechanism of 
this selective transfection, three possible intracellular barriers to transfection were 
investigated in both cancer and non-cancer cells. We concluded that escape from 
the endocytic pathway served as the primary intracellular barrier for PB-mediated 
transfection. Most likely, PB vectors were entrapped and rendered non-functional in 
acidic lysosomes of non-cancer cells, but survived in less acidic lysosomes of 
cancer cells. The work highlights the importance of identifying intracellular barriers 
for different gene delivery systems and provides a new paradigm for designing 
targeting vectors based on intracellular differences between cell types, rather than 
through the use of targeting ligands.  
      The PB vector was further developed to simultaneously deliver anticancer drugs 
and genes, which showed a synergistic effect demonstrated by significantly 
enhanced gene expression in vitro. Due to the thermosensitive gelation behavior, 
the PB vector packaging both drug and gene was also investigated for its in vitro 
sustained release properties by using polyethylene glycol diacrylate as a barrier gel 
to mimic the tumor matrix in vivo. Overall, this work resulted in the development of a 
gene delivery vector for sustained and selective gene delivery to tumor cells for 
cacner therapy. 
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CHAPTER 1.  GENERAL INTRODUCTION 
 
1.1  Introduction  
Despite all the effort and work over the last 30 years, cancer is still the second 
leading cause of death in the US, surpassed only by heart disease. Currently 
available therapies must be augmented with new strategies that take advantage of 
innovative technologies. Gene therapy for cancer is one of those emerging 
strategies, which can be defined as transmission of the genetic material into the 
target cells to treat inherited and acquired diseases by correcting genetic defects or 
introducing new therapeutic functions into target cells.  
From this concept, gene therapy basically requires a therapeutic gene, a 
method to induce it into target cells, and its subsequent expression into those cells. 
The therapeutic gene or the gene of interest is usually encoded in a plasmid, which 
also contains other signal sequences, such as a promoter and enhancer that could 
regulate gene expression. The promoter provides recognition sites for RNA 
polymerase to initiate DNA transcription. Enhancers can enhance the production of 
desired genes by several hundred times(1). DNA delivery methods mainly fall into 
two categories: physical techniques and vector-assisted delivery systems. Physical 
methods are usually adopted in the delivery of naked DNA, which include 
microinjection(2), bombardment such as gene gun(3), electroporation(4-6), laser 
beam(7), ultrasonic(8-9) and high pressure(3). Although significant transfection 
efficiencies have been achieved using these mechanical and electrical strategies, 
the associated harmful effects and invasive nature greatly inhibit their clinical 
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application.   
Vector-assisted systems include viral and non-viral gene vectors. Viral vectors, 
such as adenoviruses, adeno-associated viruses and retroviruses, posses an inborn 
ability to access host cells, thus leading to a highly efficient transfection. That is why 
more than 70% of current clinical trials for gene therapy have employed viral vectors. 
However, viral vectors tend to induce an immune response that might trigger severe 
inflammatory reaction and cause insertion mutagenesis(10), In addition, they have a 
limited DNA packaging capability and are difficult to manufacture(11). Especially 
after the death of Jesse Gelsinger in a clinical trial in 1999(12-13) and the leukemia-
like disease developed in a French patient in 2002(14), considerable attention has 
been turned to finding safer alternatives. Non-viral vectors are promising candidates 
with attractive advantages in flexible design, low cost and easy scale-up production 
except for bearing low safety risks. Improving the transfection efficiency to the level 
of their viral counterparts is believed to be the main task. Non-viral vectors mainly 
include naked DNA, liposomes and polymeric carriers. Naked DNA requires physical 
methods to achieve transfection as stated above. Liposomes have a unique bilayer 
structure that can encapsulate DNA in the aqueous core while fusing with the 
hydrophobic cell membrane. Currently they account for the largest fraction of non-
viral vectors that are under clinical trials. The main problem with liposomes is 
clearance from the blood stream, which has been shown to be decreased by the 
modification of targeting ligands(15-16), but disadvantages in preparation and 
storage still limit their development. Polymeric vectors provide researchers 
numerous possibilities to design the desired multifunctional structures. 
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Cationic polymers are a family of polymer-based non-viral vectors that are most 
widely studied. Electrostatic interactions make it possible to form a DNA-polycation 
complex, which is termed a polyplex. Polymers frequently used for DNA 
encapsulation and delivery include polyethyleneimine (PEI)(17-19), poly-L-lysine 
(PLL)(20) and dendritic PLL(21-23), arginine or guanidine-rich proteins(24-25), 
synthetic peptides(26), polyamidoamine (PAMAM) dendrimers(27), chitosan(28-30) 
and their various derivatives. These amine-carrying cationic polymers are all able to 
condense DNA efficiently and protect it from enzyme degradation, which is a 
prerequisite but does not necessarily guarantee successful gene delivery. This is 
because gene delivery is a process involving multiple steps that could individually or 
cooperatively limit the ultimate transfection efficiency depending on different cell 
types and vector systems. In general, polyplexes need to undergo extracellular 
delivery, attach to the surface of target cell, be internalized and entrapped in 
endosomes, escape from endosomes, move through the cytoplasm toward the 
nucleus and get across the nuclear membrane for possible gene expression. Based 
on increasingly understanding the mechanism of gene delivery, multifunctional 
vectors could be designed to overcome rate-limiting barriers and achieve desired 
transfection with high selectivity and low toxicity.  
We synthesized a family of self-assembling pentablock copolymers via atom 
transfer radical polymerication (ATRP) reaction(31), which exhibit temperature- and 
pH- induced micellization and gelation. The central triblock is commercially available 
Pluronic F127 whose amphiphilic nature make it form micelles in aqueous solution 
above critical micelle concentration (CMC)(32). This micellar structure has been 
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shown to promote cellular entry(33). The cationic end-blocks poly(diethylaminoethyl 
methacrylate) (PDEAEM) are the essential functioning segments to condense DNA 
and provide pH buffering in the endosome with their protonable tertiary amine 
groups(34). The pentablock copolymers retain the thermo-sensitivity of Pluronic and 
the pH sensitivity of PDEAEM, meanwhile obtaining enhanced mechanical 
properties(35). The stronger gel is favorable for in vivo sustained release because it 
can resist the current in tissue fluid or blood stream and keep a steady release 
profile. These self-assembled injectable hydrogels have clinical advantages over 
other chemically cross-linked hydrogels(36) that involve harsh crosslinking 
environments, or scaffolds(37) that need to be surgically implanted. Moreover, in 
order to improve the stability and reduce the cytotoxicity caused by excess positive 
charges on the surface of polyplexes, free Pluronic was added to shield these 
charges by hydrophobic interaction between polypropylene oxide (PPO) blocks(38). 
Taken together, this novel vector can be injected into tumors or tissues as sol and 
transform to gel under body temperature and release DNA drug in a sustained way. 
The previous work has proved the biocompatibility and effectiveness of this 
pentablock copolymer for in vitro gene delivery. Preliminary results were also 
obtained for sustained release and in vivo transfection.  
1.2  Objectives  
The overall objective of this research was to explore the mechanism of the 
pentablock copolymer mediated gene delivery and develop a multifunctional vector 
system that can not only selectively transfect cancer cells, but also provide a long 
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term gene expression by sustained release.   
1.3  Dissertation Organization 
In Chapter 3, the pentablock copolymer vector was investigated for its 
transfection efficacy in different cell types. A selective transfection in cancerous cells 
over non-cancerous cells was found. Intracellular trafficking was undertaken to 
understand this selective transfection, which implied that different barriers to 
transfection in specific cells might be a possible reason.   
Chapter 4 and Chapter 5 continued investigation into the mechanism of the 
selectivity observed with pentablock copolymer vectors by examining each possible 
barrier to transfection in cancer and non-cancer cell types. Epidermal growth factor 
(EGF), nuclear localization signals (NLS) and chloroquine (CLQ) were either 
conjugated to or mixed with the vector to examine their influence on transfection 
through overcoming the corresponding barrier.   
Chapter 6 focused on investigating the effect of CLQ on polyplex dissociation by 
using water soluble quantum dots. Because CLQ was found to have restored the 
difference in gene expression between cancer and non-cancer cells, study on its role 
in gene delivery is of great importance. This part of research was a collaboration 
with Dr. Aaron Clapp in the department of chemical and biological engineering at 
ISU. 
Chapter 7 presented a new application of the vector in co-delivery of gene and 
drug. Sustained release in vitro was also investigated with an improved experimental 
set-up to mimic the situation in vivo.  
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CHAPTER 2.   LITERATURE REVIEW 
 
Remarkable progress has been achieved in polymeric gene delivery within the 
last fifty years. Aiming at the transfection efficiency of viral vectors while maintaining 
non-toxicity, researchers have come up with a large number of systems either 
derived from the “classical” cationic polymers, such as polyethyleneimine (PEI), 
poly(L-lysine) (PLL),  polyamidoamine (PAMAM), poly (2-(dimethylamino)ethyl 
methacrylate) (PDMAEMA) and chitosan, or developed out of novel architectures 
such as the synthetic peptides. Multifunctionality becomes an increasingly 
recognized requirement for current polymeric vectors owning to the complicated 
nature of the gene delivery mechanism. In fact, it is pertinent to first understand the 
biological barriers encountered by transgene vectors before considering various 
carriers in detail.  In this chapter, principle barriers (extracellular and intracellular) to 
polymeric gene delivery will be reviewed and possible strategies to overcome these 
obstacles will be discussed thereafter. 
2.1  Principal Barriers to Polymeric Gene Delivery Systems 
Upon complexation of DNA and cationic polymers (polycation) via electrostatic 
interactions, the formulated polyplexes are administrated to the tissues or cells of 
interest. Unless administrated locally, polyplexes need to traverse the whole 
extracellular route and reach the target cells (Fig. 2.1). Once the attached polyplexes 
get internalized via endocytosis, they are first sequestered in an acidic vesicle 
termed endosome, which begins the intracellular delivery.  Endosomes tend to fuse 
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with lysosomes where various enzymes could degrade the DNA payload and bring 
an end to the delivery.  Thus, it is required for polyplexes to escape endosomal 
compartments to continue the route towards nucleus. Although several challenges 
exist in the crowded cytoplasm, the surviving DNA or/and well maintained polyplexes 
can enter the nucleus for gene expression. Detailed discussion about each barrier 
will be stated below with an emphasis on intracellular ones. 
2.1.1  Extracellular Barriers 
     Polycations condense DNA into tight polyplexes under salt-free or very low salt 
conditions 
 
     Fig. 2.1.   Schematic illustration of polymeric gene delivery in vitro 
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conditions to completely or partially block the access of nucleolytic enzymes(2). 
However, the electrostatic interactions between DNA and polycations will become 
weaker as the surrounding salt concentration increases and might consequently 
result in the unpacking of DNA from its carrier. When polyplexes travel to distant 
target sites of action, blood components such as serum proteins and blood cells 
could absorb on their surface either by ionic binding or hydrophobic interaction, 
which leads to increase in particle size and formation of large aggregates(3-6). 
Rapid clearance will then occur by phagocytic cells and reticulo-endothelial system 
(RES)(7). In particular, when polyplexes were intramuscularly injected, they were 
most likely be trapped in the negatively charged extracellular matrix and unable to 
transfer further to tissues of interest(8).  
The biological environment is far more complicated than in vitro conditions. Many 
properties of vectors, such as size, zeta potential, colloidal stability and protection for 
DNA depend on the local environment.  The optimization of vectors in serum-free 
conditions may not be as effective as expected, because certain biophysical 
characteristics of vectors exhibited in buffers probably tend to alter in vivo. For 
example, the positive charges are necessary for condensing DNA, associating cells 
and hence efficient transfection in vitro; however, these charges can cause a 
number of side effects with blood constituents and specialized organs during in vivo 
application(9-10), leading to quick clearance and short half-lives. Therefore, it is 
highly necessary to consider or mimic the practical situation when designing vectors 
and making in vitro transfection protocols.   
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2.1.2  Cellular Uptake  
       Even if the polyplexes can manage to evade the degradation by nuclease in 
plasma and the clearance by RES, they still face significant challenges from the cell. 
The first challenge is to associate with cell membrane and get entry in the cell.  
       Cell membrane carries negative charges due to the presence of negatively 
charged glycoproteins, proteoglycans and glycerophosphate(11-12). This enables 
polyplexes carrying positive charges to bind to the cell surface and then be 
internalized by endocytosis (refers to cellular uptake of macromolecules into 
membrane-bound vesicles derived by invagination and pinching-off of pieces of 
plasma membrane(13)). Endocytosis can be classified into two broad categories, 
phagocytosis or cell eating which is typically restricted to specialized mammalian 
cells, and pinocytosis or cell drinking which occurs in all cells(14). Depending on the 
membrane coat, the size of particle generated and intracellular fate of the 
internalized particle, pinocytosis mainly has three endocytic pathways: clathrin-
mediated endocytosis, caveolae-mediated endocytosis and macropinocytosis. 
Kinetically, endocytosis can also be divided into three modes: fluid-phase, 
adsorptive, and receptor-mediated endocytosis(15).  
The predominant entry pathway for polymeric gene delivery systems is clathrin-
mediated endocytosis (CME), which is also the most extensively studied form of 
endocytosis.  Briefly, transmembrane receptors and their bound ligands are 
assembled by cytosolic coat proteins (e.g. clathrin) into clathrin coated membrane 
pits. These pits invaginate and pinch-off from the membrane to form clathrin-coated 
vesicles that carry the encapsulated receptor-ligands into cells(16). The efficiency of 
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receptor-mediated endocytosis correlates with both the affinity of the ligand-receptor 
interaction and the concentration of these complexes in clathrin-coated pits. 
Following internalization, the clathrin coat is rapidly depolymerized, which allows 
endocytic vesicles to fuse with each other to form early endosomes(17). From there, 
endosomal contents are sorted to appropriate intracellular destinations. Fusing with 
lysosomes is the fate for most polyplexes failing to escape endosomes, which leads 
to enzymatic degradation of DNA payloads and no more access to their target sites.  
By contrast, the internalization through caveolae-mediated endocytosis is believed to 
use the non-digestive route(18-19). Caveolae-mediated endocytosis, also termed 
potocytosis, is a mechanism by which both small and large molecules can be 
transported into cells(20-21). Caveolae are hydrophobic, caveolin-coated membrane 
microdomains, usually appearing as flask-shaped invaginations of the plasma 
membrane. They are now known to be present on most cells(22), but especially 
abundant in skeletal muscle cells, adipocytes and endothelial cells in which they 
were first described(23). Caveolae are suggested to mediate the extracellular 
shuttling of serum proteins from the bloodstream into tissues(14). Besides, it has 
been reported that caveolae play a role in the uptake of PLL/DNA complexes(19). 
Actually, the endocytic pathways for entry of polyplexes are cell type(24)and 
intruding particle dependent (25-26). For example, in one study, small particles 
(<200 nm) were found to be internalized via clathrin-mediated endocytosis, whereas 
large particles (>500 nm) gain cellular entry via caveolae-mediated endocytosis(27). 
But it was recently discovered that small polymeric particles (< 25 nm) but not larger 
particles (> 42 nm) enter live cells via a novel mechanism that results in trafficking 
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outside of the endo/lysosomal pathway(28). Since polyplexes becoming ineffective 
with DNA degradation in lysosomes is a crucial obstacle for inefficient transfection, 
caveolar uptake that avoids lysosomal degradation holds the promise for entry of 
polymeric gene-delivery vectors (13, 19), especially in endothelial cells in which 
caveolae constitute 10 to 20% of the cell surface(14).  
Macropinocytosis is another pathway allowing avoidance of lysosomal 
degradation. It also has the potential to mediate the uptake of cationic carriers 
because of its ability to engulf large molecules such as bacteria (29). The vesicle 
formed is called macropinosome whose membrane components are recycled back 
to plasma membrane(30). The dynamic structure and leaky nature of 
macropinosomes enables encapsulated particles to escape readily, which together 
with the advantage in non-digestive route make macropinocytosis gain increasing 
attention as a potential mode of cellular uptake for gene vectors. It has been 
demonstrated that the uptake of large TAT-fusion proteins occurs via 
macropinocytosis(31). 
No matter what kind of endocytic pathway is employed, polyplexes need to be 
efficiently and specifically internalized into tissues or cells of interest.  To improve 
the internalization efficiency, especially to endow the vector system with impactful 
targeting ability seems to be the major task concerning cellular uptake, which, 
however,  should be based on further understanding of the mechanism and 
influencing factors involved in this process. Recently, the uptake process of PEI-
based polyplexes has been reported to contain three phases according to their 
movement characteristics(32). Phase I was characterized by very slow cytoskeleton-
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mediated movement, phase II showed polyplexes of increased velocity with normal 
and confined diffusion in the cytoplasm, phase III was characterized by fast active 
transport within the endocytic vesicles along the microtubules with motor proteins.    
2.1.3  Endosomal Escape  
Unless polyplexes take the non-digestive route to enter cells(12), they will be 
completely or partially entrapped in the first endocytic vesicle, early endosome. The 
early endosomes are formed with close proximity to the plasma membrane and then 
depending on the physiochemical properties of internalized materials(33-34), either 
fuse with sorting endosomes to recycle the encapsulated content back to cell 
membrane and out of the cell by exocytosis, or develop into late endosomes which 
are located further away from cell membrane. The late endosomes primarily function 
to transport internalized materials to the lysosomes probably along microtubules(32, 
35). Although endosomes show some cell dependent characteristics(36-39), the 
typical pH of early endosome ranges between 5.5-7.0 and late endosomal pH drops 
to 5.0-5.5, while lysosomal pH further goes down to 4.0-5.0. Polyplexes that have 
been sequestered in lysosomes usually suffer a loss in DNA activity due to the 
richness of various acidic hydrolases. This enzymatic degradation of DNA is 
considered to be a major intracellular barrier that dramatically compromises the 
transfection efficiency(40).  Even though a portion of DNA can fortunately be kept 
away from vesicular degradation, this only results in accumulation of transgenes in 
the vesicles and limits their further transport to the nucleus. Thus degradation and 
entrapment in endo/lysosomes can be regarded as two separate barriers(13). When 
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DNA was directly delivered into the cytosol by microinjection or osmotic shock (41), 
gene expression was found to be much higher than obtained using the co-culture 
method probably due to successfully overcoming the barriers associated with 
endo/lysosomes.  
2.1.4  Cytoplasmic Delivery 
Polyplexes that have managed to escaped from endo/lysosomes need to 
undergo cytoplamic trafficking towards the nucleus. The cytoplasm is composed of 
cytoskeletal elements, a variety of subcellular organelles, large molecules, and small 
organic and inorganic solutes. The cytoskeleton, constructed by three classes of 
filaments, actin filaments, microtubules and intermediate filaments, not only gives 
the cell its shape, but also regulated the cytoplasmic transport of organelles and 
large complexes. Although the solvent viscosity of cytoplasm is comparable to that 
of water(42-43), cytoplasmic vesicles or microinjected beads diffuse in the cytoplasm 
500 to 1000 times slower than in aqueous solutions(44-45). The cytoplasmic 
movement becomes even more limited for proteins, because of potential interactions 
with intracellular components(46). Therefore, the cytoplasm constitute a major 
diffusional barrier for polyplexes or plasmid DNA to accomplish nuclear 
localization(47).  
The endocytic route can transport polyplexes along microtubules for a little while 
before releasing them into the cytoplasm(32, 35). This indeed provides some help. 
However, polyplexes still need travel through the rest of route in the cytoplasm and 
gain their entry into the nucleus. Because of the large of number of available salts 
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and proteins including enzymes in the cytoplasm, polyplexes get involved again in 
threats of dissociation and attacks from nucleases (48) as they met during the 
transport in biological fluids. But the polyplexes may become more susceptible at 
this moment after experiencing several hostile situations. Thus, polyplex unpacking 
could occur due to the interaction with other competing particles, such as spermine 
and spermidine at concentrations  in the millimolar range (49).  In that case, the DNA 
payload loses the protection of polymeric carriers and is subjected to degradation by 
nucleases. It has been reported that the plasmid DNA microinjected into the 
cytoplasm undergoes rapid degradation with half-life of less than 90min(48). In 
another study, more than three orders of magnitude higher plasmid DNA needed to 
be injected into the cytoplasm to give the same level of expression as when it was 
microinjected in the nucleus(50). But the reasons for this finding may also involve 
the barrier associated with nuclear entry and not the cytoplasmic entrapment. Dowty 
et al. reported that microinjection of plasmid DNA into the proximity of the nucleus 
resulted in significant enhancement of the transfection efficiency compared to the 
microinjection far (60-90 μm) from the nucleus(51). This indicates the trafficking of 
plasmid DNA toward the nucleus is indeed hindered in cytoplasm and affects the 
overall gene transfer. The metabolic instability(48) and negligible mobility (for 
sequences larger than 2000 bp(52))(51) of plasmid DNA mainly account for its loss 
or sequestration in the cytoplasm. Thus, the diffusion of DNA in cytoplasm might be 
an important rate-limiting barrier in non-viral gene delivery(52). 
For the polyplexes not experiencing dissociation to release DNA payload into 
cytoplasm, they will continue transport to the nucleus. In this case, DNA can be 
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effectively protected against degradation and saved for later gene expression. But 
the diffusion difficulty still applies to cytoplasmic trafficking of polyplexes. In general, 
the larger the polyplexes are, the slower the mobility. However, there may exist other 
mechanisms for the transport of polyplexes in the cytoplasm in addition to passive 
diffusion. It has been reported by Suh and co-workers that PEI/DNA nanocomplexes 
displayed efficient perinuclear accumulation within minutes, which was proposed to 
be mediated by motor protein-driven transport on microtubules(53). But they did not 
examine whether the polyplexes were localized in endosomes or cytoplasm. Further 
research must be done to understand the machinery underlying this proposed active 
transport. 
2.1.5   Nuclear Localization 
Unlike drug delivery in which the cytoplasm is the desired destination for 
therapeutic drugs, gene delivery requires the gene of interest to be delivered into the 
nucleus, transcribed into mRNA, and subsequently translated into the desired 
proteins.  Nuclear import, the final barrier known to limit gene expression(51, 54-55), 
includes two basic mechanisms: through nuclear pores or by sequestration on 
nuclear membrane breakdown during mitosis(56). The transport of polyplexes or 
DNA from the cytoplasm into the nucleus is limited by the presence of the nucleus 
envelope, which consists of two lipid layers, the outer membrane is continuous with 
the endoplasmic reticulum, and the inner membrane is the main residence of integral 
membrane proteins. Nuclear pore complex (NPC) span the nuclear envelope, which 
allow passive diffusion of small molecules (up to 9nm in diameter, or 50kDa) or 
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active transport of larger molecules (up to 26-28nm or 1MDa)(57-58). Active 
transport is mediated by the nuclear localization signal (NLS) in an energy 
dependent manner. Classical NLS sequences are characterized by a stretch of basic 
amino acids. SV40 NLS, the monopartite NLS derived from simian virus (SV) 40 
large T-antigen, is the most extensively studied NLS with one cluster of basic amino 
acids(59-62). Bipartite NLS, found within the Xenopus protein known as 
nucleoplasmin, contains two clusters of basic amino acid regions separated by a 10-
12 residues(63). The cargo containing the classical NLS binds to importin-α adapter, 
which in turn binds to importin-β to form a complex. The complex then mediates the 
interaction with NPC for an active nuclear import(22).The nonclassical NLS lacks the 
stretch of amino acid and binds to transportin instead of importin-β(64). Due to the 
dynamic nature of NPC, its conformation could undergo considerable changes in 
response to specific signals. For example, during passive transport, the NPC 
channel has a cross section of 9 nm, while this channel increases up to 25 nm 
during active translocation(46); in some cases the channel can be further dilated 
(e.g. up to 60nm) by some specific interaction(65). This conformational change of 
the NPC make it possible to permit active translocation of molecules as large as 25-
50MDa(46).  
The molecular weight cut-off for passive diffusion of linear double stranded DNA 
was reported to be between 200-310bp(66), or around 600bp, as observed 
elsewhere(67). The plasmid DNA usually has several kilobase pairs, which make it 
extremely difficult to enter the nucleus by passive diffusion(46). However, the 
plasmid DNA can make its way to the nucleus by active translocation after binding to 
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NLS containing proteins present in the cytoplasm, for example, the plasmid DNA 
was found to enter the nucleus by a process mediated by the nuclear targeting 
signal included in karyophilic proteins(51). It has been suggested that the molecular 
diameter is important for the entry to the nucleus through NPC, but there is no 
limitation on the length of the molecule(68). The plasmid DNA is very flexible in 
shape with a diameter ranging from 3.5 to 14nm(69), and is thus capable of being 
transported though the NPC. The polyplexes, however, usually have a spherical 
shape with the diameter up to several hundreds of nanometers, and are unlikely to 
undergo the nuclear uptake though NPC, though the fairly small polyplexes could 
still achieve access to nucleus in this manner(70).  
The primary mechanism for nuclear transport of polyplexes lies in the disruption 
of nuclear envelope during mitotic phase in dividing cells. Once the only barrier 
separating the cytoplasm and nucleus disappears, polyplexes in the proximity of the 
nucleus can go straight inside by diffusion.  As a result, the proliferation rate plays a 
significant role in gene transfer due to the high dependence of nuclear uptake on 
mitosis(71-73). Rapidly dividing cells with frequent nuclear envelope breakdown are 
much more likely to be transfected than non-dividing cells. There may also exist 
other mechanisms for nuclear uptake of polyplexes or DNA. Godbey and coworkers 
reported that PEI/DNA polyplexes could enter the nucleus via fusion with the nuclear 
envelope(74). They suggested the polyplexes could come into contact with 
phospholipids during endosomal disruption or cytoplasmic trafficking, and the 
phospholipids might remain adhered to the polyplexes by ionic interactions and 
facilitate the nuclear import. But a later study showed that the nuclear entry of 
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PEI/DNA polyplexes into L929 cells did not involve phospholipid fusion, since no 
signal of endosomal membrane was observed in the nucleus; instead, membrane 
disruption seemed necessary for nuclear entry which was suggested to depend on 
the cell type(72). Contrasting studies proposed that cell division is not required for 
some PEI-based polyplexes for they could transfect non-dividing cells(50, 75). More 
efforts are still needed to fully understand the mechanism of nuclear transport of 
polyplexes. As the final obstacle for gene delivery, the nuclear envelope can prevent 
a large portion of cytoplasmic polyplexes and/or plasmid DNA from entering the 
nucleus for carrying out gene expression(50).  
2.1.6   Vector Unpacking 
For DNA transcription to occur, the polymer/DNA polyplexes must dissociate 
and release the intact DNA somewhere along the route. The order of nuclear import 
and vector unpacking is still unclear. It has been reported that PEI/DNA polyplexes 
were found in the nucleus as associated condensates(74). In another study, the 
cytoplasmic release of pDNA from polyplexes composing different polycations was 
analyzed by fluorescence resonance energy transfer (FRET) with confocal 
microscopy. Linear (L) PEI/DNA polyplexes underwent a rapid unpacking after 
escaping from endosomes, while branched (B) PEI/DNA polyplexes retained in a 
condensed state. These intracellular characteristics showed a clear correlation to the 
transfection efficiency with LPEI/DNA polyplexes revealing considerably higher and 
faster gene expression compared to BPEI/DNA polyplexes. In the pDNA/PLL 
polyplexes, neither endosomal escape nor pDNA disassembly was observed(76). 
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The degree of polymerization was suggested to play an important role in the 
dissociation of polyplexes by examining the transfection efficacy of PLL with various 
lengths. Above an optimal length, overall transfection decreases as PLL length 
increases, indicating shorter polycations have a higher probability of dissociating 
from DNA(77). Following the same line, 25 kDa PEl is known to lead to higher 
transfection efficacy than that obtained with higher molecular weight of PEI(78). 
However, the polycations should have enough protonable moieties to effectively 
condense DNA and provide desired protection. Thus there is certain lower limit for 
the molecular weight of each type of polycation in gene delivery. For example, PEl 
and poly(β-amino esters) with molecular weights below 10 kDa exhibited poor 
performance as compared to higher molecular weight versions(79). Early 
disassembly and release of DNA from the vector into the cytoplasm may suffer 
severe loss of DNA by cytoplasmic sequestration or degradation. The disassembly 
occurring in perinuclear region, or inside of the nucleus would be desirable for 
efficient gene delivery and expression(50). 
2.2  Strategies to Improve Extracellular and Intracellular Trafficking 
Once polymer-DNA polyplexes form, they need to reach the site of action safely 
by overcoming many extracellular barriers, and eventually need to enter the nuclei of 
interested cells for desired gene expression by addressing all intracellular obstacles 
along the route. Strategies that have been developed for fighting against the 
limitations in polymeric gene delivery will be reviewed.   
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2.2.1  Hydrophilic Modification by PEG 
Positive charges are necessary for polymers to condense DNA and associate 
with cell membrane. However, these charges may lead to unwanted interactions with 
blood components, fast clearance and cytotoxicity(80). Improving the stability of 
polyplexes in biological environment and prolonging their circulation time represent 
the main challenges for extracellular delivery. PEG is a linear polymer that can be 
fully hydrated in aqueous solution. Once conjugated to cationic polymers, the highly 
mobile and hydrated PEG chains can form a protective layer to inhibit the interaction 
from approaching particles. PEG is nontoxic and poorly immunogenic and has been 
approved by the food and drug administration (FDA) for topical and internal use in 
human. Gene delivery vesicles with PEG blocks on their surfaces can circumvent 
the adsorption of serum proteins, thus lowering the recognition by RES and keeping 
them active in blood circulation for longer period of time(81). The prolonged 
circulation time enables them to diffuse into malignant tissues by enhanced 
permeability and retention (EPR) effect(82-83). PEGylation or pegnology originated 
in the 1960s and has been extensively applied to cationic polymer-based transgene 
systems, such as PEI(84-85), PLL(86-89), PAMAM(90), Chitosan(91), PDMAEM(92-
94), primarily to enhance the stability and biocompatibility of polyplexes by shielding 
the excess positive charges. Most of this PEGylation is achieved by covalent 
coupling (grafting or blocking) to the target polymers (prePEGylation), which could in 
turn change the biophysical properties of that polymer or the corresponding polyplex. 
For example, it has been reported that PEG interfered with DNA condensation 
process and resulted in more linear structured DNA condensates with PEGylated 
24 
 
PAMAM relative to the case of PAMAM(95). Furthermore, as the degree of 
PEGylation increases, the overall gene delivery efficiency tends to decrease as 
observed in PEI-based vectors, which might be due to the change in PEI ability of 
condensing DNA and buffering in endosomes(96-97). Similar results were reported 
for PEO modified polymeric systems(88, 98). The molecular weight of PEG might 
also cast some influence on the transfection efficiency(99). In order to minimize the 
negative influences of PEG on the conjugated polymers especially in term of DNA 
condensation, PEG has been be alternatively introduced to the vector after polyplex 
formation, that is postPEGylation or PEGylated polyplexes(3, 100-102). This 
strategy has been shown to provide higher shielding effect and longer circulation 
time relative to prePEGylation in two subcutaneous tumor models(103). The major 
drawback of postPEGylation lies in the additional sequential step of synthesis and 
purification which is inconvenient and time-consuming; furthermore, the degree of 
surface PEGylation is not well defined(96).  
Aside from PEG (or PEO), Pluronics (triblock copolymer of PEO-PPO-PEO) are 
another attractive and safe alternative to improve the stability of polyplexes in 
biological conditions(104). Pluronics could be included in the gene carrier system via 
chemical reactions as those used for PEGylation; moreover, because of its 
hydrophobic PPO moiety, Pluronic forms micellar structures in aqueous solution 
which can then be bound to other hydrophobic segments by self-assembly(105). 
Also, Pluronics have been reported to be able to improve gene expression in 
different delivery routes(106-107). For example, Pluronic P123 has been shown to 
perform better than PEO with addition of free Pluronic 123 on PEI based gene 
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delivery(98). In addition to shielding the positively charged surfaces of polycation 
based vectors, nano-particles with overall neutral or even negative charge may also 
be desirable to prevent unwanted serum interactions due to charge-charge 
repulsion(10, 108-109).  
2.2.2  Receptor Mediated Endocytosis 
After successful extracellular delivery out of the blood into several organs, 
polyplexes mainly accumulate in the liver or lung(110). Selective association with 
and entrance into the desired tissues or cells are required and considered to be 
essential for later intracellular delivery and final gene expression. This process is 
usually achieved by modification of transgene vectors with specific targeting ligands 
that can recognize the corresponding receptors expressed on cell surfaces and 
promote cellular uptake via receptor-mediated endocytosis through the clathrin-
coated pits. For targeted gene delivery, both transfection efficiency and selectivity 
are expected to improve due to the increased internalization of polyplexes. 
Construction of a targeting gene vector begins with selection of appropriate ligands 
for specific cell types. First of all, the ligand should bind with high affinity to the 
receptors expressed on the target cells; second of all, the ligand should be able to 
be coupled to the vector conveniently; Finally, modification with the ligand should not 
negatively affect the original properties of the vector, such as the particle size, 
interaction between polymer and DNA, stability of polyplexes in serum, and other 
special functionalities induced by different polymers.  
Ligands that have been identified to be effective for targeted gene delivery 
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include: asialoglycoproteins(111-113), lactose(5) and galactose(114), which 
specifically bind to hepatocytes; transferrin (Tf)(96, 115-116), epidermal growth 
factor (EGF)(32, 117) and folate(102, 118), which are usually used for targeting 
tumor cells,  mannose specifically associating with macrophages(119); RGD 
peptides for integrin-mediated targeted delivery, and so forth.  Large ligands, such 
as Tf and EGF, could bring certain changes (e.g. the steric hindrance) to the vector 
system and need to be characterized carefully, whereas smaller ligands, such as 
lactose, galactose, mannose, folate, and short RGD sequences, would be relatively 
less complicated in use. Some ligands are very specific to certain cell types, such as 
asialoglycoproteins, whereas others are not, such as Tf and EGF, because of the 
universal expression of these kinds of receptors on cell surface, yet tumors over-
express them compared to normal cells. Ligands also differ in the internalization rate 
and other biophysical properties that should be considered when choosing them for 
targeted gene delivery.   
In general, the targeting ligands only provide targeting or enhanced uptake by 
receptor-mediated endocytosis, but they do not help in DNA packaging or particle 
stabilization. Thus, they need to be incorporated to a gene transfer system that has 
already been tested for the required properties to delivery gene and optimized for 
transfection conditions. Regarding the approach of ligand conjugation, there are 
different strategies in terms of the binding sites.  The targeting ligands can be 
directly conjugated to the polymer that is responsible for condensing DNA. 
Galactosylated PEI (5% galactose) has been reported to efficiently neutralize DNA 
and selectively transfect the hepatocytes compared to fibroblasts(120), but the large 
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size of these polyplexes limited their use in vivo, so the length of the saccharide was 
tuned to produce relatively small and stable particles(121). However, the tendency of 
cationic polyplexes to form aggregates in physiological conditions does not change 
by adjusting the size of attaching ligands. As it has been mentioned above, 
PEGylation can effectively stabilize polyplexes in serum containing environment. 
Using PEG as a spacer between targeting ligands and DNA binding domains can 
not only improve the aqueous solubility and serum stability, but also increase the 
accessibility of the targeting ligands on the surface of polyplexes for the ligands 
could be protruded outwards with PEG chains(97, 122-123).  By using PEG as a 
tether, a multifunctional transgene carrier could be constituted as a ligand-PEG-
polycation, in which cell specificity, steric stabilization and DNA affinity are 
integrated(124). For short ligands, highly mobile PEG chains may also shield the 
ligands and inhibit their functions as has been found in a study of conjugation of a 
tetrapeptide of RGDC to PEI with or without PEG spacer(125). Whereas a longer 
RGD peptide, ACDCRGDCFC, indeed rendered great specificity when incorporated 
to PEI gene delivery system with a PEG spacer(97). To further fulfill the accessibility 
and the efficiency of targeting ligands, conjugation of ligands could be carried out 
after the formation of polyplexes. Blessing and coworkers compared the different 
strategies of including EGF into PEI-based transgene vectors shielded by PEG, and 
found EGF binding at the distal end of the PEG showed one order of magnitude 
more efficient than direct attachment of EGF to PEI with post PEG shielding(126).  
Besides the position of ligand binding, the number of ligands in polyplexes also 
matters. Moreover, the properties of the polymers, the buffers used to make 
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polyplexes and other transfection facilitators may work cooperatively with the 
targeting ligands and should be considered when designing vectors for targeted 
gene delivery(77, 100, 117, 126-129).   
2.2.3  Endosomal Buffering   
Several strategies have been developed to ensure the protection and release of 
polyplexes from endocytic vesicles, which include co-administrating lysosomotropic 
agents to trigger membrane disruption, and incorporating polymeric components 
possessing great buffer capability or fusogenic peptides in vector constructs. 
2.2.3.1  Lysosomotropic Agents 
Lysosomotropic agents are weak bases, such as chloroquine, ammonium 
chloride and methylamine, that can accumulate in acidic compartments (e.g. 
endosomes and lysosomes), raise the lumen pH, lead to osmotic swelling and inhibit 
the biological functions of corresponding organelles(130), for example, inhibit the 
maturation of endosomes thus retards degradation of DNA by lysosomal enzymes. 
Chloroquine is the most frequently used enhancer for achieving better endosomal 
release and high level of gene expression. In the earlier days of polymeric gene 
delivery, chloroquine was routinely added to cells along with the transgene vectors 
to facilitate endosomal escape and achieve high level of gene expression(131-133). 
However, ammonium chloride, another compound known to inhibit the acidification 
of endocytotic vesicles, has been found to produce a lower increase in transfection 
efficiency compared to chloroquine(131, 134), though it has also been shown to lead 
to complete escape of nanoparticles from endo/lysosomes(135). Similar results were 
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reported for the contributing effects to transfection between CLQ and sucrose(136). 
It seems that chloroquine possesses some other feature that can affect transfection 
in a positive way. Cheng and coworkers synthesized a family of chloroquine 
analogues and concluded though a series of comparative studies that chloroquine 
has at least three mechanistic features to induce enhancement in gene expression: 
pH buffering, polyplex unpacking, and alteration of the biophysical properties of the 
released DNA(137). Moreover, they suggested that the essential part of chloroquine 
is the aliphatic amino moiety, but the aromatic ring also plays an important role. 
These findings are very helpful in the development of the ideal substitutes for 
chloroquine, because the use, especially in term of clinical application, of 
chloroquine is limited due to its toxic properties. In in vitro studies, chloroquine could 
still be used as a tool to investigate the mechanism of gene delivery for specific 
systems. What is worth mentioning is the effectiveness of chloroquine in enhancing 
gene transfer is also cell type specific(138-139). 
2.2.3.2  Buffering Polymers and Fusogenic Peptides  
An alternative approach to achieving endosomal release is osmotic endosomal 
disruption. Polymeric carriers that have protonable groups, such as secondary and 
tertiary amines, can buffer in acidic compartments and induce corresponding rupture 
under osmotic pressure, which is usually considered as the proton sponge effect. 
The “proton sponge hypothesis” was first proposed by Boussif et al. in testing PEI for 
its gene transfer potential in 1995(140). When PEI buffers the inner acidic 
endosome, a number of protons will be pumped into compartment via ATPase, and 
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counter-ions such as chloride will flow inside passively to neutralize the membrane 
potential, which together lead to an increase in the internal osmotic pressure and 
eventually the breakage of endosome (Fig. 2.2). This hypothesis has been 
evidenced by Sonawane et al. who reported that internalization of vectors containing 
strongly buffering polyamines PEI or polyamidoamine (PAMAM), compared to the 
vectors containing non-buffering PLL, further increased the endosomal Cl- 
concentration, 
lowered the acidification rate, swelled the endosome in size, and lead to the lysis of 
endosome(141).  Fluorescence imaging also showed the far better endosomal 
escape ability of PEI-containing polyplexes than PLL-containing ones(142). These 
studies highlighted the importance of biologically titratable amine groups in the 
vector constructs. PEI has a very high density of amines, but only 15-25% of which 
are protonated at physiological pH(143), making it an extraordinary proton sponge. 
Likewise, with large numbers of second and tertiary amines, PAMAM dendrimers are 
 
Fig. 2.2.  Schematic of the pronton-sponge mechanism. Protonation of the proton-sponge  
polymer (green) causes increased influx of protons (and counter-ions) into endocytic 
vesicels. Increasing osmotic pressure causes the vesicle to swell and rupture (1) 
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thought be another proton sponge type of polymers. In particular, the surface charge 
and buffering capability could be controlled by varying the number of generations in 
synthesis(144). This tunability makes it possible to design most effective vectors for 
specific applications(145). Poly (2-(dimethylamino)ethyl methacrylate) (PDMAEMA) 
also shows good endosomal escape indicating its potential as a proton sponge(92). 
Imidazole-containing polymers represent a new class of polymers that exhibit both 
required buffering capacity and great biocompability since imidazole is a component 
of histidine(146-147). But the pKa of imidazole ring is around 6(147), which indicates 
that histidines could only be protonated in an acidic environment. However, at 
biological pH, histidines or polyhistidines cannot be positively charged and are 
unable to form polyplexes with DNA, thereby requiring their grafting onto other 
cationic polymers.  
The high transfection efficiency among proton sponge polymers is believed to 
be due in large part to the efficient endosomal release from digestive endocytic 
pathways. However, for those polymers lacking the ability to escape endosomes, 
structure modification is applicable. It has been reported that PLL has minimal 
buffering capacity in the range of pH 5 to 7 relative to PEI and PAMAM dentrimers 
(148). Thereby, PLL-based vectors usually work with certain membrane disrupting 
agents(149) or consist of other polymers that have great buffering capacity to 
achieve better endosomal release.  Histidine has been incorporated into PLL in 
various strategies to provide an endosomal/lysosomal escape route without the 
addition of endosomolytic agents; histidylated polylysines (HpK) have been shown to 
be significantly more efficient and less toxic than unmodified PLL (89, 150-152). 
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Depending on the cell type, the optimal histidine conjugation was found to be 33-
50% of the amino groups in PLL(153). In another study, the transfection efficiency of 
HpK polymers was found to have a strong correlation with the pH of endocytic 
vesicles(154). PLL was also modified with PAMAM to form a head-tail type 
polycation and resulted in around 100-fold higher transfection efficiency relative to 
that for PLL polyplexes(155). Imidazole modified β-cyclodextrin(156) or 
chitosan(157-158), and PEI modified chitosan(159-160) are some other 
representative examples of polymeric carriers that are constructed with endosomal 
escaping functionality.   
Apart from including proton sponge polymers in the vector structures, fusogenic 
peptides, synthesized to mimic the process of membrane destabilization by viruses, 
were also used to enhance endosomal escape. These peptides destabilize 
membranes by increasing the negative curvature strain of the lipid bilayer or 
undergo change in formation to trigger endosomal membrane rupture (161). There 
are a good number of peptides that have been identified as fusogenic peptides(161-
163). For instance, HA2 (sequences from influenza virus hemagglutinin)(164-166), 
amphipathic peptide GALA(167-168) and a truncated HIV-1 Tat protein(169) function 
via conformational change following membrane fusion, whereas peptides HRVs 
derived from rhinovirus VP-1 (170) induce membrane destabilization by increasing 
the curvature of membrane. These functional peptides can be conjugated to 
polymers to increase the efficacy of gene transfer by facilitating endosomal release. 
Moore and coworkers incorporated fusogenic peptides, INF7 and H5WYG which 
function at different pHs, into PEG-peptide based carrier system, respectively. The 
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transfection efficiency was shown to gain great enhancements by coupling these 
peptides, but INF7 performed better than H5WYG in that study(171-172). Lee et al. 
also reported the effectiveness of attaching fusogenic peptide KALA to PEG-g-PLL 
vectors to improve gene transfer(87).  
2.2.4  Cytoplasmic Trafficking 
The loss of DNA and slow mobility are two main obstacles for the cytoplasmic 
transport of gene delivery vesicles. The naked DNA that is released into the 
cytoplasm after polyplex disassociation becomes far more susceptible to the attack 
from endogenous nucleases, but complexing with polymeric carriers can reduce this 
damage to DNA payload(48). Thus, the approaches to improve the stability of 
polyplexes can also help to decrease the loss and DNA in cytoplasm. Moreover, the 
cytoplasmic mobility of polyplexes is superior to that of DNA alone owning to the 
advantage of smaller size and probably the potential active transport mechanism via 
cytoskeletal networks. Although the applicability of this active transport of polyplexes 
was hyphothesized, it provides a new perspective to explore and address the barrier 
associated with cytoplasm, and needs to be paid attention to(173).   
2.2.5  Active Nuclear Localization  
Although the exogenous material can definitely achieve the nuclear import 
through the nuclear membrane embedded nuclear pore complex (NPC)(174), the 
hourglass-like NPC cannot allow large cargo to transit though passively(175). It was 
suggested that plasmid DNA does not have the ability to actively go across the 
nuclear envelope(22, 58), unless assisted by the particular nuclear localization 
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signal (NLS). Both the size limit and the intensity of DNA nuclear transport could be 
increased by the attachment of strong nuclear localization signals(66). Therefore, 
including an NLS in the plasmid DNA is considered as an applicable approach to 
improve nuclear transport, especially in non-dividing cells(176).  
One approach involves non-covalent association of NLS sequences to DNA via 
electrostatic interactions. Microinjection of SV40-derived NLS bound DNA into the 
cytosol of sebrafish embryo resulted in rapid nuclear uptake and enhanced gene 
expression(177-178). Through ionic interactions, the NLS peptide is bound to DNA 
to facilitate nuclear localization, and meanwhile it also packages DNA into small 
particles similar to what DNA condensing agents do. Nevertheless, only peptide 
sequences  with more than eight positively charged amino acids could efficiently 
condense DNA(133), and longer peptides provides better condensation. Ritter et al. 
developed a tetrametric NLS peptide consisting of four copies of the SV40 NLS with 
glycine residues as the spacers(179). This NLS construct was able to condense 
DNA into small polyplexes and improve both nuclear uptake and gene expression on 
several cell lines. The non-specific ionic interactions do not allow control of the DNA-
peptide binding sites, and thus might interfere with the transcription activity of the 
DNA. Sequence specific binding of NLS to DNA could be achieved by the specific 
interaction between DNA and peptide nucleic acid (PNA) consisting of certain NLS. 
In this manner, the NLS could be designed to bind the DNA in a region not involved 
in gene expression (180-181). Alternatively, DNA and NLS could be associated 
specifically though biotin-streptavidin interactions. The NLS-conjugated streptavidin 
was coupled to biotinylated linear DNA, resulting in enhanced nuclear transport in a 
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size dependent manner in permeabilized cells. Increased gene expression was 
observed after microinjection of this DNA-NLS conjugates into the cytoplasm of 
HeLa cells(182-183).    
In a construct of DNA-NLS associated by non-covalent binding, the NLS could 
be lost during the intracellular trafficking. To prevent this dissociation, various 
methods have been used to covalently attach NLS peptides to plasmid DNA. 
Covalent coupling of SV40 NLS peptides to plasmid DNA  by photoactivation has 
been shown to significantly increase the binding to importin-α, but no nuclear uptake 
was observed after cytoplasmic microinjection(184).  Similar results were reported 
for NLS-plasmid DNA conjugates covalently bonded by diazo-coupling through 
PEG(185).  These trials of non-specific association of NLS peptides to plasmid DNA 
bring about increase of binding to importins, but not of gene expression, which 
probably due to the inhibition of the reporter gene expression. Several approaches 
of sequence specific binding have been developed to address this problem.  A single 
NLS peptide was coupled to a specific site on plasmid DNA by triple helix formation 
and photoactivated psoralen binding(186). By this technique, multiple NLSs could be 
introduced in a site-specific manner. Nevertheless, in spite of the defined structure of 
DNA-NLS conjugate, there was no significant increase in gene expression over the 
non-modified plasmid(58). In another study, one SV40 derived NLS was coupled to 
linear DNA at the 3' end capped with hairpin. 10- to 1000-fold increase in gene 
expression was observed relative to unmodified DNA(187).  However, with the same 
method or just coupling NLS to the 5' end rather than 3' end of the linear DNA, no 
increase in gene expression was observed in the cell lines studied(188-189). The 
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discrepancy between these results indicates that the effectiveness of NLS 
incorporation in gene delivery depends on different experimental setups and cell 
types(190). The number of NLS coupled to DNA might also be an influencing factor, 
yet the results are controversial regarding how the number of NLS affects the gene 
expression. As shown above, one single NLS linked to a linear DNA lead to 
significant enhancement in the gene expression(187), while others reported an 
active transport with around 100 NLS per plasmid DNA(183). Contrasting results 
suggested large number of NLS could inhibit the gene expression(184). Currently, 
no definitive conclusion could be drawn in regard to the optimal number of NLS for 
efficient gene expression.   
Besides adding NLS peptides to plasmid DNA, the NLS can also be attached to 
the DNA condensing components. In one study, the polyplexes containing NLS 
coupled PLL showed about 50-60% increase in the transfection efficiency compared 
to PLL without NLS, which could be attributed to the enhanced binding to importins, 
because PLL itself cannot do(191-192). Melittin, a component of bee sting venom, 
has been covalently attached to PEI to enhance the nuclear transport. Microinjection 
of melittin-PEI/DNA into the cytoplasm in HeLa cells resulted in 4-fold increase in 
gene expression over PEI/DNA polyplexes alone. This activity was abolished after 
co-injection with wheat germ agglutinin (WGA), indicating the involvement of NPC in 
the nuclear important of melittin containing polyplexes(193-194). Although inclusion 
of NLS in the vector could facilitate its nuclear transit though the NPC whose size 
limit which can be dilated up to 60nm, the polyplexes sized around 150nm are still 
excluded (195). Thus even with NLS, most of polyplexes are still too large to be 
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imported into the nucleus(55). Furthermore, the current literature is unclear on the 
efficacy of adding NLS to gene delivery vesicles with some researchers 
demonstrating enhanced gene expression and others showing little to no 
improvement. Further study is required to ascertain which type and extent of NLS 
signal incorporation is the most effective.  
2.2.6  Improve Vector Unpacking 
The vector packing and unpacking seems to be a dilemma in gene delivery.  For 
the earlier route towards the target cells, DNA needs to be effectively condensed 
and remain undamaged; following the internalization and endocytic transport, DNA 
still needs the protection of polymeric carriers in an enzyme rich environment; even 
during the later cytoplasmic transport towards nucleus, DNA can hardly avoid the 
fate of being inactivated by nucleases unless it stays complexed with its carrier. But 
upon getting into the nucleus, DNA must be unpacked from the carrier to enable 
transcription.  Efficient disassociation of polyplexes could be facilitated using 
degradable polymers. Low molecular weight polymers or oligomers can be 
crosslinked via disulfide bonds to develop thiol-triggered degradable polymers which 
can condense DNA in the extracellular environment and release DNA upon the 
intracellular balance of thiols and disulfide bonds(149, 196-199). With the 
characteristics of degradability, poly(Cys-Lys10-Cys)  showed better transfection 
efficiency than PLL alone(149, 198). Although the degradable carriers could release 
DNA intracellularly more readily, it is impossible to control the degradation site. Too 
much DNA released into the cytoplasm can result in considerable DNA loss. To 
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better control the intracellular unpacking of polymer/DNA polyplexes, thermo-
responsive polymeric carriers have been developed to condense and release DNA 
in response to the temperature change(200-203). At higher temperatures such as 
37ºC, the thermo-responsive polymeric carriers can compact DNA tightly and deliver 
it into the target cells safely; whereas as the temperature decreases below the 
transition temperature, the polyplex will become loosely bound and even 
dissociated. Thus, by applying appropriate stimuli, the DNA could be released site- 
and timing-specifically. Significant increase in the transfection efficiency was 
observed by introducing a short cooling period during the process of post-
transfection as compared to the process with constant temperature at 37ºC. 
Furthermore, cooling the cells in 20h of transfection resulted in much higher level of 
gene expression than cooling them immediately after transfection, indicating it is 
more favorable to release DNA in the later intracellular stage which is probably 
closer to the nucleus(200, 202).   
2.3  Concluding Remarks 
The use of functional polymeric carriers is the strategy to overcome the 
extracellular and intracellular barriers in gene delivery. However, mono- or 
bifunctional polyplexes are not enough to address the multiple barriers present for 
most gene delivery systems. The ideal polymeric carriers should incorporate 
multifunctional components to address the rate limiting barriers with minimal 
interference between one functionality and another. For different vectors and cell 
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types, the rate limiting steps may vary and thus need to be examined before 
incorporating any additional functional component. 
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CHAPTER 3.   NOVEL PENTABLOCK COPOLYMERS FOR 
SELECTIVE GENE DELIVERY TO CANCER CELLS 
 
Modified from a paper published in Pharmaceutical Research, 2009, 26: 700-713 
Bingqi Zhang, Mathumai Kanapathipillai and Surya Mallapragada 
Abstract 
The ideal transgene vectors for cancer therapy are expected to show no or low 
transfection efficiencies in normal cells but high transfection efficiency in carcinoma 
cells. In this study, the novel poly(diethylamino ethylmethacrylate)(PDEAEM) 
/Pluronic F127 pentablock copolymers were found to be able to mediate 
high-efficiency transfection of human cancerous SKOV3 and HT1080 cell lines while 
showing significantly lower efficacy in non-cancerous ARPE-19 and 3T3 cell lines. 
This is in contrast to the uniformly high transfection seen in all the cell lines using 
ExGen, a commonly used polymeric vector. The intracellular routes of polyplexes 
were investigated by confocal microscopy in SKOV3 and ARPE-19 cell lines after 
appropriately labeling the polymer and DNA. It was found that many polyplexes 
translocated into nuclei within 3h of transfection in SKOV3 cells, yet only few 
polyplexes were observed in the nuclei of APRE-19 cells. This difference in the 
number of polyplexes in the nuclei was also observed in the cells at 10h and 24h 
post-transfection, indicating that lesser nuclear entry in the ARPE-19 cells may result 
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in the lower efficiency of transfection. Since the SKOV3 proliferation rate was found 
to be much higher than that of the ARPE-19 cells, the nuclear entry of polyplexes was 
assumed to be correlated with the proliferation rate, and it was hypothesized that the 
novel pentablock copolymers could mediate gene delivery selectively in fast growing 
cells. Furthermore, in APRE-19 cells, free DNA showed a weak signal or was 
localized around the cell membrane area, which implied that the uncomplexed DNA 
may have been degraded or exported out of the cell via exocytosis. Thus the different 
intracellular barriers to gene transfer may also account for the observed difference of 
transfection efficacy. In co-cultures of HT1080 and ARPE-19 cell lines, the selectivity 
of GFP transfection in HT1080 versus the ARPE-19 cells was around 21 and 1 for the 
transfection mediated by pentablock copolymers and ExGen, respectively. Although 
the validity of the hypothesis that our pentablock copolymer could selectively 
transfect hyperproliferative cells needs further examination, this present work 
provides a new perspective to design targeting vectors for cancer therapies based on 
different characteristics among specific cell types. 
3.1  Introduction   
One of the features of the ideal non-viral transgene vector is cell specificity, 
which is so far usually achieved via receptor-mediated endocytosis by integrating cell 
specific ligands in the gene transfer system(1-3). With a receptor on the target cell 
surface and a matching ligand that can be attached to the synthetic vector, a 
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targeting gene delivery system could be established and expected to enhance the 
gene expression by increasing cellular uptake in the specific cell types. Through this 
receptor-mediated uptake, only the cells having some recognized over-expressed 
receptors could be “designed” as the target with the prerequisite that the ligand is 
also available and attachable to the vector of interest without compromising its DNA 
condensing ability, serum resistance and/or other particular properties. Commonly 
investigated ligands include asialoglycoprotein specific for hepatocytes(4-6), 
mannose for macrophages(7-9), and transferrin(10-11)and folate(12-13) for certain 
tumor cells. These have been reported to improve the transfection efficacy selectively 
in the target cells. Although the polymeric vectors have great flexibility to be tailored 
for particular applications like ligand modification, there are several limitations of this 
approach. In many cases, the receptors are over-expressed on the specific cell types, 
but they are also expressed by other cells, thereby decreasing the targeting efficiency.  
Moreover, interactions with serum proteins in the bloodstream and aggregation could 
further reduce the specificity of cellular uptake(14-15). A well known fact is that the 
same gene delivery system may exhibit quite different transfection efficiencies in 
different cell types(16-18), indicating there are particular cellular characteristics that 
affect the gene expression and could potentially be used to build up a cellular screen 
to selectively express foreign genes by specific cells. As an important cellular 
characteristic, the cell cycle has been reported to play a significant role in gene 
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transfer due to high dependence of gene expression on the mitotic phase, especially 
with the use of non-viral vectors(19-21). This suggests that the entry of complexes 
into the nucleus may require or benefit from the disruption of nuclear membrane; thus, 
the greater the number of cells entering mitosis, the higher the gene expression(19). 
But in some cases, mitotic activity would not act as a limiting factor if the vectors 
possess an excellent nuclear localization ability and turn out to be versatile like 
poly(ethyleneimine) (PEI)(22). However, if the vectors only have access to nucleus 
during mitosis, their transfection efficiency would be extremely dependent on how 
fast the cells proliferate. In other words, targeting could be achieved among cell types 
with significantly different proliferation rates, such as most tumor cells and normal 
cells, even without the use of targeting ligands.  
In this present work, we report a novel pentablock copolymer with the potential 
selectivity to selectively transfect fast growing cells. The novel amphiphilic pentablock 
copolymer developed in our laboratory exhibits temperature- and pH-induced 
micellization and gelation(23). The central triblock Pluronic F127 contributes to the 
temperature responsiveness and has been reported to be able to promote cellular 
entry(24). The end-blocks of poly(diethylaminoethyl methacrylate) (PDEAEM) are the 
essential functional cationic segments to complex with DNA and to provide pH 
buffering in the endosome with their protonatable tertiary amine groups(25). In order 
to improve the stability and reduce the cytotoxicity caused by the excess positive 
60 
 
charges on the surface of copolymer/DNA polyplexes, free Pluronic F127 was added 
to the polymer-DNA complexes to shield these excess charges(26). Previous work 
has proved the high transfection efficiency of the pentablock copolymer and the 
stabilization effect induced by Pluronic F127 in serum supplemented medium in 
cancer cell lines. Furthermore, this transgene system is also injectable and can form 
thermoreversible gels in vivo for sustained release. Therefore, combining its potential 
selectivity for transfecting fast-growing cells, and its ability to be injected 
intra-tumorally to form gels for sustained gene delivery makes it promising as an ideal 
sustained and targeted transgene vector for cancer therapies.  
3.2  Materials and Methods 
3.2.1  Materials 
The SKOV3 human ovarian carcinoma and ARPE-19 human retinal cell lines 
were obtained from ATCC™(Manassas, VA). The 3T3 Swiss mouse fibroblast cell line 
was kindly donated by Dr. Nilsen-Hamilton’s Laboratory (ISU, Ames). Living ColorsTM 
HT-1080 Retro DsRed-Express cell line, a clonal human fibrocarcinoma derived cell 
line that stably expresses DsRed-Express, was obtained from BD 
Biosciences-Clontech. Cell culture reagents including Dulbecco’s Modified Eagle 
Medium (DMEM), heat inactivated fetal bovine serum (FBS), 0.25% trypsin-EDTA 
and Hank’s buffered salt saline (HBSS) were purchased from Invitrogen (Carlsbad, 
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CA) and the Dulbecco’s MEM : Ham’s Nutrient Mixture F-12, 1:1 Mix (DMEM/F-12) 
from ATCC (Manassas, VA). Luciferase assay system and passive lysis buffer were 
purchased from Promega (Madison, WI). HEPES salt used to make Hepes buffer 
saline (HBS), Lactate dehydrogenase (LDH) kit, paraformaldehyde and 
Bromodeoxyuridine (Brdu) were obtained from Sigma (St Louis, MO). Alexa 
Fluor®647 carboxylic acid, succinimidyl ester (written as Alexa 647 henceforth), 
ethidium monoazide (EMA), 4',6-diamidino-2-phenylindole (DAPI) dilactate and 
ProLong® Gold antifade reagent were also purchased from Invitrogen (Carlsbad, CA). 
ExGen 500® (written as ExGen henceforth) was purchased from Fermentas Life 
Sciences (Hanover, MD). DNase I was purchased from Ambion (Austin, TX). 
HiSpeed Plasmid Maxi Kit was obtained from Qiagen (Valencia, CA). Pluronic F127 
[(PEO)100-b-(PPO)65-b-(PEO)100], (where PEO represents poly(ethylene oxide) and 
PPO represents poly(propylene oxide)) micro pastille surfactant was donated by 
BASF (Florham Park, NJ) and used without further modification.  
3.2.2  Pentablock Copolymer Synthesis and Attachment of Alexa Fluor 647  
The pentablock copolymer PDEAEM13-b-PEO100-b-PPO65-b-PEO100- 
b-PDEAEM13 used in the present work (Scheme 3.1) was synthesized via atom 
transfer radical polymerization (ATRP) as previously reported(23), with Mn=17,533 
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and Mw/Mn=1.14, as judged by 1H NMR (in deuterated chloroform) and Gel 
Permeation Chromatography  (GPC) (tetrahydrofuran mobile phase, 
poly(methylmethacrylate) calibration standards) respectively. In order to attach the 
fluorescent dye Alexa Fluo 647 for intracellular trafficking studies, this pentablock 
copolymer was amine functionalized by transforming the bromine group into azide 
and then further into triphenylphosphine and finally into the amine group after 
hydroxylation (Scheme 3.2). The transformation was confirmed by the presence and 
subsequent absence of a peak at about 31 ppm in the 31P NMR spectrum. Alexa 647 
was reacted with amine modified pentablock similar to a procedure reported 
previously(27). Briefly, for a 20mg/ml polymer solution in 0.1 M sodium bicarbonate 
buffer, around 100 μg of the dye was added. The mixture was stirred in the dark at 
room temperature for 1 hour. The unattached dye was removed by extensive dialysis 
for 2 days. The polymer with conjugated dye was then freeze dried.  
 
 
Scheme 3.1. Chemical structure of pentablock copolymers 
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3.2.3  Plasmid DNA Purification and EMA Attachment  
Bacteria containing the 6.7 kb pGWIZ-luc plasmid (GeneTherapy Systems Inc, 
CA) encoding the luciferase reporter gene or the 4.7 kb pEGFP-N1 plasmid 
(ClonTech, CA) encoding for green fluorescence protein (GFP) were grown in 
selective Luria-Bertani (LB) medium and then purified using the Qiagen HiSpeed 
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Scheme 3.2. Amine functionalization of pentablock copolymers 
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Maxi Kit. The concentration of DNA was tested using a NanoDrop spectrophotometer. 
A260/A280 was at least 1.8 for all DNA used.  DNA was labeled with the fluorescent 
probe ethidium monoazide (EMA, 8-azido-3-amino-6-phenyl-5- 
ethylphenanthradinium chloride) according to the procedures reported 
elsewhere(28-29) with minor modifications. Briefly, appropriate amounts of plasmid 
and EMA were mixed giving a 50:1 molar ratio of nucleotide to probe. The solution 
was incubated on ice for 30min before being exposed to UV light of principal 
wavelength 312nm. After 20 min photolysis, most of the DNA had been covalently 
bound with EMA, and the excess EMA and intercalated EMA were removed by 
performing ethanol precipitation three times.  
3.2.4  Polyplex Formation  
Polymer/DNA polyplexes at various N/P ratios were formulated by adding 
appropriate quantities of unlabeled or labeled pentablock copolymer (2mg/ml) 
solution in 0.5× HBS, pH 7.0 to plasmid DNA solutions which were properly prediluted 
with the same HBS buffer to get the equal mixing volume. The mixture was briefly 
vortexed and allowed to incubate at room temperature for 20 min to ensure 
complexation. If required, Pluronic F127 solution (10 mg/ml) in 0.5× HBS, pH 7.0 was 
added to the formulation to get the F127/pentablock copolymer wt. ratio of 5 with 
gentle vortexing followed by another 10 min incubation. We will be referring 
throughout this work to four abbreviations for the different vectors used to form 
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polyplexes: PB refers to the pentablock copolymer alone, PBD refers to the 
pentablock copolymer with the fluorescent dye attached, PL refers to Pluronic F127, 
and correspondingly, PB-PL refers to the pentablock copolymer with subsequent 
added Pluronic F127 for shielding the excess positive charges.  
3.2.5  Cell Culture  
The SKOV3, 3T3 and HT1080 cells were grown in Dulbecco’s Modified Eagles 
Medium (DMEM, Invitrogen) supplemented with 10% (v/v) fetal bovine serum (FBS, 
heat inactivated, GIBCO) at 37°C under a humidified atmosphere containing 5% CO2. 
ARPE-19 cells were grown in DMEM/F-12 (ATCC) containing 10% FBS under the 
same conditions. Cells were passaged approximately every 2-3 days for SKOV3 and 
HT1080, 4-5 days for APRE-19 and 7-8 days for 3T3 cells.  
3.2.6  In vitro Transfection  
For the transfection based on luciferase activity, cells of interest were seeded 
into a 96-well plate at an initial density of 1.2×104  to 3×104 cells per well in 200μl 
growth medium and allowed to incubate for 24~48h depending on the cell type, to 
reach 70% confluence when transfection could be performed. Polyplexes prepared at 
given N/P ratios were added to the newly changed FBS-supplemented medium with 
0.6ug of DNA per well. After 3h transfection at 37°C, the medium containing 
polyplexes was replaced with fresh growth medium and cells were allowed to grow 
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for another 45h post-transfection until the luciferase assay was performed. The total 
duration of transfection and post-transfection was kept at 48h. ExGen 500, a sterile 
solution of linear 22 kDa polyethylenimine (PEI), was used as positive control at N/P 
ratio of 6 according to the manufacturer’s protocol. The luminescence from lysed 
cells in 20μL passive lysis buffer per well was measured in arbitrary Relative 
Luminescence Units (RLU) on an automated Veritas™ Microplate Luminometer using 
the Renilla Luciferase Assay System from Promega. Each transfection was done in 
triplicate.  
To compare the transfection efficacy between different cell types, luciferase 
activity in each well was normalized by the total amount of proteins determined by 
Bicinchoninic Acid (BCA) protein assay kit and expressed as mean RLU per milligram 
of cell protein. As for the comparison between different conditions of the same type of 
cells, RLU per well was utilized to obtain values since transfection was performed 
with the same initial number of cells per well. In the trafficking experiments, cells of 
interest were seeded onto poly-L-lysine coated coverslips in 6 well-plates at a density 
of 1×105 cells per well and subsequently transfected with polyplexes at 3μg DNA per 
well following the same procedures used in the case of 96-well plate. At specific time 
points during transfection or post-transfection, cells were fixed with 4% 
paraformaldehyde and mounted on the glass slide that held a drop of mounting 
medium to keep cells from drying out.  
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Specifically for the transfection of HT1080/ARPE-19 co-cultured cells, separately 
cultured HT1080 and ARPE-19 cells were seeded together onto 6-well plates at 
varied ratios of cell number and incubated in co-culture media, 50/50 (v/v) until being 
transfected with polyplexes at 2μg EGFP-N1 plasmid per well. EGFP expression was 
examined qualitatively by fluorescence microscopy and quantitatively by flow 
cytometry.  
3.2.7  Flow Cytometry  
After transfection, the cells were harvested from 6-well plates and cells from 
each well were suspended in 3ml HBSS. Then cell suspensions were transferred to 
15ml centrifuge tubes and centrifuged for 12min at 1200rpm. Supernatants were 
removed and cells pellets were resuspended in 3ml fresh HBSS. After another 
centrifugation, cells were finally suspended in 0.5ml of 2% paraformaldehyde in PBS 
and stored at 4°C for later analysis with a Becton-Dickinson FACSCanto flow 
cytometer. 
3.2.8  Cytotoxicity 
The cytotoxicity of polyplexes was measured with LDH assay, as the amount of 
LDH in the cell culture medium is representative of the cell death following the 
membrane rupture. To get a better knowledge of the stage at which most cell death 
occurs, the LDH activity was assayed twice, at the end of 3h transfection and after 
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the additional 45h post-transfection. Triton-X was used as a negative control to 
provide 100% cytotoxicity.   
3.2.9  Confocal Microscopy  
EMA and Alexa Fluor 647 were selected to label DNA and the pentablock 
copolymer respectively in this study, because their non-overlapping spectra 
minimized the potential interference that could occur between the two dyes. Confocal 
images were collected with a Prairie Technologies Confocal Microscope (Prairie 
Technologies, Madison, WI) and analyzed with MetaView software (Universal 
Imaging Corporation). An argon/krypton mixed gas laser with 488 and 633nm 
excitation lines was used to induce fluorescence. Excitation of EMA bound to DNA 
was achieved by using the 488 nm laser, with the emitted fluorescent wavelengths 
observed using a 600/40 nm notch filter. Alexa Fluor 647 attached to pentablock 
copolymer was excited by the 633nm laser with the emitted fluorescent wavelengths 
observed using a 700/75 nm notch filter. The thickness of the cells was estimated by 
varying the scanning plane from the bottom to the top of the cells and images were 
collected at the central plane with optical sections of 0.5~0.7μm. 
3.2.10  Proliferation Measurement 
Proliferation rate was expressed as the ratio of the number of daughter cells to 
the number of total cells and measured by counting cells stained with Brdu and DAPI. 
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Brdu labeling was performed immediately following transfection by replacing the 
medium containing polyplexes with fresh growth medium containing 5μM Brdu. After 
18h incubation, cells were fixed with 4% paraformaldehyde and stored in 1% 
paraformaldehyde at 4°C until performing immunocytochemistry.  
3.2.11  Statistical Analysis  
The data is presented as mean and standard deviation, which are calculated 
over at least three independent experiments. Significant differences between two 
groups were evaluated by Students’ t-test with p<= 0.05 or p<0.1, as specified.  
3.3  Results and Discussion 
3.3.1  Transfection and Cytotoxicity among Different Cell Types  
In order to use the pentablock copolymers for cancer therapy, we tested the 
ability of the pentablock copolymer vectors to selectively transfect cancer cells 
(SKOV3) versus ARPE-19 cells using reporter genes (Fig. 3.1). Relative to the blank 
cells and naked DNA, polyplexes of PB and PB-PL under different N/P ratio 
conditions exhibited up to three orders of magnitude higher efficiency in SKOV3 cells 
contrasting with the slight difference in ARPE-19 cells. ExGen, a linear 
polyethyleneimine vector, was used as a positive control, and did not exhibit a 
significant difference in transfection efficiency between the two different cell types, 
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and the transfection efficiencies in both cell types were over three orders of 
magnitude higher than those of the negative controls. This demonstrates a potential 
selective transfection ability of the pentablock copolymer vectors compared to 
established vectors such as ExGen. 
Although it is a commonly known fact that transfection efficiency could be largely 
dependent on cells due to the complex cellular structure and consequently varied 
gene delivery mechanisms, the big differences in transfection efficiencies of SKOV3 
and ARPE-19 cells, which we may refer to as a cancer cell line and “normal” cell line 
respectively, provides a challenging possibility that this pentablock copolymer might 
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Fig. 3.1. Transfection of ARPE-19 and SKOV3 cells by PB/DNA and PB-PL/DNA at N/P 
ratios of 20 and 30 as denoted by the numbers following abbreviations. Blank cells and 
naked DNA were used as negative controls and ExGen at N/P ratio of 6 was used as the 
positive control according to the provided protocol. Luciferase activity was expressed as the 
relative light units (RLU) per mg of protein (n= 4, mean±S.D.* =p<0.05, ** = p<0.01).  
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possess a natural selectivity to transfect cancer cells or in general, the type of cells 
bearing some specific features of SKOV3 cells. Therefore, 3T3 cells were used to 
further test the transfection of normal cell lines mediated by pentablock copolymers. 
As shown in Fig. 3.2, similar to the case of APRE-19 cells, the pentablock copolymers 
lead to very low transfection efficiencies, almost comparable to those of blank cells, 
and ExGen still appeared to be a highly effective vector independent of the cell-line 
type. Therefore, the hypothesis that pentablock copolymers might specifically 
transfect the cancer cells sharing some key feature with SKOV3 cells was 
investigated further to determine if differences in proliferation rates of the different cell 
types were responsible for the differences in transfection efficiencies using the 
pentablockjcopolymers.   
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Fig. 3.2. Transfection of 3T3 cells by PB/DNA and PB-PL/DNA at N/P ratios of 20 
and by ExGen at N/P ratio of 6 for different transfection periods. Luciferase activity 
was expressed as relative light units (RLU) per well (n= 4, mean±S.D.). 
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3.3.2  Proliferation Measurement   
The cell cycle mitotic phase has been reported to be a favorable period for 
nuclear transport using non-viral vectors(20). Although there are a number of 
intracellular barriers that work synergistically to cause a low level of gene expression 
relative to the DNA taken up by cells, usually less than 1%(30), the nuclear transport 
of polyplexes has been recognized as the rate-limiting step in DNA delivery(31), and 
has been found to be an important factor in the transfection of cell lines versus 
slow-dividing primary cells such as neurons. Hence, theoretically, the faster the cell 
proliferates, the greater the chances for DNA to enter nuclei, thus the higher the gene 
expression would be. It was reported that gene expression was enhanced by 
enhancing cell proliferation with growth factor(32). To test the proliferation rates of the 
different cell types, Brdu was employed to stain the newly created cells with all nuclei 
labeled with DAPI. With the concern of minimizing the influence of host species on 
transfection characteristics, SKOV3 and ARPE-19 cells, which are both of human 
origin, were used for this study as opposed to the 3T3 cells which are mouse-derived. 
The test was conducted on transfected cells, in case the polyplexes have an effect on 
the proliferation. (Representative images shown in Fig.3.3). The proliferation rate was 
expressed as the number of daughter cells (pink) divided by the number of total cells 
(blue). The SKOV3 cells were found to proliferate significantly faster (p<0.1) than the 
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ARPE-19 cells, with the rate of 54%+15% vs. 25%+12%. This potentially supports 
our hypothesis that the slower dividing rate of ARPE-19 cells probably resulted in less 
DNA importation to the nuclei of ARPE-19 cells and consequently to lower levels of 
gene expression.  
To investigate this further, intercellular trafficking studies of pentablock 
copolymer/DNA polyplexes in SKOV3 and ARPE-19 cells were performed during 
transfection and post-transfection, by labeling the pentablock copolymer with a 
fluorescent dye.  Since any modification to the polymer can potentially change its 
physiochemical properties, the transfection efficiency and cytotoxicity of the dye 
labeled pentablock copolymer PBD was investigated. Fig. 3.4 indicates that there are 
indeed differences between PBD and the pentablock copolymer alone. Higher N/P 
ratios are required for PBD to obtain a similar level of gene expression as PB does, 
 
 
Fig. 3.3. Proliferation measurement of SKOV3 cells (A) and ARPE-19 cells (B) with nuclei labeled 
by DAPI (blue) and newly formed cells labeled by Brdu (pink)  
 
A B 
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which might be most likely due to the compromised DNA affinity by the dye 
attachment. There have been previous reports that oversubstitution of the molecular 
conjugates could interfere with the interaction of the polymers with DNA(33). In this 
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Fig. 3.4. Transfection of SKOV3 cells (A) and ARPE-19 cells (B) with the vector of PB 
and PBD at various N/P ratios. (n= 4, mean±S.D.) 
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case, the dye Alexa 647 attached to the end of polymer main chain could affect the 
polymer complexation with DNA in an unfavorable way, either by steric hindrance or 
by positive charge shielding. The Alexa 647 molecule (MW=1250) accounts for 
~50wt. % of a PDEAEM block (MW=2405 with 13 units), and together with the 
proximity between the dye and the tertiary nitrogen, it is reasonable to see a negative 
influence of Alexa 647 on transfection. However, it is interesting to point out that such 
a significant difference was brought about by only five percent of dye with respect to 
the pentablock copolymer. In addition to the DNA binding capability reduction by the 
conjugation of Alexa 647, the resulting reduced charge density might also contribute 
to a lower cytotoxicity at a given N/P ratio.  
3.3.3  Cytotoxicity Analysis Using LDH Assay 
Cationic vectors can be cytotoxic, though the cytotoxicity of the pentablock 
copolymers can be tailored by adjusting the ratio of the cationic and non-cationic 
blocks in the copolymer (25). To evaluate the cell viability during the total transfection, 
an LDH assay was used. As shown in Fig. 3.5, the cytotoxicity of all the polyplexes is 
fairly acceptable for both SKOV3 and APRE-19 cells, expect for the P30 vector with 
the very high N/P ratio, and these two cell types seem to have a similar susceptibility 
to the vector. The vector of PB-PL with the Pluronic shielding the excess positive 
charges showed less damage to cells than the pentablock copolymer alone, 
suggesting that the shielding effect from PL improved the biocompatibility of 
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Fig. 3.5. Cytotoxicity of polyplexes on SKOV3 (top) and ARPE-19 cells (bottom) with 
LDH assay at various N/P ratio as denoted by the numbers following abbreviations. n= 
4, mean±S.D. * =p<0.05, ** =p<0.01 
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pentablock/DNA polyplexes. Cytotoxicity of PBD/DNA was indeed much lower than 
that of PB/DNA counterparts for both cell types, which further proved the great 
influence of dye conjugation on the charge density. It was also found that interestingly, 
for both cell types, ExGen led to an even higher toxicity in the later 45h of 
post-transfection relative to the first 3h, while most of pentablock copolymer 
polyplexes seemed to act differently. It is worth noting that for the polyplexes such as 
P30/DNA that exhibited a high toxicity in the first 3h transfection, there was not much 
additional cytotoxicity in the next 45h.  
ExGen carries plenty of primary and secondary amines and is known to be much 
more cytotoxic than complexed ExGen where most charges of amines have been 
neutralized by DNA; moreover, the membrane destabilization effect(34) of free PEI 
and its interference with transcriptional and translational processes(35) might also 
account for its toxicity. On the other hand, the intense charge density of PEI would not 
allow the release of the DNA cargo readily, so the ExGen/DNA polyplexes showed a 
slower toxicity rather than a quick one, which is in good agreement with the report by 
Godbey and co-workers(35). However, transgene vectors with tertiary amines as the 
functional moieties like pentablock copolymers, have been reported to be less toxic 
than those with primary residues like PEI(26, 36). Therefore, even after 
uncomplexing from DNA they did not show as much long-term toxicity as ExGen, 
instead showing an initial cytotoxicity during the first 3h probably due to relatively 
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larger percentage of uncomplexed polymer at a given higher N/P ratio or the 
relatively faster release of DNA. However, the cytotoxicity of PBD/DNA was found to 
show a different trend during the whole transfection process compared to PB/DNA in 
the ARPE-19 cells, with higher cytotoxicity in the post-transfection stage than that in 
the transfection period. If the uncomplexed PBD is presumed to be a major source of 
cytotoxicity, apart from the membrane damage during cellular entry, there should be 
more uncomplexed PBD in the later 45h post-transfection in ARPE-19 cells relative to 
SKOV3 cells where nearly no cytotoxicity was observed. This implies that some 
intracellular differences between the two cell types may affect the relatively weak 
complexation of PBD and DNA, which was investigated in the intracellular trafficking 
studies of the polyplexes. Taking the transfection efficacy and cytotoxicity into 
account, PBD at an N/P ratio of 40 was used for the intracellular trafficking study. 
3.3.4  Intracellular Trafficking of PBD/DNA Polyplexes  
Based on the proliferation results that showed that SKOV3 cells proliferate faster 
than ARPE-19 cells, our initial hypothesis was that the significant differences in 
transfection efficacy between the two cell lines were largely due to the positive effect 
of proliferation rate on nuclear transport. To check if nuclear uptake actually occurs 
more in SKOV3 cells than in ARPE-19 cells, pentablock copolymer/DNA polyplexes 
were tracked at 3h, 10h and 24h after the start of transfection. Fig. 3.6 shows a 
representative image of the APRE-19 cells at 3h, where colocalization of pentablock 
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copolymer and DNA was clearly observed with yellow dots, suggesting that 
polyplexes remained in their original form, and in particular some polyplexes had 
localized to the perinucleus as seen in cells 1, 3, and 4. However, the most 
impressive feature of the 3h sample resides in the dissociated polyplexes which 
could be easily detected by the abundant red, and relatively fewer green dots. 
 
 
Fig. 3.6. Confocal images from labeled pentablock copolymers and DNA in ARPE-19 cells 3h 
after transfection. Images on the left colored green represent DNA, the center ones colored red 
represent the pentablock copolymers and the images on the right are the alignment of the other 
two images. Panel A and Panel B are from different observation spots. Scale bar is 20 μm. 
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Moreover, except for cells 3 and 4, the red free pentablock copolymer appeared to be 
dominant and the green DNA was just absent, especially in cells 1 and 2. We have 
postulated two possible reasons for the absence of the free DNA. One possibility is 
that DNA was degraded by the nuclease in the cytosol, and the other is that the DNA 
was exported out of the cell. The appearance of strong red and weak green signals 
has been found to be typical among all the images), which may imply that the DNA is 
subjected to degradation during or after release from the polyplexes. This was proved 
by testing the intensity of fluorescence of DNA-EMA and degraded DNA-EMA (as 
shown in Fig. 3.7), and by integrating within the range of the filter from 580nm to 
620nm. It was found that the untreated DNA-EMA was as twice fluorescent as the 
degraded one. It was once reported that the digestion of EMA labeled RNA induced a 
14-fold decrease in the fluorescence intensity (37). Therefore, the free DNA was not 
 
Fig. 3.7. Fluorescence spectra of DNA-EMA and degraded DNA-EMA treated with nuclease I 
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totally absent as it appeared to be in the aligned images, but had probably been 
degraded by the nucleases to some extent and showed less intense fluorescence 
compared to the bright red fluorescence from pentablock copolymer. When focusing 
on cells 5 and 6, free DNA was found localized around the cell membrane or close to 
the membrane, potentially awaiting transportation out of the cell. This feature was 
also found commonly in the 10h samples as it was shown in the representative cell 3 
of Fig. 3.8, where free DNA accumulated   along the outer membrane or may be 
sequestrated by the cell membrane. The nearly doubled nucleus and the 
incompletely separated nuclear envelope of cell 3, as indicated by the lower arrow, 
demonstrates an obvious late mitosis phase – telophase. Moreover, DNA and 
pentablock polymer have been observed in the dividing nucleus with non-perfect 
colocalization, suggesting that they both either entered into the nucleus in an 
 
 
 
Fig. 3.8. Confocal images from labeled pentablock copolymer and DNA in ARPE-19 cells 
10h after transfection. Image on the left colored green represents DNA, the center one 
colored red represents the pentablock copolymers and the image on the right is the 
alignment of the other two images. Scale bar is 20 μm.  
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uncomplexed form or dissociated from each other after nuclear entry as polyplexes. 
But the large number of polyplexes accumulating right outside the nucleus, as well as 
the small amount of free DNA observed, point to the second possibility. The 
intranuclear DNA and pentablock copolymer are close to the dividing area, indicating 
that the nuclear entry possibly took place during the nuclear division and may have 
been facilitated by nuclear membrane breakdown (21). In addition, the feature of 
strong red and weak green was also found in this 10h sample as shown by arrows in 
cells 1 and 2. Therefore, by comparing the cells after 3h transfection, and those after 
another 7h posttransfection, the latter showed an enhanced nuclear uptake probably 
due to the mitotic activity, but maintained the appearance of dominant red 
fluorescence. This implies that the DNA might be degraded after uncomplexation, 
and the accumulation of DNA close to or even at the cell membrane suggests a 
possible export mechanism from the cell. When post-transfection time was extended 
to 21h as seen in Fig. 3.9, the transfected cells exhibited an increased amount of 
DNA in the nuclei either complexed or uncomplexed as shown in cells 3, 4 and 5.  
The other features were consistent with the previous two time points concerning 
varied intensity of green fluorescence from DNA and membrane concentrated 
distribution of DNA, as especially indicated with the arrow in cell 2.      
The polyplexes, however, had a totally different intracellular route in SKOV3 cells as 
shown in Fig. 3.10. A large quantity of fairly good colocalization of green and red dots 
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Fig. 3.10. Confocal images from labeled pentablock copolymer and DNA in SKOV3 
cells 3h after transfection. Images on the left colored green represent DNA, the center 
ones colored red represent the pentablock copolymers and the images on the right 
are the alignment of other two images. Scale bar is 20 μm. 
 
 
 
Fig. 3.9. Confocal images from labeled pentablock copolymer and DNA in ARPE-19 cells 24h 
after transfection. Images on the left colored green represent DNA, the center ones colored red 
represent the pentablock copolymers and the images on the right are the alignment of the other 
two images. Panel A and Panel B are from different observation spots. Scale bar is 20 μm.  
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suggests that DNA was still effectively protected from degradation in the well 
maintained polyplexes. More importantly, polyplexes had localized into nuclei in 
considerable numbers at 3h after transfection which is dramatically higher than the 
cases of all APRE-19 cell samples in test, and which might be contribute to the 
differences in the transfection efficacy of the pentablock copolymers between the two 
cell types. Besides, all of the DNA and pentablock copolymers have been shown to 
be perfectly overlaid; therefore the polyplexes in the nuclei are the ones originally 
present in the cytoplasm rather than being reformed by the DNA and pentablock 
copolymers that entered into the nuclei separately. Therefore, at least a portion of 
DNA is transported into nuclei complexed with the pentablock copolymer. There is a 
possibility of uncomplexed DNA entering the nucleus as well, since plasmid DNA has 
been well known to be able to enter into the nuclei(30). But considering the 
degradation by nucleases(38) and the low diffusion rate caused by the hindrance of 
cytoskeleton and binding with other cytoplasmic elements(39), the free DNA would 
have a small chance to successfully locate into the nuclei.  
As SKOV3 cells proliferate faster than the ARPE-19 cells, the higher transfection 
efficiency of SKOV3 cell line was hypothesized to result from its consequently 
facilitated nuclear uptake. The nuclear uptake of polyplexes appeared to be common 
in SKOV3 cells samples, even as early as 3h after transfection. Panels A to C in Fig. 
3.11 might represent three different stages in mitosis according to the varied 
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appearance of nuclei. Although it is hard to say at which exact stage each set of cells 
is in, they all seem to be after prometaphase, during which the disintegration of the 
nuclear membrane occurs. That is probably the reason why each nucleus undergoing 
division shows polyplexes inside. Since similar phenomena were just observed less 
frequently in the ARPE-19 cells 10h after transfection, the slower dividing rate could 
largely account for the lower transfection efficiency. 
The SKOV3 samples for 10h and 24 after transfection look similar to those of 3h 
 
 
Fig. 3.11. Nuclear transport of polyplexes during mitosis from SKOV3 cells after 3h 
transfection. Images on the left colored green represent DNA, the center ones colored red 
represent pentablock copolymers and the images on the right are the alignment of other 
two images. Panels A, B and C are from different observation spots. Scale bar is 20 μm. 
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(Fig. 3.12), except for the less perfect colocalization and more free DNA in the nuclei, 
which is reasonable as the dissociation can be expected to develop over time. 
However, relative to the rare colocalization at the same time points in ARPE-19 cells, 
the tight binding in SKOV3 cells implied a long-term protection provided by the 
 
Fig. 3.12. Confocal images from labeled pentablock copolymer and DNA in SKOV3 
cells 10h (panel A) and 24h (panel B) after transfection. Images on the left colored 
green represent DNA, center ones colored red represent the pentablock copolymers 
and the images on the right are the alignment of the other two images. Panel A and 
Panel B are from different observation spots. Scale bar is 20 μm. 
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pentablock copolymer. This agrees well with LDH results regarding the cytotoxicity of 
PBD/DNA in post-transfection, which appears to be proportional to the amount of 
uncomplexed PBD. Although long-term protection might reduce the cytotoxicity as 
well as the loss of DNA, the relatively few DNA released for further transcription and 
translation might present a potential bottleneck to gain higher gene expression. 
Therefore, the differences in transfection efficiency between ARPE-19 and SKOV3 
cell lines might be due to the lower proliferation rate of the ARPE-19 cells, thereby 
lowering nuclear uptake. Although the exogenous material can definitely achieve the 
nuclear import in the interphase cells through the nuclear membrane embedded 
nuclear pore complex (NPC)(40), the hourglass-like NPC cannot allow large cargo to 
transit though passively(41)with the midplane as narrow as 40 nm(42). The inclusion 
of nuclear localization signal (NLS) in the vector could facilitate the transit and to 
some extent enhance the size limit up to 60nm, but the polyplexes sized around 
150nm are still excluded(43). Thus even with a NLS, the polyplexes are still too large 
to be imported into the nucleus(31). Since our pentablock copolymer/DNA polyplexes 
formed at N/P ratios of 20 have a size distribution ranging from 100nm to 500nm in 
serum supplemented growth media (data not shown), and do not possess any NLS 
moieties, it would be difficult for them to traverse the nuclear membrane through NPC 
even though opportunities exist to bind with the intracellular NLS. In this case, the 
more realistic strategy of nuclear localization should be the entry after nuclear 
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breakdown in mitosis. The more often cells experience a mitotic phase, the more 
DNA could be transported into the nuclei to get more genes expressed. Based on the 
fact that much more DNA either complexed or uncomplexed has been found in the 
nuclei of faster dividing SKOV3 cells,  the higher level of gene expression in SKOV3 
with respect to ARPE-19 cell line is related to the faster proliferation rate of the 
SKOV3 cells.  
To test this assumption further, we extended the duration of transfection of 
ARPE-19 cells to 6h (Fig. 3.13) and found that the gene expression mediated by 
PB-PL20 PB-PL30 PB20 PB30 ExGen
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Fig. 3.13. Transfection of ARPE-19 cell line by PB/DNA and PB-PL/DNA polyplexes with 
different transfection period at N/P ratio of 20 and 30 as denoted by the numbers 
following abbreviations. ExGen was used as a positive control at N/P ratio of 6 according 
to the provided protocol. Luciferase activity was expressed as the relative light unit (RLU) 
per well (n= 4, mean±S.D.* =p<0.05, ** = p<0.01). 
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most of the pentablock copolymer vectors was enhanced to a significantly higher 
level relative to the case of 3h transfection, suggesting more DNA has been available 
for the cells in mitosis. The exception of P30 and ExGen might be due to the negative 
effect of the accompanying increased cytotoxicity especially at higher N/P ratios. In 
addition to this cause, the excellent nuclear delivery ability of ExGen could make it 
benefit little from lengthened transfection. Further extending transfection to 10h, 
resulted in no significant differences. Apart from causing increased cytotoxicity, cells 
might have been too confluent to proliferate any further to aid in nuclear uptake. 
Secondarily the intracellular DNA in ARPE-19 cells was found to be much lesser than 
that in SKOV3 cells, which may be directly caused by the less effective cellular 
uptake, or probably due to the degradation of DNA by the nuclease in lysosome or 
cytoplasm, or due to the exocytosis of DNA. Consequently, the limited amount of 
DNA available in cytoplasm further inhibited the nuclear transport. In the SKOV3 
images, the polyplexes were dominant in the cytoplasm especially at 3h indicating 
that almost all the intracellular pentablock copolymers were complexed with DNA 
when entering into cells. Since the amount of pentablock copolymer in SKOV3 and 
ARPE-19 cells have not been found to be very different, the less powerful cellular 
uptake may just partially explain the small quantity of DNA in ARPE-19 cells. The 
degradation and exocytosis of DNA are also possibilities. After being internalized via 
endocytosis which is known as the major, if not the sole mode of cellular entry(20), 
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the polyplexes are trapped in the early endosomes. These early endosomes either 
fuse with each other to form late endosomes and subsequently endo-lysosomes by 
fusing with lysosomes or recycle their contents back to the cell surface(44). The 
endocytosed polyplexes are accordingly subjected to three fates, being recycled to 
plasma membrane and subsequent exocytosis, released into cytoplasm, or delivered 
to endo-lysosomes via late endosomes(39). Although the degradation most likely 
takes place in endolysosomes(45), the escape might also be facilitated by the lower 
pH (~5.0) of endolysosomes(46). Polyplexes released into cytoplasm still encounter 
diffusional barriers to traverse the highly crowded cytoplasm(47), and metabolic 
barriers to maintain DNA intact before eventually localizing into the nucleus. It has 
also been reported that the intracellular barriers to DNA transfer vary with cell type(20, 
22). Therefore, under the intracellular environment of APRE-19 cells, the binding 
affinity of the internalized polyplexes might be reduced, which in turn caused more 
DNA to be degraded or released. The released DNA again could be degraded during 
the long journey to the nucleus. As a result, lesser DNA was observed in ARPE-19 
cells than in SKOV3 cells.  
3.3.5  Transfection of Co-cultured HT1080/ARPE-19 cells  
The selectivity that potentially between cancer and normal cells transfected with 
pentablock copolymer polyplexes was further studied on another carcinoma cell line 
HT1080 by co-culturing it with ARPE-19. In this manner both qualitative and 
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quantitative data can be obtained in an environment closer to the in vivo situation. 
Consistent with the earlier results obtained using separate cultures of different cell 
lines, the pentablock copolymers showed selectivity of transfection of cancer cells 
 
 
Fig. 3.15. EGFP expression in HT1080/ARPE-19 co-cultures transfected with 
ExGen/DNA (EGFP-N1) polyplexes at N/P ratio of 6. 
 
 
Fig. 3.14. Transfection of HT1080/ARPE-19 cells with PB/DNA (EGFP-N1) polyplexes at N/P 
ratio of 20. After being labeled with DAPI, HT1080 cells are shown in purple (overlap of red 
and blue) and ARPE-19 cells are shown in blue (A); EGFP expression in HT1080 cells are 
indicated in yellow (B). 
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even in co-culture with non-cancerous cells. EGFP expression was seen only in the 
HT1080 cells even though they were fewer in number relative to the ARPE-19 cells  
(see Fig. 3.14). For the transfection mediated by ExGen, however, EGFP was evenly 
expressed in both of these two cell types (see Fig. 3.15), indicating that the 
transfection efficacy of ExGen is indeed independent of cell type. This finding was 
further confirmed and quantified with flow cytometry (Fig. 3.16) where the selectivity 
of transfection of cancer cells using the pentablock copolymer vectors was around 21 
whereas no selectivity was exhibited in the transfection mediated by ExGen. Since 
HT1080 cells were found toproliferate even faster than SKOV3 cells (data not shown 
here), this selectivity obtained using the pentablock copolymer mediated transfection 
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Fig. 3.16. EGFP expression in co-cultured HT1080/ARPE-19 cells mediated by PB-PL at N/P ratio of 20 
(A) and ExGen at N/P ratio of 6 (B). Selectivity was expressed as the ratio of percentage of cells with
EGFP expression in cancerous HT1080 cells over the percentage in ARPE-19 cells. Co-culture 1 and 
co-culture 2 indicate two co-culture conditions in which HT1080 and ARPE-19 cells were initially 
seeded at ratios of 1:2 and 1:3, respectively. Sep-culture represents the transfection performed on 
individually cultured cells as opposed to co-cultures.  
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could be related to the proliferation rate.   
3.4  Conclusions  
In summary, we have reported an interesting finding that the pentablock 
copolymer-mediated transfection was significantly higher in the cancerous SKOV3 
and HT1080 cell lines as compared to the non-cancerous APRE-19 and 3T3 cell lines, 
which implies that they may possess natural transfection selectivity for specific cell 
types. Through proliferation measurements and confocal microscopy-based 
trafficking studies, the faster proliferation rate of SKOV3 cells and the more 
formidable intracellular barriers of APRE-19 cells were found to contribute to this 
result. The selectivity was found to be about 21 for the transfection of HT1080 over 
that of APRE-19 cells using pentablock copolymers. However, the well-known and 
commonly used vector ExGen induced an almost evenly high transfection in all cell 
types in this study and did not show any selectivity. Since primary cells typically have 
even slower proliferation rates than most cell lines, the pentablock copolymers are 
expected to have a better selectivity between carcinoma and primary normal cells, 
thereby providing an excellent vector to deliver genes for cancer therapies. 
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CHAPTER 4.  THE MECHANISM OF SELECTIVE TRANSFECTION 
MEDIATED BY PENTABLOCK COPOLYMERS;                 
PART I: INVESTIGATION OF CELLULAR UPTAKE 
 
Modified from a paper published in Acta Biomaterialia, 2011, 7:1570-1579 
Bingqi Zhang and Surya Mallapragada 
 
Abstract 
    We have developed poly(diethylaminoethylmethacrylate) (PDEAEM) and 
Pluronic F127 based pentablock copolymer vectors with the ability to selectively 
transfect cancer cells over normal cells in in vitro cultures, as described in a previous 
report. Understanding the mechanism of this selectivity will enable us to better design 
polymeric vectors with inherent selectivity for specific cell types based on intracellular 
differences and not on the use of targeting ligands that have shown variable success, 
depending on the system. We assume that the selectivity was due to different 
intracellular barriers to transfection in the different cell types. Part I (this manuscript) 
focuses on investigating if cellular entry is one of the barriers to transfection, through 
conjugation of epidermal growth factor (EGF) to the pentablock copolymer vector. 
Results indicate that EGF conjugation increased transfection efficiency the most 
when conjugated to the outer surface of polyplexes, with minimal disruption to DNA 
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packaging and maximal accessibility to receptors. The overall resulting enhancement 
in transfection, however, was a moderate three to five fold increase as compared to 
the condition with no EGF involved, implying that the addition of EGF fails to overcome 
the intracellular barrier to transfection that probably involves some step other than 
cellular uptake in pentablock copolymer system. Therefore the differences observed 
in the selectivity of transfection between cancer and normal cell lines is probably not 
controlled by differences in cellular entry, and the intracellular barriers to transfection 
in this system are likely to be endosomal escape or nuclear entry, as investigated in 
Part II, the companion manuscript to this work. 
4.1  Introduction  
    Successful gene delivery systems exhibit good transfection efficiencies, 
specifically in cells of interest, while minimizing toxicity to untargeted cells. For clinical 
applications, safe, efficient and convenient methods are required. While viral gene 
carriers exhibit significantly higher transfection efficiencies than non-viral vectors, they 
show increased potential for immune responses that can hinder gene delivery, trigger 
severe inflammatory reactions, and cause nonspecific gene integration into host 
genome. Therefore, there has been significant interest in recent years to develop 
non-viral polymeric vectors because of their low immunogenicity, great DNA 
packaging capability and flexible tunability of structures. Through rational design, 
multifunctional vectors are desired that exhibit not only good transfection efficiencies, 
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but also good biocompatibility, and cell selectivity. Previously, we reported a novel 
self-assembling pentablock copolymer/Pluronic F127 transgene system(1). The 
cationic poly(diethylaminoethyl methacrylate) (PDEAEM) blocks bind to DNA and 
provide pH buffering capability. The central Pluronic F127 blocks contribute to 
temperature responsiveness and have been reported to be able to promote cellular 
entry(2). Besides the attractive properties above, recent work has shown that 
pentablock-based vectors might have intrinsic selectivity in transfecting cancer cell 
lines as opposed to normal cell lines, presumably due to different intracellular barriers 
to transfection in the different cell types(3). Understanding the mechanism of 
selectivity will potentially help in designing polymeric vectors with inherent selectivity 
for different cell types, and we aim to do this by identifying the intracellular barriers to 
transfection using the pentablock copolymer vectors, and then investigating 
differences in intracellular barriers to transfection between cancer cell lines and 
normal cell lines.  
The three commonly investigated intracellular barriers include cellular uptake, 
endosomal escape and nuclear entry. In Part I of this study, we investigate whether 
cellular entry is one of the main intracellular barriers to transfection in the pentablock 
copolymer vector systems by incorporating epidermal growth factor (EGF), a 
53-residue peptide that binds to the EGF receptor with high affinity(4), into the 
polyplex constructs in different ways, with the aim of enhancing transfection in cancer 
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cell lines through receptor-mediated cellular uptake. A number of studies have shown 
the efficacy of EGF incorporation in enhancing transfection efficiency of some 
polymeric vectors in tumor cells that overexpress the EGF-receptor(5-11). However, 
most of these published results are based on polyethyleneimine (PEI) or poly-L-lysine 
(PLL) type vectors and the results might not be broadly applicable to all polymeric 
vectors. Different gene delivery systems could be limited by different intracellular 
barriers; for instance, in a system where cellular uptake significantly limit transfection 
efficiency, addition of EGF may lead to significant enhancement of transfection 
efficiency, whereas it may make no difference for a system where the vector can enter 
cells easily. Thus, influence of EGF attachment to the vector on transfection efficiency 
in tumor cells could demonstrate whether or not cellular uptake is a major transfection 
barrier in that system.  
To achieve prolonged circulation of the vector in the blood stream and 
accumulation in target sites, free Pluronic F127 was further added to form a shield 
around the polyplex by self-assembly and block undesired interactions with serum 
proteins(12). Compared to various PEGylation strategies (prePEGylation or 
postPEGylation) that have been most frequently and extensively employed to reduce 
surface charges(13-17), Pluronic shielding in our system can be achieved 
conveniently, and provides the additional feature of thermosensitive gelation, allowing 
for the development of an injectable gel for clinically feasible sustained gene delivery. 
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To fulfill the potential of EGF as a cellular uptake facilitator for tumor cells while 
minimizing its interference in the resulting vectors, we employed various incorporation 
strategies such as attaching the EGF to the pentablock copolymers, or to the Pluronic 
shields. All of these studies were accompanied by detailed characterization of vector 
properties, with an aim to understand how the cellular uptake and transfection of 
pentablock copolymer vectors are affected by EGF.  
4.2  Experimental 
4.2.1 Materials  
    N,N-(diethyl amino)ethyl methacrylate (DEAEM) were purchased from Sigma (St 
Louis, MO) and Pluronic F127 was kindly donated by BASF (Florham Park, NJ). 
Recombinant human epidermal growth factor (EGF), Alexa Fluor 647 carboxylic acid, 
succinimidyl ester, (written as AF647 hereafter), 4',6-diamidino-2- phenylindole (DAPI) 
dilactate and ProLong Gold antifade reagent were purchased from Invitrogen 
(Carlsbad, CA). Luciferase assay system and passive lysis buffer were purchased 
from Promega (Madison, WI). Lactate dehydrogenase (LDH) assay kit and HEPES 
used to make Hepes buffered saline (HBS) was obtained from Sigma-Aldrich (St Louis, 
MO). ExGen 500 was purchased from Fermentas Life Sciences (Hanover, MD). Cell 
culture reagents: Dulbecco’s Modified Eagle Medium (DMEM), heat inactivated fetal 
bovine serum (FBS), 0.25% trypsin-EDTA and Hank’s buffered salt saline (HBSS) 
were purchased from Invitrogen (Carlsbad, CA). HiSpeed Plasmid Maxi Kit was 
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obtained from Qiagen (Valencia, CA). pGWIZ-luc (GeneTherapy Systems Inc, CA) 
plasmid encoding the luciferase reporter gene and EGFP-N1 (ClonTech, CA) plasmid 
encoding GFP reporter gene were purified with Qiagen HiSpeed Maxi Kit. Chemicals 
for synthesis, copper bromide, succinic anhydride, N-hydroxysuccinimide, sodium 
azide, 1-propylamine, 2-pyridinecarbaldehyde were obtained from Sigma-Aldrich (St 
Louis, MO). Pyridine, dimethylformamide (DMF), tetrahydrofuran (THF) and all other 
chemicals were purchased from Fisher Scientific and used without further purification. 
N-Propyl-pyridynyl methanimine (Nppm) was prepared by reacting 1-propylamine with 
2-pyridinecarbaldehyde(18). All chemicals were used without further purification. 
4.2.2 Cell Culture  
    The human ovarian carcinoma SKOV3 and human epidermoid carcinoma A431 
cell lines were obtained from ATCC™(Manassas, VA). Cells were grown in DMEM 
supplemented with 10% (v/v) heat-inactivated FBS at 37°C under a humidified 
atmosphere containing 5% CO2. Subculture was carried out every 2~3 days. A431 
cells are known to overexpress EGF receptors(19). They are thus expected to show 
higher rates of transfection when using EGF containing vectors, as compared to 
SKOV3 cells that just express moderate level of EGF receptors(20). 
4.2.3 EGF Attachment to The Pentablock Copolymers 
    The pentablock copolymers (Fig. 4.1a) used in this study were synthesized by 
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Fig. 4.1.  Schematic illustration of formation of various polyplexes with pentablock copolymer (PB) 
and Pluronic F127 (PL). (a) The pentablock copolymer molecules form micelles in aqueous solution 
via self-assembly in the same way as Pluronic F127; The pentablock micelles condense plasmid 
DNA into polyplexes of PB/DNA via ionic interactions. (b) Excess positive charges on the surface of 
PB/DNA were shielded by further addition of free F127 micellar solution via self-assembly; (c) By 
using EGF conjugated pentablock copolymer and Pluronic F127, four other types of polyplexes, 
PBE/DNA, PBE-PL/DNA, PB-PLE/DNA and PBE-PLE/DNA, were produced and investigated for 
use in transfection.  
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atom transfer radical polymerization and have been characterized in detail and tested 
for cytotoxicity, as described earlier(1, 18). Four abbreviations are used: PB - the 
pentablock copolymer alone; PBE - the pentablock copolymer attached to EGF; PL - 
Pluronic F127; PLE - Pluronic F127 attached to EGF; and correspondingly, PB-PL, 
PB-PLE, PBE-PL and PBE-PLE refer to the vectors with DNA complexed and shielded 
with varied physical mixture combinations of PB, PBE, PL and PLE. Formation of 
various polyplexes investigated in this study are shown schematically in Fig. 4.1. 
    To achieve EGF conjugation, the chain ends of the pentablock copolymer were 
first converted to an amine reactive N-Hydroxysuccinimide (NHS) ester through 
azidation, carboxylation and NHS activation. The azidation reaction was adopted from 
a procedure reported by Lutz and co-workers(21). In short, the pentablock copolymer 
with bromide end groups (18 000 g. mol-1, 5.4 g, 0.3 mmole), sodium azide (195 mg, 3 
mmole) and DMF (8 ml) were added to a flask. The mixture was reacted for 24 hours 
at 50°C. After that, the pentablock copolymer was precipitated in n-hexane, filtered 
and dried under reduced pressure. Carboxylation was achieved by click chemistry. 
Briefly, the azide functionalized pentablock (2.1 g, 0.11 moles), copper bromide (47 
mg, 0.33 mole) and Nppm ligand (99 mg, 0.66mole) were added into a round-bottom 
flask, followed by purging with argon for a couple of minutes. Degassed THF (4 ml) 
and pentyonic acid (64.8 mg, 0.66 mmole) were added into the mixture that was then 
stirred overnight at room temperature. The carboxyl-functionalized pentablock was 
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precipitated in n-hexane and filtered and dried under vacuum.  
    The carboxyl terminated pentablock was then activated by reacting with NHS as 
reported in literature(22). Briefly, to a round bottom flask connected with an argon line 
and bubbler, 2.3 g of carboxy-pentablock (0.128 mmole), 0.0792 g of 
N,N’-dicyclohexylcarbodiimide (DCC) (3× excess, 0.384 mole), 0.0442 g of 
N-hydroxysuccinimide (NHS) (3× excess, 0.384 mole), and 8 ml of dichloromethane 
were added. After reaction for 24 hours at room temperature, the mixture was filtered 
and precipitated in cold diethyl ether. Next, the NHS functionalized pentablock 
copolymer was conjugated with EGF. 30 mg of NHS activated pentablock copolymer 
was mixed with 200µg of EGF in 1 ml of PBS (pH 7.4). After 4h reaction, an additional 
30 mg of NHS-pentablock was added. The reaction was maintained at room 
temperature for 24 hours. The reaction mixture was dialyzed against 0.2× PBS using 
cellulose ester membrane (MWCO, 10000, Spectrum Labs) for 48 h in order to 
remove the uncoupled EGF. Finally, lyophilized products were collected.  
4.2.4 EGF Attachment to Pluronic F127 
    The strategy for attaching EGF to Pluronic F127 was similar to that employed with 
pentablock copolymer. Firstly, the hydroxyl end groups of Pluronic were converted to 
carboxyl groups by treating it with succinic anhydride in pyridine as reported in the 
literature(23). In short, Pluronic (32g, 2.5 mmole) and succinic anhydride (1g, 10 
mmole) were dissolved in pyridine (100 ml). The reaction was carried out at 40° C for 
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24 hours. The mixture was precipitated in diethyl ether, dissolved in toluene and 
reprecipitated in diethyl ether. Dried product was then achieved under vacuum. Next, 
the carboxyl terminated Pluronic was converted to an amine reactive NHS ester 
following the procedure described above. Finally, EGF was conjugated to Pluronic via 
reaction between amine and NHS groups. The amount of EGF in modified Pluronic or 
pentablock copolymer was found to be about half of the amount initially added in the 
reaction based on EGF ELISA kit, indicating either a moderate conjugation efficiency 
or some change in EGF activity after being conjugated to Pluronic.  
4.2.5 Polyplex Formation  
    All polymer solutions used in forming polyplexes were prepared in 0.5× HBS buffer, 
pH 7.0 unless stated otherwise. Briefly, various quantities of EGF- or EGF-free 
pentablock copolymer solution (2mg/ml) were added to the fixed volume of plasmid 
DNA solution (in water) to get desired N/P (nitrogen/phosphate) ratios. The mixture 
was gently vortexed and allowed to incubate at room temperature for 20 min to ensure 
complexation. An appropriate amount of EGF-containing or EGF-free Pluronic F127 
solution (10 mg/ml) was added to the mixture to form a shield layer around the newly 
formed polyplexes by self-assembly.  
4.2.6 Gel Retardation Assay 
    A gel retardation assay was used to assess complexation between the DNA and 
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the polymer(s) under various conditions. Polymer/DNA complexes were formed as 
described above. 40µl of each complex solution was loaded in a well for 
electrophoresis assay on a 1% agarose gel with Tris-acetate (TAE) buffer at 50V for 
120 min. DNA bands were visualized under UV light with ethidium bromide staining. 
4.2.7 Particle Size  
    Test polyplex solutions were transferred to Malvern disposable cuvettes and 
measured by a Malvern Zetasizer Nano-ZS90 dynamic light scattering system 
(Malvern Instruments, Southborough, MA). The size distribution profile was graphed 
as the mean of three independent experiments.  
4.2.8 Atomic Force Microscopy (AFM)  
    Samples were prepared according to the procedure used for formation of 
polyplexes, but using water instead of HBS buffer. Each sample contains 3ug DNA in 
a 300μl volume. The polyplexes were imaged on a Dimension3000 AFM with a 
version IV controller (Digital Instruments, Santa Barbara, CA) in tapping mode. 
Topographical images were obtained with 512×512 pixel resolution at a scan size of 
5μm and scan speed of 1 Hz, and analyzed with nanoscope software (version 5.30r3). 
4.2.9 Cytotoxicity 
The cytotoxicity of polyplexes was examined based on the amount of cytoplasmic 
lactate dehydrogenase (LDH) released into the medium following membrane rupture. 
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For a better understanding of how cytotoxicity develops with transfection, medium 
was collected twice for LDH assay, at the end of 3h transfection and additional 45h 
post-transfection. Blank cells were used as a negative control to provide 0% 
cytotoxicity and Triton-X was used as a negative control to provide 100% cytotoxicity. 
Cytotoxicity was determined as follows: 
              
Here, Abs refers to the absorbance at 490nm characterizing LDH.  
4.2.10   In vitro Transfection  
     Cells of interest were seeded into a 96-well plate or 6-well plate with an initial 
density of 1.2×104 or 1.5×105 cells per well one or two days before transfection. 
Polyplexes prepared at given N/P ratios were added to each well with 0.6µg of DNA 
per well for 96-well plates and 3µg DNA per well for 6-well plates in serum-containing 
media. Cells were allowed to incubate for 3h when polyplexes were removed by 
replacing the old medium with fresh growth medium (at t=3h).Cells in the 6-well plate 
were sampled at different time points within the 3h transfection for flow cytometry. 
After additional 45h post-transfection (at t=48h), cells in 96-well plate were lysed and 
tested for luciferase activity. The luminescence was measured in arbitrary Relative 
Luminescence Units (RLU) on an automated Veritas™ Microplate Luminometer. 
Each transfection was done in triplicate. ExGen 500, a sterile solution of linear 22kDa 
                               Abs (sample) – Abs (blank cells) 
Cytotoxicity %  =   ――――――――――――――― × 100                                                                                               
                               Abs (Triton-x) – Abs (blank cells) 
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polyethylenimine (PEI), was used as positive control at an N/P ratio of 6 according to 
the manufacturer’s protocol.  
4.2.11  Flow Cytometry 
    The pentablock copolymer was labeled with AF647 according to a procedure 
reported elsewhere, named PBD for short(3). Cells grown in the 6-well plate were 
transfected with PBD contained polyplexes following the procedures described above. 
At specific time points during transfection, cells in the well of interest were trypsinized 
and resuspended in 2% paraformaldehyde after centrifuging twice in HBSS buffer. 
Samples were stored at 4°C for later analysis with a Becton-Dickinson FACSCanto 
flow cytometer.  
4.2.12  Confocal Microscopy 
    Cells of interest were seeded onto poly-L-lysine coated coverslips and 
subsequently transfected with PBD containing polyplexes. Following 3h transfection, 
cells were fixed with fresh 4% paraformaldehyde and then treated with 300nM DAPI in 
PBS for 5min. The coverslip was washed thoroughly with PBS and mounted on a 
glass slide. Confocal images were collected with the objective of 63-er Oil / N.A. 1.4 on 
a Leica TCS SP5 X Supercontinuum Confocal Microscope. 
4.2.13  Statistics  
    The data are presented as mean and standard deviations calculated over at least 
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three independent experiments. Significant differences between two groups were 
evaluated by Student’s t-test with p≤ 0.05.  
4.3   Results and Discussion 
4.3.1 Effect of EGF Conjugation on the Polyplex Properties 
The particle size of polyplexes in HBS buffer (Fig. 4.2) and serum-containing 
media (Fig. 4.3) were measured by the Malvern Zetasizer Nano-ZS90 system. All 
polyplexes in HBS buffer appeared to be of a fairly stable size around 150nm with a 
narrow distribution. There were no aggregates even when the time was extended to 
5h. However, in the media containing serum, both size and distribution increased with 
time, indicating that polyplexes were interacting with serum proteins (data were 
summarized in Table 4.1). The addition of free PL or PLE did stabilize the polyplexes 
to a mean size of 200-250nm as compared to unshielded counterparts, which 
 
 
    Fig. 4.2.  Size distribution of polyplexes at N:P ratio of 20 in 0.5× HBS buffer pH=7.0 measured 
    (a) immediately; and (b) 5h after polyplex formation. 
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indicates that the presence of EGF did not affect the charge shielding by Pluronic. The 
size of PBE-based polyplexes was found to be much smaller than PB-based 
polyplexes at both time 0h and 5h. Similarly, the other two pairs of vectors 
 
 
Fig. 4.3.  Size distribution of polyplexes at N:P ratio of 20 in media with 10% serum measured (a) 
immediately; and (b) 5h after polyplex formation. (c) The ability of PB and PBE to condense DNA was 
examined using agarose gel electrophoresis.  
 
1 10 100 1000 10000
0
5
10
15
 
 
in
te
si
ty
 %
diameter/nm
 PB
 PBE
 PB-PL
 PB-PLE
 PBE-PL
 PBE-PLE
a
1 10 100 1000 10000
0
5
10
15
 
 
in
te
si
ty
 %
diameter/nm
 PB
 PBE
 PB-PL
 PB-PLE
 PBE-PL
 PBE-PLE
b
113 
 
distinguished only by the DNA condensing agent, PB-PL and PBE-PL, and PB-PLE 
and PBE-PLE, exhibited a similar trend after 5h of incubation in serum-containing 
media, implying that the EGF conjugated to PB might help reduce the formation of 
large aggregates with serum proteins by charge shielding, similar to that reported for 
other targeting ligands(24-25). However, that also implies that the DNA binding affinity 
of the conjugated polymer could be reduced at the same time. In our study, this 
negative effect of EGF conjugation on DNA interactions was shown using a gel 
retardation assay (Fig. 4.3c). PBE exhibited a slightly weaker inhibition of DNA 
Table. 4.1 Mean size of polyplexes in buffer and media containing serum. 
Values indicate means ± standard deviations (n = 3); 0 or 5h means the incubation time after 
polyplex formation; *, ^ and # indicate p≤0.05; ** indicates p≤0.01.  
 
Mean diameter in buffer   
Time=0 
Mean diameter in buffer 
Time=5h 
Mean diameter in serum     
containing media/nm 
 Diameter/nm PDIa Diameter/nm PDIa Time=0 Time=5h 
PB 110±5 0.26±0.04 113±5 0.31±0.00 425±17 ** 564±73 * 
PBE 114±10 0.38±0.04 114±3 0.59±0.07 323±24 ** 444±18 * 
PB-PL 123±16 0.28±0.02 133±13 0.29±0.04 200±35 420±34 ^ 
PB-PLE 123±14 0.43±0.05 129±10 0.42±0.01 215±40 389±47 # 
PBE-PL 130±13 0.43±0.04 144±25 0.40±0.08 212±16 344±27 ^ 
PBE-PLE 131±20 0.54±0.06 130±19 0.52±0.09 243±30 309±37 # 
a polydispersity index by DLS. Samples in serum containing media showed high PDI ≈ 1 due to the 
variety of particles in serum.  
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migration relative to PB as shown with the gel pattern at N/P =1. At higher N/P ratios, 
DNA was completely retarded in the wells for both polyplexes. The non-neutralized 
charges have been considered a major cause for cytotoxicity by destabilizing the cell 
membrane in cationic polymer-based gene delivery systems(26-27). Thus EGF 
conjugation might also lead to a change in cytotoxicity. As shown in Fig. 4.4, PBE 
indeed showed a significantly lower toxicity compared to PB at the end of 3h 
transfection, further confirming the occurrence of charge shielding from EGF, though it 
was still inferior to the charge shielding from PL or PLE. However, EGF scarcely 
affected the toxicity of polyplexes when it was conjugated to Pluronic, which was 
 
 Fig. 4.4.  Cytotoxicity of various polyplexes on A431 cells measured by LDH 
 assay during and after transfection. The number following each abbreviation   
 denotes the N/P ratio. Values indicate means ± standard deviations (n = 3)  
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consistent with the size measurement results. After removing the medium containing 
polyplexes, the toxicity post-transfection would be caused by the internalized 
polyplexes, which was found to be very low for all types of polyplexes.  
AFM was employed to further investigate the influence of EGF on the morphology 
of polyplexes (Fig. 4.5) The main structures of both kinds of polyplexes appeared to be 
rods, toroids, spheres and some intermediates, which are the typical structures for 
DNA condensates(28-29). Herein, the EGF conjugated to Pluronic did not cause any 
obvious change in the morphology of polyplexes.  
 
4.3.2 Effect of EGF Conjugation on Transfection  
Higher N/P ratios lead to tighter DNA binding and thus better DNA protection, but 
 
 
  Fig. 4.5.  AFM images of polyplexes of (a) PB-PL and (b) PBE-PLE at N:P ratio of 25 on the   
  surface of mica 
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they also result in higher cytotoxicity and less DNA release. The balance between 
these two makes the transfection efficiency change with N/P ratio nonlinearly, which is 
as shown for most of our polyplexes (Fig. 4.6). For SKOV3 cells, PB-PLE mediated 
the highest level of transfection at N/P of 30 among all competitive counterparts. 
There may be two reasons: PB-PLE has better accessibility of EGF to EGF receptors 
on the cell surface; EGF will not affect the complexation between PB and DNA, since 
the PLE was added after the formation of DNA condensates. This greatest 
effectiveness of incorporating a ligand on the most accessible position has been 
reported by attaching a peptide or EGF to PEGylated PEI polyplexes(5-6, 30). Thus, it 
is not surprising that PBE-PL showed the most inefficient transfection due to the less 
chance of EGF being exposed to the cell surface receptors and the potential 
interference with DNA condensation by conjugating EGF to the pentablock copolymer. 
But even with the potential beneficial effects of EGF attachment, such as facilitating 
internalization, reducing aggregation and decreasing toxicity, PBE did not induce any 
improvement of gene expression, and instead performed even worse than PB, which 
emphasized the negative influence of EGF on transfection when conjugated to DNA 
condensing agents. This effect was consistently seen in PB-PL vs. PBE-PL and 
PB-PLE vs. PBE-PLE. Although the EGF-caused decrease in DNA binding affinity 
was found to be not dramatic in the gel retardation assay, it truly made a big difference 
on the overall transfection efficiency.  
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Fig. 4.6.  Influence of EGF conjugation on luciferase transfection efficiency of various 
polymeric vectors in (a) SKOV3 and (b) A431 cells at different N/P ratios. PB-PL represents 
the polyplexes composed of pentablock/DNA condensate and free Pluronic F127 shield. 
PBE and PLE represent the EGF conjugated pentablock copolymer and Pluronic F127, 
respectively. Values indicate means ± standard deviations; n≥5; and symbols indicate the 
significant differences with p≤0.05 (single symbol) or ≤ 0.01(double symbols)  
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    The A431 cell line is known to over-express EGF receptors (EGFR) and the 
incorporation of EGF in the polyplexes is expected to produce a greater effect in these 
cells. PB-PLE, however, did not perform the best in A431 cells as in SKOV3 cells; 
instead PB-PL, PB-PLE, PBE-PL, PBE-PLE lead to similar levels of gene expression. 
PBE performed better than PB at lower N/P ratios as opposed to the trends seen in 
SKOV3 Cells. Interference of EGF conjugation with DNA affinity did not seem to 
reduce the transfection efficiency as much as it did in SKOV3 cells. Presumably, the 
benefit due to the presence of EGF outweighs the loss of DNA binding affinity in the 
microenvironment of A431 cells, as indicated by the slight influence of N/P ratio on 
overall gene expression level. However, the EGF conjugated to the Pluronic shield 
was not able to introduce any enhancement of transfection, even with the large 
number of available EGFRs on the cells. There might be two reasons for this. Firstly, 
the PB-PL type of vectors might have a good ability to get across cell membrane by 
themselves, and the presence of EGF thereby did not cause any significant changes 
in overcoming this barrier, compared to PB type vectors. Apart from the benefits 
associated with charge shielding, Pluronic has been found to promote cellular 
uptake(31). Secondly, the amount of EGF might be not sufficient to show a significant 
effect. The number of EGF molecules per polyplex has been found to be crucial for 
efficient gene delivery(7, 32). When EGF concentration was doubled in the reaction 
with NHS activated Pluronic F127, the PB-PLE vector led to 3~5 fold enhancement in 
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transfection efficiency as compared to PB-PL in both cell types (Fig. 4.7a,b). Free EGF 
was added along with transfection to test whether the enhancement was due to EGF 
receptor mediated endocytosis. As shown in Fig. 4.7c, transfection by PB-PL was not 
  
 
Fig. 4.7.  Transfection of (a,c) SKOV3 and (b) A431 cells mediated with PB-PL type polyplexes 
containing high concentration of EGF. Free EGF (2μg/well) was added along with polyplexes 
(N/P=20) in transfection (c) as competitor to polymer-conjugated EGF. PB-PL presents the 
polyplexes composed of pentablock/DNA condensate and free Pluronic F127 shield. PLE represents 
the EGF conjugated Pluronic F127. In regard to PB-PL+PLE, the polyplex was first formulated with 
PB-PL as usual but using 80% of the required amount of PL, the additional 20% was made up by 
PLE following 10min incubation. In this manner, PLE might have a greater chance to locate on the 
outer surface of Pluronic shield. Values indicate means ± standard deviations (n=3), * and ** indicate 
the significant difference compared to PB-PL with p≤0.05 and p≤0.01, respectively.  
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affected by addition of exogenous EGF, whereas PB-PLE performed far less efficiently 
in the presence of EGF as compared to the condition without EGF competition. This 
confirms the involvement of EGF-EGF receptor interaction in PB-PLE mediated 
transfection.  
Expression levels of EGFR are high in A431 (~3×106 receptors/cell)(33) and 
intermediate in SKOV3 (~1×105 receptors/cell)(20), but SKOV3 achieved 2-fold 
increment in transfection efficiency by vector PB-PLE at lower EGF concentration 
while A431 was not enhanced at all; at higher EGF concentration, SKOV3 and A431 
showed similar degree of transfection improvement by PB-PLE. There seem to be 
other factors that could limit EGF-EGFR interaction. It has been suggested by Swell et 
al. that the level of EGFR was not simply associated with magnitude of ligand 
response(34). Frederiksen et al. also reported that overexpression of EGFR might not 
be a prerequisite for efficient gene delivery through receptor-mediated internalization, 
because of nonlinear relationship between transfection and the amount of EGFR(35). 
Since only 0.1~0.2% of the EGFRs in A431 are high-affinity receptors with a Kd of 7 
×10-11M(35), the affinity of EGFR might also relate to transfection efficiency and 
account for the present finding for A431 cells compared to SKOV3 cells. On the other 
hand, doubling of EGF just brought slight increase to the transfection by PB-PLE in 
SKOV3 cells, indicating that the level of EGF in polyplexes might have been sufficient 
in facilitating transfection. In particular, the position of EGF in the polyplexes played an 
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important role for accomplishing improvement on transfection. When PLE was added 
after the formation of PB-PL/DNA and formed a vector referred to as PB-PL+PLE, the 
resultant improvement in transfection efficiency was comparable to that achieved with 
PB-PLE, but the amount of PLE used in PB-PL+PLE was only 20% of that in PB-PLE. 
The PLE added later probably helped transfection much more than the PLE directly 
used as a shield agent. Since the outer surface of the polyplex potentially interacts the 
most with cell membrane receptors, ligands such as EGF only need to occupy this 
most advantageous surface to show effect on transfection efficiencies. However, the 
improvement in transfection efficiency was only modest at best, suggesting that 
cellular uptake might not be the main intracellular barrier that the pentablock 
copolymer vectors need to overcome. 
4.3.3 Cellular Uptake  
Flow cytometry measurements revealed that more than 95% of cells had been 
internalized by both PB-PL and PB-PLE type of polyplexes within 30 minute of 
incubation (Fig. 4.8a). After just 10 minutes of transfection, nearly all cells showed 
fluorescence from PB-PL type of polyplexes (data not shown). This internalization rate 
was much faster than linear PEI and PEGylated PEI that was reported to ferry DNA 
into only 10% of cells after 30 minutes of incubation, and even faster than EGF 
conjugated PEGylated PEI which showed an internalization in more than 80% of cells 
in the same time period(36). Conjugation of EGF may have increased the cellular 
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internalization rate as reported in PEI systems(9, 36). However, in the pentablock 
copolymer vector system, polyplexes with and without EGF showed an equally fast 
 
Fig. 4.8.  Cellular uptake of polyplexes with and without EGF conjugation in SKOV3 
cells, reflected by percentage of cells that are positive for (a) AF647 and (b) the 
median fluorescence intensity (MFI) per cell. Values indicate means ± standard 
deviations (n=3), * or # indicate significant difference between PBD-PL and PBD-
PLE with p≤0.05, where PBD denotes the pentablock copolymer labeled with AF647.  
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internalization. This result further confirmed our previous assumption that the PB-PL 
type of polyplexes might be inherently very efficient at passing through cell 
membranes. Even though functionalization with EGF made no difference to the 
internalization rate, it did lead to an increased internalization in the time course of 
transfection as shown in Fig. 4.8b. The increase in the amount of internalized 
polyplexes as characterized by the fluorescence intensity developed with time 
smoothly and ended up with a 1.2-fold enhancement at 3h transfection. Compared to 
other reports of 3 to 4-fold increase in internalization and up to 100-fold enhancement 
in transfection efficiency in EGF modified PEI systems(5, 36), the improvement in the 
pentablock copolymer vector system is small; however, it is in good agreement with 
the moderately enhanced transfection efficiency. Intracellular trafficking showed 
similar results for internalization of polyplexes formed with PB-PL and PB-PLE (Fig. 
4.9). After quantification of over 400 cells at various regions of each sample, the count 
of red dots representing pentablock copolymers was found to be 91±15 per cell with 
EGF containing constructs as compared to 63±5  per cell with the EGF-free 
counterparts (p=0.06). In both cases, we observed no particles clearly attached to the 
cell membrane, which indicates that flow cytometry only measuring internalized 
polyplexes.        
4.3.4 Effect of EGF in Different Systems 
Considering the multiple barriers for highly efficient gene delivery, there might be 
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other rate limiting steps other than cellular uptake, such as endosomal escape, DNA 
unpacking and nuclear localization. Overcoming a single barrier cannot necessarily 
guarantee the success of transfection. As it has been reported for Poly(L-lysine) (PLL) 
based vectors, gene delivery through EGF receptor-mediated internalization was  
 
Fig. 4.9. Representative confocal images of SKOV3 cells after 3h incubation with 
PBD-PL/DNA (a) and PBD-PLE/DNA (b). Pentablock copolymers were labeled with AF647 
(pseudo-red) and nuclei were stained with DAPI (pseudo-blue). Scale bar = 10μm. 
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inefficient without the aid of endosome-releasing agents(10, 35, 37), implying that the 
ligand and endosomolytic agents together play an essential role in PLL mediated gene 
delivery. However, for vectors composed of PEI with great advantage in escaping the 
endosome, the incorporated EGF could make an independent contribution on 
increasing transfection efficiency(5-6). Thus, rate-limiting steps are specific for vectors 
and cell types and need to be investigated individually for each system. In our 
pentablock copolymer/Pluronic based vectors, the cellular uptake does not seem to be 
the major barrier, since the intrinsic internalization of non-EGF polyplexes was found 
to be very fast and the enhancement in transfection efficiency triggered by EGF was 
not dramatic. These results provide some insights into the intracellular barriers for 
transfection, and the fact that cellular entry might be more of a barrier for vectors such 
as PEI but not for the pentablock copolymers. This could potentially be related to the 
micellar structure of the copolymers, which has been shown in drug delivery studies to 
improve cellular entry(2). Further investigation of other potential intracellular barriers 
that may markedly increase the transfection efficiency by overcoming them is 
described in Part 2 of this manuscript.  
4.4   Conclusions    
    EGF receptor mediated gene delivery was investigated with various EGF 
containing polyplexes on SKOV3 and A431 cells. PB-PLE exhibited the best 
transfection efficiency on two different tumor cell lines due to increased internalization. 
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However, the observed overall 3~5 fold enhancement by EGF was relatively low 
compared to other reports involving PEI and different polymeric vectors. This 
discrepancy should result from different intracellular barriers among transgene 
systems. Our PB-PL type of polyplexes showed an extraordinarily fast internalization, 
implying that cellular uptake might not be the real barrier step for this specific system, 
thus compromising the beneficial effect from EGF. This work provides valuable 
insights into the design of gene delivery vectors by changing the polymer architecture 
to facilitate cellular entry. Furthermore, in order to design multifunctional vectors, the 
corresponding barrier steps, which are usually vector and cell specific should be 
extensively examined and evaluated.   
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CHAPTER 5.  THE MECHANISM OF SELECTIVE TRANSFECTION 
MEDIATED BY PENTABLOCK COPOLYMERS;                
PART II: NUCLEAR ENTRY AND ENDOSOMAL ESCAPE 
 
Modified from a paper submitted to Acta Biomaterialia, 2011, 7:1580-1587 
Bingqi Zhang and Surya Mallapragada 
 
Abstract 
Transfection efficiencies of non-viral gene delivery vectors commonly vary with 
cell type, due to differences in proliferation rates and intracellular characteristics. Our 
previous work has demonstrated that the poly(diethylaminoethylmethacrylate) 
(PDEAEM)/Pluronic F127 pentablock copolymers  exhibit transfection in vitro 
selectively in cancer cell lines as opposed to non-cancerous cell lines. This study 
continues the investigation of intracellular barriers to transfection using this vector in 
“normal” and cancer cell lines to understand the underlying mechanisms of the 
selectivity. Results from part I of this investigation showed, using conjugated 
epidermal growth factor (EGF), that cellular uptake of these polyplexes is not a major 
barrier in these systems. In part II of this work, we continue investigation into the 
other potential intracellular barriers, endosomal escape and nuclear entry, using a 
lysosomotropic agent chloroquine (CLQ), and a nuclear localization signal (NLS) 
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SV40 respectively. Lack of effectiveness of NLS peptide in improving the transfection 
efficiency suggests that nuclear uptake might not be the major intracellular barrier 
using the pentablock copolymer vectors, or that the nuclear transport might not be 
primarily achieved through nuclear pores. However, inclusion of CLQ led to a 
dramatic enhancement in the level of gene expression, with almost two orders of 
magnitude increase in expression seen in normal cell lines, compared to that the 
increase observed in cancer cell lines. The different lysosomal pH values in normal 
versus cancer cells was believed to cause the pentablock copolymer vectors to 
behave distinctly during transport through endocytic pathways, with greater loss of 
functional DNA occurring in normal cells containing more acidic endocytic vesicles in 
contrast to cancer cells with less acidic vesicles. Interestingly, CLQ introduced almost 
no enhancement in the transfection with the control vector ExGen that lacked 
selectivity of transfection. Exploiting intracellular differences between normal and 
cancer cells for gene delivery vector design offers a new paradigm to achieve 
transfection selectivity based on intracellular differences rather than conventional 
approaches involving vector modification using specific ligands for targeted delivery.   
5.1   Introduction 
Cell physiology may affect the intracellular trafficking of non-viral vectors, leading 
to cell type specific transfection efficiency(1-2). However, there might be similarities in 
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transfection profiles of cells that can be grouped into the same category based on 
shared specific characteristics that could be involved in the process of gene delivery; 
for example, polarized cells vs. non-polarized cells, and endothelial vs. epithelial 
cells(3). Therefore the differences in these influencing characteristics among cell 
categories could be utilized to design cellular and/or subcellular targeting transgene 
vectors. The most frequently used “difference” comes from cell membranes 
containing various receptors, such as the epidermal growth factor (EGF) receptors 
and folate receptors, which make it possible to achieve selectivity between specific 
receptor over-expressing cells and non-overexpressing counterparts via 
receptor-mediated endocytosis. However, the goal of achieving desired selectivity 
implies selective gene expression in cells of interest, rather than the selective gene 
uptake by those cells. Although many researchers have reported selective 
transfection based on ligand-receptor aided cellular entry, this works only if the 
cellular entry is the barrier to transfection. However, gene delivery is a complex 
process and following the cellular entry, there are several potential barriers to 
overcome, such as endosomal escape(4-7), efficient protection for DNA(8), trafficking 
in the cytoplasm(9), nuclear uptake and vector unpacking (10-11). Efforts to improve 
transfection efficiency and selectivity need to be based on a detailed identification of 
rate limiting barriers to the specific gene delivery system(10).  
    We have shown earlier that the poly(diethylaminoethylmethacrylate) (PDEAEM) 
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/Pluronic F127 pentablock copolymers developed in our group possesses natural 
selectivity for transfecting cancerous cell lines versus non-cancerous cell lines, and 
this selectivity was assumed to be correlated with cell proliferation rate and other 
cellular characteristics that may affect the gene delivery(12). Identifying the rate 
limiting step(s) and intracellular barriers in gene delivery is important for 
understanding the mechanism and perfecting the vector design. For the pentablock 
copolymer and Pluronic system, we have observed a positive effect of increasing 
cellular uptake on the overall gene expression by incorporating EGF, but the small 
3~5 fold enhancement in transfection and lack of differences in cellular uptake rates 
suggest that cellular entry might not be the rate limiting step(13). The micellar 
structure of the polymer probably makes it already very accessible to the cell 
membrane(14), thus minimizing the role of a cellular uptake facilitator such as EGF. 
In this work, we investigated two other possible barriers for the gene delivery 
mediated by this pentablock copolymer, namely nuclear uptake and endosomal 
escape. By comparing the effects of these other potential intracellular barriers in 
cancer and normal cell lines, we hope to elucidate the mechanism behind the 
selectivity of transfection.    
    Nuclear uptake has been considered a common barrier for gene expression, 
especially for slowly dividing or quiescent cells(15-17). Plasmid DNA can enter the 
nucleus in two ways, through nuclear pores or by sequestration on nuclear 
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reformation during mitosis(18). However, it was suggested that plasmid DNA does 
not have the ability to actively go across the nuclear envelope(19-20), unless 
assisted by the particular nuclear localization signals (NLS) such as SV40 NLS, the 
most commonly used NLS that is derived from the SV40 large T-antigen(21-23). 
DNA-NLS conjugates can bind to importin-α and subsequently importin-β to form a 
complex that mediates the interaction with the nuclear pore complex for an active 
nuclear import(19). Here we aim to determine the influence of incorporating SV40 
NLS in the transgene vector on the transfection efficiency.  
    To accomplish nuclear entry, the DNA payload must first be available in the 
cytoplasm by escaping from the endosome before it transforms to a lysosome. 
Otherwise the DNA would be degraded within the lysosome or recycled back to the 
cell surface(6). That is why endosomal escape has been recognized as another key 
step in non-viral gene delivery(5-6). In the present work, we used chloroquine, a 
diprotic weak base known to facilitate endosomal escape(24), to examine the effect 
of endo/lysosomal trapping on transfection efficiency with the pentablock copolymers 
in cancer versus non-cancerous cell lines. The identification of the intracellular 
barrier(s) to transfection can allow for examination of differences in cancer and 
non-cancerous cell lines to understand the mechanism of selective gene expression 
in specific cell types. 
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5.2   Experimental 
5.2.1 Materials  
The human ovarian carcinoma SKOV3, human epidermoid carcinoma A431 and 
human retinal cell lines ARPE-19 were obtained from ATCC™(Manassas, VA). The 
human skin keratinocyte cell line HaCaT was kindly donated by Dr. Ian Schneider’s 
Laboratory (ISU, Ames). Dulbecco’s Modified Eagle Medium (DMEM), heat 
inactivated fetal bovine serum (FBS), 0.25% trypsin-EDTA and Hank’s buffered salt 
saline (HBSS) were purchased from Invitrogen (Carlsbad, CA). ARPE-19 growth 
media Dulbecco’s MEM: Ham’s Nutrient Mixture F-12, 1:1 Mix (DMEM/F-12) was 
purchased from ATCC (Manassas, VA). Luciferase assay system and passive lysis 
buffer were purchased from Promega (Madison, WI). HEPES salt used to make 
Hepes buffered saline (HBS), chloroquine diphosphate salt, heparin, 
Deoxyribonuclease II (DNase II) from bovine spleen and paraformaldehyde were 
obtained from Sigma (St Louis, MO). SV40 NLS (PKKKRKVG) was obtained from 
AnaSpec (Fremont, CA). Recombinant human epidermal growth factor (EGF), Alexa 
Fluor®647 carboxylic acid, succinimidyl ester (written as AF647 hereafter), 
LysoTracker® Red DND-99, 4',6-diamidino-2-phenylindole (DAPI) dilactate and 
ProLong® Gold antifade reagent were purchased from Invitrogen (Carlsbad, CA). 
ExGen 500 was purchased from Fermentas Life Sciences (Hanover, MD). HiSpeed 
Plasmid Maxi Kit was obtained from Qiagen (Valencia, CA). Pluronic F127 
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[(PEO)100-b-(PPO)65-b-(PEO)100], (where PEO represents poly(ethylene oxide) and 
PPO represents poly(propylene oxide)) was donated by BASF (Florham Park, NJ) 
and used without further modification. 6.7kb pGWIZ-luc (GeneTherapy Systems Inc, 
CA) plasmid encoding the luciferase reporter gene was purified with Qiagen HiSpeed 
Maxi Kit.  
5.2.2 Polyplex Formation  
The pentablock copolymer used in this study was synthesized by atom transfer 
radical polymerization and has been characterized in detail and tested for cytotoxicity 
as described earlier (25-26). For intracellular trafficking studies, the pentablock 
copolymers were labeled with AF647 according to the procedure reported elsewhere 
and named PBD for short(12). During the polyplex formation, all polymer solutions 
were prepared in 0.5× HBS buffer, pH 7.0 unless stated otherwise. Briefly, various 
quantities of unlabeled or labeled pentablock copolymer solution (2mg/ml) was added 
to plasmid DNA solution (in water) which was either pre-complexed with SV40 NLS or 
not, to obtain desired N/P (nitrogen/phosphate) ratios. The mixture was gently 
vortexed and allowed to stand at room temperature for 20 min to ensure 
complexation. Appropriate amount of Pluronic F127 solution (10 mg/ml) was further 
added to form a shield layer around the newly formed polyplexes by self-assembly. In 
some cases, EGF attached Pluronic F127 was used to endow the polyplexes with cell 
surface targeting ability. The procedure for EGF attachment is described in Part I of 
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this investigation(13). Four abbreviations are used: PB the pentablock copolymer 
alone, PBD the AF67 labeled pentablock copolymer, PBE the pentablock copolymer 
attached by EGF, PL Pluronic F127, PLE Pluronic F127 attached to EGF and 
correspondingly, PB-PL and PB-PLE refers to the pentablock copolymer with 
subsequently added PL and PLE, respectively.    
5.2.3 NLS Attachment to Pluronic F127 
    Pluronic F127 was functionalized to be amine active through 
N-hydroxysuccinimide (NHS) activation following the procedure described 
previously(13). Due to the fact that SV40 NLS possesses multiple primary amines on 
a single molecule, the amount of SV40 NLS in the feed was maintained in excess in 
such a way that each peptide could only be reacting with a single NHS. Briefly, 10mg 
of NHS-activated Pluronic was added to a solution of 2mg of SV40 NLS in 1ml of 
PBS (pH 7.4). The mixture was stirred at room temperature for 4 hours when an 
additional 10 mg of NHS-Pluronic was added. After reacting for another 20h, the 
resultant solution was dialyzed against 0.2× PBS using Dialysis Cassette (Thermo 
Scientific, MW cut off 10000) for 48 h and lyophilized product was finally obtained.  
5.2.4 Gel Retardation Assay 
    Polymer/DNA polyplexes with or without NLS were formed as described above. 
40µl of each polyplex solution was loaded in a well for electrophoresis assay on a 1% 
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agarose gel with Tris-acetate (TAE) running buffer at 60V for 120 min. DNA bands 
were visualized with ethidium bromide staining. In testing protection ability of 
pentablock copolymer to DNA against nuclease, DNase II (1μl of 100unit/μl) was 
added to preformed polyplex solutions (containing 0.25μg DNA per sample) and 
incubated for 20min at 37°C, followed by additional 40min incubation at 80°C to 
ensure enzyme deactivation. Heparin (1μl of 100μg/μl) was then added and allowed 
to act for 20min to release DNA packaged in the polyplexes. About 40ul of this 
mixture was transferred into each well of a 1% agarose gel for electrophoresis.   
5.2.5 Cell Culture  
    The SKOV3, A431 and HaCat cells were grown in DMEM supplemented with 10% 
(v/v) FBS at 37°C under a humidified atmosphere containing 5% CO2. ARPE-19 cells 
were grown in DMEM/F-12 containing 10% FBS under the same conditions. All cell 
types were sub-cultured every 2-3 days, expect for APRE-19 which was passaged 
once a week. 
5.2.6 In vitro Transfection  
    Cells of interest were seeded into a 96-well plate or 6-well plate with an initial 
density of 1.2×104 or 1.5×105 cells per well and ready for transfection in one or two 
days after reaching 70-80% confluence. Half an hour before transfection, the old 
medium was replaced with fresh growth medium containing 10% FBS with or without 
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100µM chloroquine. Polyplexes prepared at given N/P ratios were added to each well 
with 0.6µg of DNA per well for 96-well plate and 3µg DNA per well for 6-well plate. 
Cells were allowed to incubate for 3h when the medium containing polyplexes was 
replaced with fresh medium with or without chloroquine (at t=3h). The chloroquine 
was allowed to be in contact with cells for another 21h and removed by changing the 
medium (at t=24h). After 45h post-transfection (at t=48h), cells in the 96-well plates 
were lysed and tested for luciferase activity. The luminescence was measured in 
arbitrary Relative Luminescence Units (RLU) on an automated Veritas™ Microplate 
Luminometer. Each transfection was done in triplicate. ExGen 500, a sterile solution 
of linear 22 kDa polyethyleneimine (PEI), was used as a positive control at N/P ratio 
of 6 according to the manufacturer’s protocol.  
5.2.7 Confocal Microscopy  
    Cells of interest were seeded onto poly-L-lysine coated coverslips and 
subsequently transfected with PBD containing polyplexes following the same 
procedures used with the 6-well plates. At specific time points during transfection or 
post-transfection, cells were rinsed and incubated in the medium containing 100nM 
LysoTracker Red for 1h. Following that, cells were fixed with fresh 4% 
paraformaldehyde and then treated with 300nM DAPI in PBS for 5min. The coverslip 
was washed thoroughly with PBS and air dried before being mounted on the glass 
slide with a drop of antifade reagent in between. Confocal images were collected with 
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the objective of 63-er Oil / N.A. 1.4 on a Leica TCS SP5 X Supercontinuum Confocal 
Microscope and analyzed with MetaView software (Universal Imaging Corporation). 
Sequential scans were used to minimize the cross-talk between different 
fluorochromes. The pinhole size was automatically adjusted by the software and 
maintained the same during imaging.  
5.2.8 Statistics  
    The data is presented as mean and standard deviation was calculated over at 
least three independent experiments. Significant differences between two groups 
were evaluated by Student’s t-test with p<= 0.05.  
5.3  Results and Discussion 
5.3.1 Transfection with NLS-modified Polyplexes 
    NLS was incorporated in the polyplex with two strategies, electrostatic coupling 
to DNA, and covalently conjugation to the Pluronic shield (PL-NLS). In the latter case, 
the NLS was expected to assist the trafficking of polyplexes toward the nucleus, and 
not necessarily to help the polyplexes enter the nucleus, due to the size limit of 
nuclear pores. However, with both types of NLS-containing polyplexes, we observed 
no improvement in transfection efficiency; by contrast, a dramatic decrease in 
transfection efficiency at higher concentration of NLS was observed, as compared to 
non-NLS formulations as shown in Fig. 5.1. For the condition with NLS directly 
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coupled to DNA, a large portion of DNA might stay packed in the polyplexes, thus 
greatly reducing the likelihood of exposing NLS to the nuclear import factors. 
Previous intracellular trafficking in SKOV3 cells showed that there was still a large 
amount of pentablock copolymer/DNA colocalization in the cytoplasm even at 21h 
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Fig. 5.1. Transfection of SKOV3 (a) and A431(b, c) cells with different types of NLS-modified 
polyplexes. In a and b, DNA was pre-complexed with NLS at various N/P ratios; in c, NLS was 
conjugated to Pluronic (PL-NLS) which was mixed with unmodified Pluronic at various amounts. 
PB-PL indicates that the polyplexes are composed of pentablock/DNA condensate with Pluronic 
F127 shield. The following number 20 or 30 denotes the N/P ratio with respect to the pentablock 
copolymer and DNA. Values indicate means ± standard deviations (n=3) 
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post-transfection(12). Once some DNA was released, the electrostatically coupled 
NLS could be replaced by competing proteins in the cytoplasm and not get to the 
nucleus. But even for vectors with NLS covalently coupled to DNA, the published 
results still show limited success(27-28). Since nuclear uptake could take place 
during cell division when cell membrane disappears, we suggest that nuclear uptake 
is not the bottleneck step for transfection of cancer cells using pentablock copolymer 
vectors. There may exist other barrier steps in the transfection process, such as 
endosomal escape, that block the route down to nuclear import. The significant 
decrease in the transfection efficiency with higher amount of NLS might be due to 
some of the NLS interfering with the transcription domain of the DNA(29), or the 
positive charges of NLS peptide weakening the stabilizing effect of Pluronic.  
    The same study was also conducted in normal cell lines ARPE-19 and HaCat 
with NLS modified vectors (some data shown in Fig. 5.2), which exhibited similar 
results suggesting that NLS does not improve transfection in all the different cell 
types studied. Thus, nuclear uptake may not be the reason for selective transfection 
of cancer cells over normal cells.  
5.3.2 Effect of Chloroquine on Transfection Efficiency  
    Chloroquine (CLQ), a weak base that accumulates in acidic organelles such as 
late endosomes and lysosomes has been suggested to be able to enhance 
transfection efficiency of non-viral gene delivery by facilitating endosomal release and 
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inhibiting lysosomal enzyme activity(30). In spite of its application as a common 
therapeutic drug for malaria(31), CLQ is not appropriate to be applied as a 
transfection facilitating agent due to its toxicity at high dose levels(32). Here we used 
CLQ as a tool to uncover the influence of endosomal escape on the overall gene 
delivery with the pentablock vectors. To maintain satisfactory cell viability, CLQ was 
kept in growth medium only for the first 24h during transfection and post-transfection.  
From the time course of gene expression, endosomal escape occurs between 
cellular uptake and nuclear uptake, and hence likely to compromise and even 
eliminate the efforts to increase gene expression through improving cellular and/or 
nuclear uptake. In order to test this possibility, vectors that appeared most effective in 
the study on EGF attachment in part I of this work(13) and NLS were included 
together with the unmodified formulations for transfection in the presence and 
absence of CLQ (Figs. 5.2a-d). The condition with CLQ showed significant 
transfection enhancement with the pentablock copolymer vectors in all cell types 
studied. In particular, the enhancement by CLQ with PB-PL based vectors was 1~2 
orders of magnitude higher in non-cancerous cell lines ARPE and HaCat, as 
compared to cancerous cells SKOV3 and A431. For ExGen, CLQ made little 
difference in all cases except for HaCat in which a small 7-fold increase was 
observed. Similar results showing very small or negative influence of lysosomotropic 
agents such as CLQ on PEI mediated gene delivery were reported by others (33-35). 
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The evident beneficial effect from CLQ on transfection efficiency using the pentablock 
copolymer vectors indicates that endosomal escape and/or neutralization of 
lysosomal vesicles represented a significant barrier in the PB-PL based gene delivery 
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Fig. 5.2. Transfection of cancer (SKOV3, A431) (a, b) and non-cancer (ARPE, HaCat) (c, d) cell lines          
with unmodified polyplexes and NLS or EGF containing polyplexes in the presence (open bars) and  
absence (cross-hatched and filled bars) of CLQ; 0.375xNLS indicates that NLS was added at N/P ratio 
of 0.375 with respect to NLS and DNA. Values indicate means ± standard deviations (n=3); ^^  
indicates p<0.01; * and ^ indicate p<0.05; # indicates p<0.1. All conditions with CLQ showed significant 
differences compared to conditions without CLQ except those marked with “&”.  
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system, especially for non-cancerous cell lines. This result was in good agreement 
with our previous intracellular trafficking studies in which ARPE cells showed less 
nuclear uptake, as well as less pentablock copolymer and DNA colocalization, 
compared to SKOV3 cells(12). We hypothesized that slower proliferation rates and 
easier DNA degradation in ARPE cells might account for the observed difference in 
transfection. From the present results, failure to escape from the endolysosome, thus 
causing more DNA degradation could be a major issue, though inefficient nuclear 
uptake is still possibly related to the slower proliferation. When a large fraction of 
DNA is degraded in the enzyme-rich lysosomes, there would be fewer polyplexes 
available in the cytoplasm and even fewer that could eventually enter the nuclei. 
However, use of CLQ in conjunction with the NLS peptides did not lead to any 
enhancement in the transfection efficiency, implying that nuclear uptake is not a 
major intracellular barrier in this pentablock copolymer vector system. Interestingly, 
the use of CLQ in conjugation with EGF-attached vectors did not show any 
cumulative improvements in transfection compared to that achieved with either of 
them being used alone for SKOV3and A431 cells, but there was a slight improvement 
in transfection for the ARPE and HaCat cells in some of the cases. In normal cell 
types, ARPE and HaCat, plenty of the polyplexes internalized with the aid of EGF 
might have been sequestered by the endosomes, making CLQ’s effect of endosomal 
release more beneficial. All in all, endosomal escape seems to be the primary barrier 
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for both cancer and non-cancer cells, but to a much greater degree for the latter. 
Therefore, the selectivity we observed between the transfection of cancer and normal 
cells might be attributed to their diverse endo/lysosomal entrapment abilities, which in 
turn could result from their different intracellular pHs. As reported in literature, normal 
cells generally have neutral cytosolic pH around 7.2, acidic endosomal pH around 6.0 
and lysosomal pH around 5.0, whereas many tumor cells have a more acidified 
cytosol and less acidified endo/lysosomes with both pH values being around 6.7(36). 
This seems to be the case for cell lines as well. Oncogene transformed 3T3 fibroblast 
cell lines were found to have significantly higher intralysosomal pH relative to 
nontransformed parental 3T3 cells(37). Although the reason for alkalinization of the 
lysosomal compartment has still been elusive, the elevated organelle pH in tumor 
cells is typically observed(38-39), which in the case of gene delivery provides a 
favorable environment for the transgene vector to maintain function in otherwise 
hostile endocytic vesicles seen in normal cells.  
   To verify this hypothesis, the role of pH on the ability of pentablock copolymers to 
protect DNA from degradation was examined with DNase II, the primary acidic 
endonuclease most active at pH 4.5 in lysosomal compartments. As shown in Fig. 
5.3a, DNA was fully condensed and retarded by the pentablock copolymer at N/P of 
20 at all three pH values investigated (lane 1, 4 and 7). The integrity of DNA released 
from the polyplexes showed little change with pH (lane 2, 5 and 8) as compared to 
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naked DNA in the absence of the enzyme. However, when treated with DNase II, 
DNA encountered increasingly reduced protection with the pentablock copolymer as 
 
   
Fig. 5.3. Protection provided by pentablock copolymer to DNA against DNase II at various 
pH values. (a) agarose gel electrophoresis of polyplexes at N/P=20 (lane 1-9) with naked 
DNA (lane 10) as control; heparin was added to release DNA from the polyplex. The amount 
of DNA either in linear or supercoiled form released from polyplexes was quantified with 
respect to naked DNA and depicted in (b); results were presented as means ± SD, n=2.  
 
 
4 5 6 7
0
100
200
300
400
500
600
 
 
P
er
ce
nt
ag
e 
(%
)
pH
 linear DNA            -DNase 
 supercoiled DNA  -DNase 
 linear DNA            +DNase 
 supercoiled DNA  +DNase
4.3           5.2           6.0             7.0
b
148 
 
the pH dropped from 7.0 to 4.3, with about 60% of supercoiled DNA at pH of 7.0 
decreasing to 20% at pH of 5.2 and further down to zero at pH of 4.3 (Fig. 5.3b). 
Notably, DNase II became more detrimental to polyplexes at lower pH values, either 
by degrading all DNA into small fragments (lane 3) or by triggering the transformation 
of DNA from supercoiled structure to linear form (lane 6). The latter is known as the 
initial phase of the action of DNase II upon DNA substrates(40), which also occurred 
to some extent in the polyplex with pH of 7.0 (lane 9). Lysosomal DNase II has been 
identified as a significant barrier to transfection due to vector degradation upon 
lysosomal sequestration(41). But the barrier could be addressed by raising 
intralysosomal pH with lysosomotropic agents such as CLQ. On the other hand, 
lysosomal degradation might no longer be such a significant barrier for cells with less 
acidified lysosomes, such as tumor cells. That could explain the observed huge 
enhancements by CLQ in transfection efficiency of normal cell lines but relatively mild 
enhancements in cancer cell lines. In other words, the selectivity of pentablock 
copolymer mediated transfection between normal and cancer cells was probably due 
to the difference in lysosomal pH values. ExGen cannot take advantage of this pH 
difference to selectively transfect cell types because of its well-known proton sponge 
effect and other endocytosis pathways that might not involve lysosomes(42). 
5.3.3 Visualizing the Effect of CLQ via Confocal Microscopy  
    CLQ penetrates and accumulates in the intracellular acidic compartments, such 
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as lysosomes, resulting in proton consumption and thus an increase in the flux of 
counterion to neutralize the membrane potential. Consequently, the intralysosomal 
pH may rise from 4.0~4.5 to over 6.0 as the alkalinizing action progresses(37, 43), 
which falls out of the pH range for most lysosomal enzymes to function(32), thereby 
protecting the entrapped contents. In the meantime, lysosomes might grow in volume 
and even end up rupturing due to the continual swelling under osmotic pressure(44). 
As shown in Fig. 5.4, cells transfected in the presence of CLQ showed obviously 
larger volume of endo/lysosomes (Fig. 5.4b, d) relative to the condition without CLQ 
(Fig. 5.4a, c), indicating the accumulation and disruption of CLQ in these acidic 
vesicles. Some vesicles achieved really impressive swelling shown by the arrows 
especially in SKOV3 cells. With increased osmotic pressure, these swollen vesicles 
might consequently rupture and lose their shapes, as seen for the most cases in 
HaCat cells with a lower lysosomal pH. As a result, the encapsulated polyplexes were 
released and became available in the cytoplasm, which can be characterized by less 
colocalization of pentablock copolymers and endo/lysosomes. In the absence of CLQ, 
we can clearly see that most of the polyplexes were separated from the 
endo/lysosomes of SKOV3 cells (Fig. 5.4a). By contrast, most of them were trapped 
in the vesicles of HaCat cells (Fig. 5.4c). With CLQ added to neutralize the acidic 
vesicles, a dramatically large number of polyplexes became available outside of the 
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endo/lysosomes of HaCat cells (Fig. 5.4d). But in SKOV3 cells, the addition of CLQ 
did not release a huge number of additional polyplexes (Fig. 5.4b). These results 
align well with the differences observed in transfection efficiencies. Thus far, the 
differences observed due to the effect of CLQ addition in cancer and non-cancer cells 
suggest endosomal escape as a transfection barrier to significantly different extents 
 
 
Fig. 5.4. Confocal images of SKOV3 (a, b) and HaCat (c, d) cells at 8h post-tranfection in the 
absence (a, c) and presence (b, d) of CLQ. Polyplexes were removed by changing media after 3h 
transfection. The colors green, red and blue were assigned to endo/lysosomes stained with 
LysoTracker Red, pentablock copolymers labeled with AF647, and nuclei stained with DAPI, 
respectively. Scale bar = 10μm 
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for the two cell types, which explains the selective transfection in cancer cells with 
pentablock copolymer vectors as seen earlier. It is difficult to obtain any information 
about how CLQ affected the amount or integrity of DNA from the images. Further 
studies will be conducted on this subject with both lysosome and DNA labeled.   
5.3.4 Effect of Ammonium Chloride versus CLQ on Transfection Efficiency 
    To further confirm that the contribution of CLQ to the transfection enhancement 
was by removing the polyplexes from the digestive endocytic route, we replaced CLQ 
with ammonium chloride (NH4Cl), another lysosomotropic agent (45), to examine if 
NH4Cl can lead to the similar enhancement as CLQ. As shown in Fig. 5.5, the 
addition of NH4Cl introduced certain increase in PB-PL based transfection for both 
cell types, especially at higher concentrations, with more intense effect in normal cell 
type HaCat vs. cancer cell type SKOV3, which further supports the notion that 
endosomal escape is the major barrier using the pentablock copolymers and is 
responsible for the selective transfection of cancer cells with pentablock copolymer 
vectors. Yet, NH4Cl addition resulted in an obviously smaller enhancement in 
transfection relative to CLQ even though they were expected to perform the same 
way in terms of disrupting endo/lysosomes. A direct reason might lie in the 
physiochemical properties of the two weak bases. CLQ probably has greater ability of 
inhibiting acidification than NH4Cl; it has been reported that CLQ raised the 
environmental pH from 5.7 to 8.4 as compared to the neutral pH achieved with 
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NH4Cl(46). 
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Fig. 5.5. Transfection of PB-PL based polyplexes and ExGen in the presence (open 
bars, indicated by w/i NH4Cl) and absence (cross-hatched and filled bars) of NH4Cl 
on SKOV3 (a) and HaCat (b) cells at two N/P ratios. Values indicate means ± 
standard deviations (n=3); symbols indicate the significant differences between 
conditions with and without CLQ; p≤0.05 (single symbol) or ≤ 0.01(double symbols).  
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   Besides disrupting endo/lysosomes, CLQ has been reported to be able to 
facilitate polyplex unpacking(46), due to its ability to bind DNA either by its intrinsic 
quinoleic moiety or by the positive charges after protonation. Thus, in addition to 
endosomal escape, CLQ triggering polyplex unpacking might be another reason for 
its dramatic and selective improvement in transfection. If differences in polyplex 
unpackaging are contributing to differences in transfection efficiencies between 
normal and cancer cells, the pH differences between normal and cancer cells should 
lead to differences in unpacking. However, agarose gel electrophoresis (Fig. 5.6) 
showed visible variance of DNA mobility with pH only at N/P ratios below 0.3, 
suggesting the polymer cannot compact DNA effectively at such low N/P ratios, 
leading to more unpacking at higher pH. At N/P ratios of 0.5 or higher (the 
 
 
Fig. 5.6. Differences in complexation of pentablock copolymer/DNA polyplexes at different pH 
values and at various N/P ratios. Polyplexes were formed at 0.5x HBS buffer, pH=7 and then 
incubated in sodium phosphate/citric acid buffers of various pH values for 6h at 37ºC before being 
loaded on 1% agarose gel for electrophoresis.  
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transfection studies were conducted at N/P ratio of 20), pH changes did not show any 
effect on polyplex dissociation. Therefore, we do not expect any significant 
differences in unpacking of polyplexes, in normal and cancer cells due to intracellular 
pH differences. So even though unpacking might be a possible mechanism for CLQ 
enhanced transfection(47), it is probably not the reason for the selective transfection 
in cancer cells observed with the pentablock copolymer vectors.  Therefore, we 
propose that the differences in pH of lysosomes played an essential role in 
determining transfection efficiency in pentablock copolymer mediated gene delivery 
in cancer cells versus normal cells. Other possible barriers such as cellular uptake 
and nuclear localization were found not to be as limiting as release from endocytic 
vesicles, when using the pentablock copolymers as vectors.  
5.4   Conclusions 
    In an effort to elucidate the mechanism underlying the selective transfection 
between non-cancer and cancer cells mediated by the pentablock copolymer vectors 
but not ExGen vectors, we tested various intracellular barriers that might affect gene 
transfer efficiency. We conclude that escape from the endocytic pathway served as 
the primary intracellular barrier for pentablock copolymer-mediated transfection, 
whereas ExGen was not limited by this process because it facilitates endosomal 
escape. This, in turn, provides insights into differences in transfection efficiencies in 
cancer and normal cells using the pentablock copolymers because of intracellular pH 
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differences in the two cell types. Pentablock copolymer/DNA vectors could have been, 
in large part, sequestered and degraded in acidic lysosomes of non-cancer cells, but 
survived and maintained function in less acidic lysosomes of cancer cells. This 
property could be taken advantage of to design vectors selectively transfecting cells 
with higher lysosomal pH, such as many tumor cells. The present work highlights the 
importance of identifying intracellular barriers for different gene delivery systems 
involving vectors and cells and provides a new paradigm for designing targeting 
vectors based on intracellular differences between cell types, rather than through the 
use of targeting ligands.       
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CHAPTER 6.   SENSING POLYMER/DNA POLYPLEX DISSOCIATION 
USING QUANTUM DOT FLUOROPHORES 
 
Modified from a paper published in ACS Nano, 2011, 5:129-138 
Bingqi Zhang, Yanjie Zhang, Surya K. Mallapragada, and Aaron R. Clapp 
 
Abstract 
    We characterized the dissociation of polymer/DNA polyplexes designed for gene 
delivery using water-soluble quantum dots (QDs). A pH-responsive pentablock 
copolymer was designed to form stable complexes with plasmid DNA via tertiary 
amine segments.  Dissociation of the polyplex was induced using chloroquine where 
the efficiency of this process was sensed through changes in QD fluorescence.  We 
found that increasing concentrations of pentablock copolymer and DNA led to 
quenching of QD fluorescence while chloroquine alone had no measurable effect.  
The mechanism of quenching was elucidated by modeling the process as the 
combination of static and dynamic quenching from the pentablock copolymer and 
DNA, as well as self-quenching due the bridging of QDs.  Tertiary amine 
homopolymers were also used to study the effect of chain length on quenching.  
Overall, these QDs were found to be highly effective at monitoring the dissociation of 
pentablock copolymer/DNA polyplexes in vitro and may have potential for studying 
the release of DNA within cells. 
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6.1   Introduction 
    Semiconductor quantum dots (QDs) have seen increasing use in conjunction with 
or as an alternative to organic fluorophores in molecular and celluar imaging for non-
viral gene delivery due to their broad excitation spectra, narrow and size-tunable 
emission spectra, and superior brightness and photostability(1, 2).  QDs can be 
coupled either to polymers or DNA to investigate intracellular trafficking of the target 
particles among stained organelles(3-8).  In particular for measuring polymer-DNA 
interactions, the distance between polymer and DNA can be sensed by Förster 
resonance energy transfer (FRET) in which QDs function as fluorescence energy 
donors(9-11).  However, regardless of method used, appropriate chemical 
modifications are required, either for QDs, DNA, or other DNA condensing agents, 
which leads to complicated processing and/or potential interference with the 
functionality of the biomolecules or nanocrystals.  Here, we report for the first time a 
facile and sensitive method to examine unpacking of polymer-DNA polyplexes 
induced by other competing agents on the basis of QD quenching.  
    We have developed a promising new thermogelling cationic pentablock copolymer 
vector for sustained gene delivery(12, 13).  In addition to favorable transfection 
efficiencies and low cytotoxicity, these vectors exhibited a selectivity for transfection 
of cancer cells versus non-cancer cells(14), however the mechanism behind this 
selectivity is not fully understood.  There have been several studies aimed at 
elucidating the intracellular mechanism of gene transfection for various polymeric 
vectors by trafficking studies and other methods(15-17).  The ability to track the 
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dissociation of polymer-DNA complexes intracellularly would provide answers to the 
key questions regarding vector unpackaging and its effect on transfection efficiency.  
As a common lysosomotropic agent, chloroquine (CLQ) has been found to 
significantly enhance transfection efficiency in many systems(18-20).  Among the 
multiple roles CLQ may play in assisting gene delivery, facilitating dissociation of 
DNA from polymers has emerged as an interesting possibility as it is also helpful for 
evaluating intracellular gene delivery barriers(21).  The main strategy currently used 
by researchers to measure CLQ triggered polyplex dissociation relies on 
intercalating DNA dyes, either by measuring the amount of released DNA following 
removal of intact polyplexes through membrane filtration(22, 23), or through a dye 
exclusion assay presuming that polyplex dissociation can be characterized by the 
susceptibility of DNA to dye intercalation(23).  However, one essential problem in 
these methods is that the intercalating capacity of CLQ with DNA can compete with 
many of the dyes used for DNA quantification, making it extremely difficult to 
accurately measure the actual amount of free DNA in solution or to assess the 
displacing effect of CLQ.  In this work, we utilize cysteine-coated CdSe-ZnS core-
shell QDs in place of common DNA intercalating dyes to measure DNA released 
from polyplexes formed with poly(diethylaminoethylmethacrylate) (PDEAEM)/ 
Pluronic F127 pentablock copolymers in the presence and absence of CLQ. 
6.2    Materials and Methods 
6.2.1 Materials Hexadecylamine (HDA, 90%), hexamethyldisilathiane (TMS2S),      
----Hexadecylamine (HDA, 90%), hexamethyldisilathiane (TMS2S), trioctyl phosphine 
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(TOP, 90%), and diethylzinc (Et2Zn) were purchased from Sigma-Aldrich (St. Louis, 
MO) and used as received.  Cadmium acetylacetonate (Cd(acac)2) and selenium 
shot (Se, 99.99%) were used as received from Strem Chemicals (Newburyport, MA).  
Trioctylphosphine oxide (TOPO, 98%) was obtained from Alfa Aesar (Ward Hill, MA) 
and used as received.  L-cysteine (≥ 99%) was purchased from Acros Organics and 
used as received.  Chloroquine diphosphate salt was obtained from Sigma-Aldrich.  
Pluronic F127 [(PEO)100-b-(PPO)65-b-(PEO)100], (where PEO represents 
poly(ethylene oxide) and PPO represents poly(propylene oxide)) was donated by 
BASF (Florham Park, NJ) and used without further modification.  Chloroform and 
carbon disulfide (CS2) were used as received from Fisher Scientific (Pittsburgh, PA).  
6.7kb pGWIZ-luc (GeneTherapy Systems Inc, CA) plasmid was purified with Qiagen 
HiSpeed Maxi Kit (Qiagen, Valencia, CA). 
6.2.2 Preparation of Water Soluble QDs by Ligand Exchange  
     CdSe-ZnS core-shell QDs were synthesized using a method previously reported 
by Clapp et al.(24) and Howarth et al.(25) with some minor modifications.  Briefly, 
appropriate quantities of hexadecylamine (HDA) and trioctyl phosphine oxide (TOPO, 
~10-30 g) were melted in a three-neck round bottom flask at ~150 °C followed by 
degassing under vacuum and purging with N2 via a Schlenk line.  The mixture was 
further heated above 300 °C where cadmium acetylacetonate (Cd(acac)2) and 
selenium precursor (1 M trioctylphosphine coordinated selenium, TOP:Se ) were 
rapidly injected by syringe into the flask through a rubber septum.  The temperature 
was then abruptly reduced to 80 °C to arrest the nanocrystal growth and ensure a 
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narrow size distribution of CdSe core particles.  CdSe cores were subsequently 
overcoated with multiple ZnS layers (three or more) by dropwise addition of 
diethylzinc (Et2Zn) and hexamethyldisilathiane ((TMS)2S) at ~140 °C. The resulting 
core-shell QDs were allowed to stir and anneal at 80 °C overnight. 
     To render CdSe-ZnS QDs water soluble, a biphasic ligand reaction and 
exchange procedure was employed which we have reported recently(26).  Briefly, 
CdSe-ZnS QDs, having been purified by three-fold precipitation in dry methanol, 
were re-suspended in chloroform (CHCl3).  Carbon disulfide (CS2) was added to the 
CHCl3 organic layer containing the QDs.  A second aqueous phase was added to 
the 20 mL glass reaction vial containing dissolved cysteine (Cys).  During 24 h of 
vigorous stirring, CS2 and Cys reacted to form dithiocarbamate (DTC) ligands having 
high affinity for the QD surface.  The newly hydrophilic Cys-capped QDs were 
collected from the aqueous layer and further purified using a 50k MW cutoff 
membrane filter (Millipore, Billerica, MA) and PD-10 chromatography column (GE 
Healthcare, Piscataway, NJ). 
6.2.3 Preparation of Pentablock Copolymers and Homopolymers 
  Poly(diethylaminoethyl methacrylate)(PDEAEM)/Pluronic F127 pentablock 
copolymers and PDEAEM homopolymers were synthesized via atom transfer radical 
polymerization (ATRP).  The detailed procedure has been described elsewhere(27). 
6.2.4 Polyplex Formation                                                       -------------------------
 ….Appropriate amounts of pentablock copolymer in HEPES buffer and plasmid 
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DNA in water was mixed at N/P (nitrogen/phosphorus) ratio of 20, followed by 
incubation at room temperature for 30 min to ensure complete complexation. 
6.2.5 Measurement of Fluorescence 
      The fluorescence spectra of QDs in the presence of pentablock copolymers, 
polyplexes, DNA, chloroquine, and homopolyemers were measured by a dual 
monochromator spectrofluorimeter (Fluoromax-4, Horiba Jobin Yvon) with excitation 
at 370 nm and slit widths of 3 nm (excitation and emission).  To ensure an 
equilibrated interaction between QDs and other reagents, mixtures were allowed to 
incubate for 30 min following addition of QDs to each sample. 
6.3    Results and Discussion  
6.3.1 Polyplex Dissociation Monitored by QD Fluorescence Quenching  
      CdSe QDs have been reported to bind molecules having tertiary amines with 
high affinity(28).  Though not previously demonstrated, hydrophilic Cys -capped 
CdSe-ZnS QDs were considered as viable binding surfaces for the pentablock 
copolymers (having similar blocks of tertiary amines) used in this work.  Interestingly, 
pentablock copolymers induced significant quenching of QD fluorescence upon 
mixing.  QDs mixed with plasmid DNA led to similar quenching effects, but to a 
lesser extent.  In contrast, the quenching effect was completely absent when QDs 
were mixed with pre-formed pentablock copolymer/DNA (penta/DNA) polyplexes as 
shown in Fig. 6.1a (black and light blue curves).  The dramatic difference in QD    
fluorescence intensity between bound   and unbound states of pentablock copolymer  
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Fig. 6.1.  (a) Fluorescence spectra showing the influence of pentablock copolymer (penta), 
DNA, CLQ, and penta/DNA polyplex on the fluorescence emission of QD615. (b) 
Fluorescence spectra showing the influence of penta, DNA, and polyplex on the 
fluorescence emission of QD615.  (c) Influence of CLQ when polyplex and QD615 are 
mixed together.  (d) Plot of QD615 quenching versus CLQ concentration generated from 
the data in (c ). 
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and DNA suggested that polyplex association/dissociation might function as a 
potential “on/off” switch for QD fluorescence (illustrated in Fig. 6.2).  CLQ alone was 
found not to influence the emission profi le of the QDs studied (QDs having an 
emission maximum at 615 nm, or QD615) though CLQ itself demonstrated an 
intense and broad emission  between 400 nm and 575 nm when excited at 370 nm  
(Fig 6.1a, dark blue and pink curves).  Thus, we were able to investigate the stability  
 
 
Fig. 6.2. Schematic illustration of the mechanism of sensing pentablock copolymer/DNA 
polyplex dissociation using QDs. QDs can be quenched by the free pentablock copolymer 
and/or free DNA, but not by penta/DNA polyplex. Once polyplex dissociates, the released 
pentablock copolymer and DNA will lead to QD quenching in such a way that polyplex 
dissociation can be monitored withthe decrease in QD fluorescence.  
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of the polyplex in the presence of CLQ by monitoring the change in QD fluorescence 
where any decrease in the intensity of QD emission is attributed to polyplex 
dissociation.  
    As expected, addition of CLQ to solutions containing penta/DNA polyplex and 
QDs resulted in significant quenching of QDs when compared with control samples 
lacking CLQ.  This provides a strong indication that CLQ indeed facilitated polyplex 
dissociation.  The newly released pentablock copolymers appear to quench QDs 
immediately once they are free in solution.  Released DNA is partially complexed 
with CLQ and therefore exhibits relatively weaker quenching effects with QDs as 
compared to naked DNA mixed with QDs as shown in Fig. 6.1b.  When pentablock 
copolymer and DNA were mixed with QDs sequentially (i.e., pentablock copolymer 
added to QD solution, followed by the addition of DNA), allowing time to equilibrate 
between additions, there was increased quenching of QDs over the effect achieved 
with either component alone.  This indicates the pentablock copolymer and DNA did 
not significantly associate into polyplexes when introduced serially to a solution 
containing QDs.  The combined quenching effects provide further evidence for 
association of pentablock copolymer and QDs via tertiary amines since these amine 
groups would otherwise interact with the phosphate groups of DNA to form 
polyplexes and partially restore the original fluorescence of QDs.  Therefore, the 
quenching observed in a polyplex solution after addition of CLQ likely results from 
both free pentablock copolymer and CLQ-bound/free DNA.  The overall quenching 
of QD fluorescence exhibited a linear relationship with the concentration of CLQ as 
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shown in Figs. 6.1c and d, further confirming the feasibility of using QDs to indicate 
polyplex dissociation induced by CLQ. 
    Although this study focused on cell-free assays, the CdSe-ZnS QDs used in this 
work showed no measurable acute toxicity in various cell lines due in part to a 
protective shell and dense coating of hydrophilic DTC-Cys ligands.  The QD-based 
quenching method can thus be utilized to sense polyplex dissociation in cellular 
environments.  For example, by co-incubating polyplexes and QDs with cells, 
dissociation of polyplexes in endosomes could be detected, which is of great 
importance for understanding the mechanism of gene delivery and improving 
transgene vectors. Furthermore, since the QDs were rendered water soluble though 
ligand exchange, various types of amino acids can be easily coupled to QDs as 
designed; for example, histidine residues can be coupled to the surface of QDs, 
leading them to readily escape endosomes.  In this case, polyplex dissociation can 
be monitored by quenching of QDs throughout the cytoplasm. 
6.3.2 Quantitative models of fluorescence quenching 
     Since the pentablock copolymer potentially acts as the primary quenching 
species, we expect the QD fluorescence to decrease (and thereby quenching to 
increase) with increasing polymer concentration.  As shown in Fig. 6.3a, the 
measured QD fluorescence intensity showed an inverse dependence on the 
concentration of pentablock copolymer.  Rather than exhibiting a linear dependence 
on concentration consistent with either static or dynamic quenching alone, the 
integrated quenching data appeared concave up (Fig. 6.3b) suggesting a 
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Fig. 6.3.  Quenching of QD as a function of concentration of the pentablock copolymer 
(penta):  (a) Fluorescence spectra and (b) integrated quenching using two models.  
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combination of quenching effects.  We fit this data with a modified Stern-Volmer 
equation that describes combined dynamic and static quenching (Fig. 6.3b, dashed 
line) in which static quenching is presumed to occur when the quencher is within a 
characteristic radius (spherical volume) consistent with a stable complex:(29) 
 
         ⁄  (    [ ])   ([ ] )            (1) 
where 
                                                   (2) 
 
Here, F0 and F are the fluorescence intensities in the absence and presence of 
quencher, respectively; KD is the dynamic quenching constant; [Q] is the 
concentration of quencher (pentablock copolymer in this experiment); V  is the molar 
volume of the sphere within which the probability of quenching is unity; V0 is the  
volume of the sphere in cm3; and NA is the Avogadro constant.  The fitted sphere 
volume was consistent with an interaction radius 15 nm.  Alternatively, a plot of  
F0/(Fe[Q]V ) versus [Q] yields a straight line with the slope equal to   which is found to 
be about 26.5 mM-1 (Fig. 6.3b, solid line). 
     In order to interpret this result, we measured the size distribution of QD-
pentablock copolymer assemblies (micelles) in solution using dynamic light 
scattering.  The data showed nearly monodisperse micelles having a mean diameter 
of 200 nm (polydispersity index, PDI = 0.062).  Based on this size distribution and 
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the average QD diameter (~15-20 nm), there are presumably many QDs within each 
micelle.  This physical arrangement suggests that QDs are likely to exhibit 
interparticle energy transfer (i.e., FRET) which would contribute to the static 
quenching component of the Stern-Volmer model shown in equations 1 and 2.  The 
fitted interaction radius will then be representative of the composite effect of FRET-
induced quenching as well as any direct quenching due to the pentablock copolymer 
alone.  If FRET is a significant quenching mechanism, we expect the fitted 
interaction radius to be on the same order as the Förster distance for QD self-
quenching (R0 ~ 4-8 nm) which is considerably smaller than the average micelle size 
(rm ~ 100 nm).  The modified Stern-Volmer model alone is insufficient to determine 
the relative static quenching contribution of QD self-quenching versus direct 
quenching from the polymer.  For this, we require experiments that isolate these 
effects; this is the subject of the next section. 
     In the case of QD quenching by DNA, again there is enhanced quenching with 
increasing DNA concentration, yet the data is concave down (Fig. 6.4a and b) 
consistent with a fluorophore having accessible and inaccessible populations to the 
quencher and a fit to the following equation: 
𝐹0 /Δ𝐹 = 1/𝑓𝑎𝐾𝑎 [𝑄] + 1/𝑓𝑎                  (3) 
where  
Δ𝐹 = 𝐹0 − 𝐹                                        (4) 
𝑓𝑎 = 𝐹0𝑎 𝐹0                                          (5) 
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Fig. 6.4.  Fluorescence emission/quenching of QD as a function of DNA:  (a) measured QD emission 
spectra, (b) integrated QD quenching (F0/F), (c) normalized quenching versus inverse DNA. 
concentration fit with a linear quenching model. 
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Here, F0 and F again refer to the fluorescence in the absence and presence of 
quencher, respectively; fa is a fraction of the total fluorophore population where the 
subscript a refers to the accessible fraction that can be deactivated by the quencher 
species; correspondingly, F0a is the initial fluorescence and Ka is quenching constant  
of the accessible fraction.  For the mechanism of quenching by DNA, guanine bases 
are thought to be responsible as electron donors(29).  Since plasmid DNA cannot 
maintain its circular structure but rather contorts into a supercoiled conformation in 
aqueous solution, the guanine bases would assume a complex distribution of 
accessibilities to the QD surface.  As a result, it might be difficult for larger QDs to 
contact these quenching sites as compared to smaller QDs.  Thus we assumed that 
only a fraction of QDs were available to be quenched by DNA.  Values for   and   can 
be obtained readily from the intercept and slope by plotting F0 / F versus [Q]
-1 (Fig. 
6.4c), which were found to be 0.62 and 0.14 L/μg, respectively. 
6.3.3 Self-quenching among QDs  
     Considering both pentablock copolymer and DNA have the capacity to associate 
with QDs, they could feasibly generate a high local concentration of QDs and initiate 
self-quenching.  The tendency of pentablock copolymer to form micelles in solution 
furthers the speculation that QD self-quenching is an important mechanism in these 
systems.  In order to test this hypothesis, we examined the quenching of two distinct 
populations of QDs, QD519 (green emitting) and QD611 (red emitting), that can 
potentially form FRET donor-acceptor pairs between QDs, as reviewed by Somers 
et al.(30)  If such a pair is formed in proximity sufficient for energy transfer (i.e., on 
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the order of the Förster distance R0), we expect to see an increase in the ratio of red 
to green QD fluorescence (favorable quenching of the higher energy fluorophores).  
In order to elucidate the functional moieties responsible for the quenching behavior 
of the pentablock copolymer, a family of poly(dimethylaminoethyl methacrylate) 
(PDEAEM) homopolymers and Pluronic F127 were included in the study.  These 
polymers comprise the end blocks and core triblock segments of the pentablock 
copolymer, respectively.  As shown in Fig. 6.5, pentablock copolymers and 
PDEAEM homopolymers preferentially quenched QD519 (higher QD611/QD519 
photoluminescence ratio) whereas DNA quenched each QD population about 
equally (ratio near 1.0).  Conversely, Pluronic F127 had no measurable effect on the 
QD emission spectra (data not shown), indicating that the core triblock structure 
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Fig. 6.5.  Quenching of two populations of QDs (mixed QDs) by DNA, pentablock copolymer 
(penta) and poly(dimethylaminoethyl methacrylate) homopolymers with polymerization degree  of 
15 (Homo15) and 35 (Homo35).  (a) Fluorescence spectra of QD519 and QD 611 (initially having 
similar intensities) mixed with various polymers.  (b) Calculated ratios of the peak Q D heights 
(QD611/QD519) shown in (a).  (c) Degree of quenching for both QD519 and QD611 as a function 
of polymer type.  
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(PEO100-b-PPO65-b-PEO100) played no direct role in the quenching achieved with the 
full pentablock copolymer.  The terminal PDEAEM blocks on pentablock copolymer 
are therefore likely to be the essential functional segments responsible for QD 
quenching, either by directly deactivating fluorescence relaxation pathways or 
aggregating QDs together.  Notably, PDEAEM homopolymers exhibited variable 
quenching effects depending on polymerization degree (i.e., molecular weight).  
Although we observed greater quenching in the QD519 population as compared to  
QD611 for all polymers, this result alone is insufficient to demonstrate energy 
transfer from QD519 to QD611 unless isolated control populations of QD519 have 
an equal or lesser tendency to be quenched in the presence of polymer than QD611.  
To this end, we studied these two populations of QDs separately and found that 
QD611 was more readily quenched by pentablock and PDEAEM homopolymers 
than QD519 (Fig. 6.6), which contrasts the observations using mixed QD 
populations and provided compelling evidence of energy transfer from QD519 to 
QD611.  The quenching data shown in Figs. 6.5c and 6.6c were combined into one 
graph to summarize the differences in polymer-induced quenching behavior between   
isolated and mixed QD samples. The normalized quenching ratio, (Q611/Q519)mixed 
/(Q611/Q519)separate, was calculated and shown in Fig. 6.7 where ratios below 1.0 
correspond to preferred quenching of the QD519 population in mixed QD samples, 
as is expected from Förster theory.  From these data, we can conclude that FRET is 
the dominant quenching mechanism for QDs exposed to pentablock copolymers in 
solution.  Similarly, PDEAEM homopolymers also showed capacity to facilitate self-
quenching (Figs. 6.5c and 6.6c) and preferential QD519 quenching in mixed 
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samples as summarized in Fig. 6.7.  As the polymerization degree of homopolymer 
increased from 15 to 35, the overall quenching increased slightly, and would 
presumably continue to increase as the molecular weight increased further. 
     In particular, the pentablock copolymer led to nearly complete quenching of QDs 
when the concentration of PDEAEM block was as high as that in other 
homopolymers (Fig. 6.6b), suggesting pentablock copolymers are more efficient at 
quenching QDs compared to homopolymers when holding the total mass of 
Fig. 6.6.  Fluorescence emission spectra indicating quenching of (a) QD519 and (b) 
QD611 by pentablock copolymer (penta) and poly(dimethylaminoethyl methacrylate) 
homopolymers with polymerization degree  of 15 (Homo15) and 35 (Homo35) at 
concentration of 2 mg/mL.  Penta(h) in (b) refers to a high concentration of pentablock 
copolymer containing the same amount of PDEAEM as in other homopolymers.  The 
quenching efficiency was given as F0/F and is depicted in (c). 
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available PDEAEM  constant.  This is notable because the core triblock Pluronic 
F127 alone showed no quenching effect with QDs whatsoever.  In an effort to 
elucidate the mechanism of quenching initiated by different polymers, varying 
amounts of PDEAEM homopolymers having degrees of polymerization of 15 
(Homo15) and 35 (Homo35) were mixed with QDs to study quenching as a function 
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Fig. 6.7.  The normalized ratio of quenching of QD611 (Q611) to quenching of QD519 
(Q519) in mixed samples.Qdenotes quenching extent, defined as F0/F; normalization was 
achieved by dividing the ratio of Q611/Q519 for mixed QDs by the ratio for separate QDs. 
The normalized ratio indicates quenching by energy transfer between QD611 and 
QD519 in mixed QD samples where a value<1.0 is consistent with preferential 
quenching of the QD519 population (which was true for all three polymer tested).  
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of concentration.  As shown in Fig. 6.8, the relationship between quenching extent 
and homopolymer concentration was well-described by the same Stern-Volmer 
model (equations 1 and 2) used to characterize pentablock copolymer-induced 
quenching, indicating that homo- and pentablock polymers share a similar 
mechanism of QD quenching.  However, the fitted quenching constants, KD, for  
Homo15 and Homo35 were found to be 0.85 mM-1 and 4.7 mM-1, respectively, far 
lower than the 26.5 mM-1 value measured using pentablock copolymer.  The unique 
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Fig. 6.8.  Quenching of QDs as a function of concentration of homopolymers (Homo15, Homo35).   
Squares show plots of quenching using the standard definition of F0/F.  Triangles show a rescaled 
version of quenching consistent with a Stern-Volmer model of static and dynamic quenching.  The 
latter definition provides a linear fit to the data.  
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micellar structure of pentablock copolymers in solution likely accounts for this 
discrepancy where several QDs can bind each micelle thus facilitating and 
enhancing self-quenching. 
     FRET-induced fluorescence quenching is expected to show strong wavelength 
dependence due to variations donor-acceptor spectral overlap.  In our study, all 
PDEAEM-containing polymers showed obvious wavelength-dependent quenching 
behavior when mixed with QDs.  Quenching measured as a function of wavelength 
(Fig. 6.9) appeared similar in shape to a plot of the spectral overlap function from 
Förster theory, J(λ), (not shown) which considers the QD emission and absorption 
spectral overlap; this further implicates a QD-to-QD self-quenching mechanism.  
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Fig. 6.9.  Wavelength dependent quenching of QDs in the presence of various polymer quenchers.  
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Static quenching could also occur through complexation between the pentablock 
copolymer and QDs, although this type of quenching typically shows little 
dependence on wavelength, as in a recent example of static quenching of QDs by 
Medintz et al.(31), and is inconsistent with the wavelength dependence shown in Fig.  
6.9. Although substantial quenching of QDs takes place immediately in the presence 
of PDEAEM homopolymer, maximum quenching occurs several minutes after the 
initial mixing as shown in Fig. 6.10.  The measured quenching dynamics are 
consistent with multiple time scales associated with static and dynamic processes, 
     
0 5 10 15 20 25 30
0.0
0.5
1.0
1.5
2.0
2.5
3.0
F 0
 / 
F
Time /min
 Homo15
 
Fig. 6.10.  Homo15 induced quenching of QD with time.  Fluorescence of QDs in the absence of 
quencher (Homo15), F0, was measured at different time points to provide accurate control for 
corresponding measure of sample quenching.  Equilibrium was reached in about 10 minutes.  
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but also reflect the unique aspects of the QD-polymer system.  In this case, we infer 
that immediate quenching results from collisions among QDs and polymer molecules, 
but that static complexation of QDs and polymers requires additional time to reach 
equilibrium resulting in saturated quenching after several  minutes.  The concept of 
static quenching in this system is unusual as it is dominated by QD self-quenching 
interactions which are mediated by associations with polymer. 
6.4     Conclusions 
     We have shown that water-soluble Cys-capped CdSe-ZnS QDs are capable of 
sensing the dissociation of DNA/polymer polyplexes following exposure to 
chloroquine.  Upon exposure to free pentablock copolymer and/or DNA, the QD 
fluorescence is quenched increasingly with concentration.  The mechanism of 
fluorescence quenching was determined by exposing QDs to polymers and DNA 
individually and in various combinations.  Studies with PDEAEM homopolymers 
suggested that tertiary amines were the functional groups responsible for quenching 
during exposure to the pentablock copolymer.  However, the greatest quenching 
effect was observed when using pentablock copolymer, presumably due to its 
unique micellar conformation.  QD fluorescence quenching was modeled using 
modified Stern-Volmer equations that account for static and dynamic quenching 
subject to modifications specific to DNA and PDEAEM.  Studies with mixed 
populations of QDs showed that energy transfer plays a significant role in the overall 
quenching effect using PDEAEM and pentablock copolymer.  These results 
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collectively suggest that these QDs have the potential to sense the dissociation of 
DNA cargo from polyplexes both in vitro and within living cells.  
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CHAPTER 7.   INVESTIGATION OF SUSTAINED CO-DELIVERY OF 
GENE AND DRUG IN VITRO USING INJECTABLE SELF-
ASSEMBLED BLOCK COPOLYMERS 
 
7.1   Introduction  
     Sustained gene delivery has attracted much attention over the past decade by its 
ability to maintain long term transfection in the target tissue and achieve a sustained 
therapeutic effect that otherwise must rely on repeated injections(1). In the 
development of such a system, investigating the in vitro release of the vector is 
usually necessary to acquire a reasonably high and steady release profile by 
optimizing formulation. More importantly, the released gene vector should maintain 
its function and possess a satisfactory ability to transfect cells.  Traditionally, such 
studies have involved collecting the vector released within a certain time course in 
an acellular environment and comparing its transfection efficacy with the control 
vectors without simulating the release process(2-4). This comparison is convincing 
in terms of vector function preservation; however, it cannot reflect the real 
transfection ability of the sustained release system, with the sustained release and 
transfection being treated as two separate processes. Thus, a more practical testing 
method is needed to investigate the transfection efficacy of a specific sustained 
release system. In this study, we reported a device that allows the vector to be 
directly released to cells, by using a polyethylene glycol diacrylate (PEG-DA) barrier 
gel to mimic the role of tumor extracellular matrix in providing a diffusion barrier for 
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the therapeutic agents to reach tumor cells. The released vector can then directly 
transfect cells using the injectable poly(diethylaminoethyl methacrylate) (PDEAEM)-
Pluronic F127-PDEAEM  pentablock copolymer (PB) vector system.   
 The self-assembled PB was previously synthesized via atom transfer radical 
polymerization (ATRP)(5), with Pluronic F127 macroinitiator to exhibit 
thermosensitive gelation. The PDEAEM blocks facilitate DNA condensation.  This 
novel vector can be injected intratumorally and can undergo sol-gel transition at 
physiological temperatures, providing vector release in a sustained manner. Upon 
copolymerization, the PB exhibits enhanced mechanical property as compared to 
the Pluronic F127 (PL) alone(4), which is favorable for in vivo sustained release,  
because stronger gels can provide longer sustained delivery and can maintain 
mechanical integrity longer. Self-assembled injectable hydrogels eventually dissolve 
and are clinically superior to other chemically cross-linked hydrogels that involve 
harsh crosslinking environments(6), or scaffolds(7) that need to be surgically 
implanted. In order to improve the stability of PB vectors in a physiological 
environment, free PL was subsequently added to PB/DNA complex to form a shield 
on the access charges by self-assembly, thus preventing aggregation with serum 
proteins(8). Along with the benefit, PL shield also provides the possibility of 
encapsulating hydrophobic anti-cancer drugs due to its amphiphilic nature(9), 
enabling the whole vector to deliver gene and drug simultaneously. Moreover, PL 
alone has been reported to have a chemosensitizing effect in multidrug-resistant 
(MDR) cells by inhibiting the P-glycoprotein related drug efflux(10).  
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The advantage of co-delivery of gene and drug has been shown to be that 
expression of specific genes can help render drug-resistant cells sensitized back to 
the drug(11-12), and uptake of drug into cells can enhance the level of gene 
expression(12-14).  Thus, a synergistic effect can be expected with a combination of 
gene therapy and drug treatment. Regarding this combination, it could be achieved 
by combining two separate treatments (gene and drug) physically(11), or by 
combining gene and drug in the same carrier and using it as a single treatment(12, 
15). The latter is more advantageous, for it can ensure delivery of gene and drug 
into the same cell, thus maximizing the synergistic effect. Yet it is also more 
complicated, for it involves synthesis of a new carrier and dealing with all possible 
interferences between the two payloads.  Here we report an easily-implemented 
method for combinational delivery of gene and drug with PB-PL type of carriers. The 
anticancer drug paclitaxel (PTX) was incorporated in the PL shield and self-
assembled into the PB/DNA complex later. By loading PTX and DNA separately, the 
potential interference can be reduced dramatically. More importantly, the two anti-
cancer agents will be delivered in a simultaneous and sustained manner.  
7.2   Experimental  
7.2.1  Materials  
    Poly(ethylene glycol) diacrylate (PEG-DA) MW=4,000 was purchased from 
Polysciences Inc. (Warrington, PA). Pluronic F127 [(PEO)100-b-(PPO)65-b-(PEO)100], 
(where PEO represents poly(ethylene oxide) and PPO represents poly(propylene 
oxide)) and photoinitiator 4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2-propyl)ketone 
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(Irgacure 2959) was obtained from BASF (Florham Park, NJ) and used without 
further modification. Lactate dehydrogenase (LDH) assay kit and heparin sodium 
salt was obtained from Sigma-Aldrich (St Louis, MO). Luciferase assay system and 
passive lysis buffer were purchased from Promega (Madison, WI).  Cell culture 
reagents: Dulbecco’s Modified Eagle Medium (DMEM), heat inactivated fetal bovine 
serum (FBS), 0.25% trypsin-EDTA and Hank’s buffered salt saline (HBSS) were 
purchased from Invitrogen (Carlsbad, CA), Dulbecco’s MEM: Ham’s Nutrient Mixture 
F-12, 1:1 Mix (DMEM/F-12) was purchased from ATCC (Manassas, VA). ExGen 500 
was purchased from Fermentas Life Sciences (Hanover, MD). HiSpeed Plasmid 
Maxi Kit was obtained from Qiagen (Valencia, CA). 6.7kb pGWIZ-luc (GeneTherapy 
Systems Inc, CA) plasmid encoding the luciferase reporter gene and 4.7kb EGFP-
N1 (ClonTech, CA) plasmid encoding GFP reporter gene were purified with Qiagen 
HiSpeed Maxi Kit. Polyester membrane with diameter of 24mm and pore size of 
3.0µm were purchased from Corning (Lowell, MA). PicoGreen dsDNA Reagent was 
purchased from Invitrogen.  
7.2.2  Cell Culture  
    The human ovarian carcinoma cell line SKOV3 and human retinal cell line 
ARPE-19 were obtained from ATCC™ (Manassas, VA).  SKOV3 Cells were grown 
in DMEM supplemented with 10% (v/v) heat-inactivated FBS at 37°C under a 
humidified atmosphere containing 5% CO2. ARPE-19 cells were cultured the same 
way but with DMEM/F-12 media. Subculture was carried out every 2~3 days. 
7.2.3 Barrier Gel Formation 
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    To simulate extracellular matrix environment for the in vitro studies, a hydrogel 
system was created. To a well of 24-well plate, 75mg of PEG-DA, 100µl of photo 
initiator (0.2 wt.% solution in water), 200µl of deionized water and appropriate 
amount of Pluronic F127 were added with the final F127concentration of 0, 7, 12, 15 
and 17 % by weight. The plate was then placed in a refrigerator overnight and gently 
vortexed before exposure to UV light. The solution was photo crosslinked under UV 
beam with 50Mw/cm2 for 2min. To avoid interference among nearby wells, a copper 
tube that fits into the well of interest was used along with a thick black paper 
covering other wells. After gel formation, they were carefully scraped out with a 
spatula and soaked in 50ml of DI water for three days at -4°C with water changed 
every day. To calculate the mass loss and swelling ratio, gels were dehydrated in an 
oven at 37°C and rehydrated thereafter. By comparing the weight of dehydrated gel 
with the weight of all feed chemicals, we found that F127 was completely removed 
by the third day of dissolution. After rehydration, the swelling ratio was determined 
by the ratio of the weight of rehydrated gel to that of dehydrated gel, which was 
found to be about 1200-1300% for a PEG-DA gel with 15% F127 dissolved away. 
When referring to PEG-DA gel throughout the manuscript, we mean a PEG-DA gel 
with F127 removed by dissolution in water. Gels formed in this way contain a 
concave top surface which allows sample loading.  
   For making gels with an indentation, the plate lid was molded with a glass tube 
(d=10mm). Instead of shining UV from above, the incident UV light was made to 
shine from below. After formation of gel, the mold was removed from the gel with 
great care to avoid any damage to the boundary of indentation. The capacity of 
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indentation depends on the length of mold (glass tube) and volume of gel solution. 
The complete process of making a molded PEG-DA gel for investigating sustained 
release is depicted in Fig. 7.1.    
 
7.2.4 Polyplex Formation 
    Pentablock copolymers (PB) used in this study were synthesized by ATRP as 
reported previously. All polymer solutions were prepared in 0.5× HBS buffer, pH 7.0 
unless stated otherwise. To form the polyplex with desired N/P (nitrogen/phosphate) 
 
Fig. 7.1. Process of making PEG-DA gel matrix with an indentation for sustained gene 
delivery; (1) gel solution containing PEG-DA, Pluronic F127 and photo initiator was UV 
crosslinked in a well mold; (2) solid gel was removed from the mold and soaked in 
deionized water to dissolve away Pluronic F127; (3) PEG-DA gel matrix was obtained and 
disinfected; (4) PEG-DA gel was set in a cell-culture well with a supporting permeable 
insert; vector gel solution was injected to the indentation and solidified in response to 
change of temperature, releasing vector to cells in a sustained fashion. Mold shown here 
was flat-bottomed, but a round-bottomed mold was also available depending on need.  
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ratios, various amounts of pentablock copolymer (2mg/ml) was added to the fixed 
amount of DNA at equal volume. The mixture was then gently vortexed and allowed 
to stand at room temperature for 20min. In an effort to improve the stability of 
polyplex with serum, free Pluronic F127 (PL) (10 mg/ml) was further added at the 
same volume to give a weight ratio of 5:1 with regard to the corresponding PB. Upon 
this, PL will self-assemble with PB on the surface of PB/DNA polyplexes and form a 
shield layer through the hydrophobic interaction. The cytotoxicity and stability of 
resultant PB-PL/DNA polyplex has been thoroughly investigated in previous 
papers(8, 16).    
7.2.5 In vitro Polyplex Release  
    Appropriate amount of Pluronic F127 was added to the polyplex solution at low 
temperatures (e.g. 4°C), to make the final F127 concentration around 20 wt%. With 
this concentration, the vector solution can be injected as liquid and form a solid gel 
in response to the change in surrounding temperature. The pre-warmed PEG-DA 
gels (soaked in warmed PBS buffer or cell growth medium) were placed in the 
Transwell inserts equipped on the 6-well plate containing 1.5ml of PBS or growth 
medium in each well. The prepared vector solution was injected into the concave 
surface of non-molded gels or the indentation of molded gels. Gelation occurred 
instantly due to temperature change. The plate was then placed on an incubator 
shaker and shaken with 100 rpm at 37°C for a week.  All buffer in the well was 
collected every day and replaced with 1.5ml of fresh PBS. 150µl of each collected 
sample was treated with 2µl of heparin (200µg/µl) for 40min to separate DNA from 
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pentablock copolymer. The concentration of DNA was then measured with 
Picogreen assay on a dual monochromator spectrofluorimeter (Fluoromax-4, Horiba 
Jobin Yvon) with excitation at 480 nm and slit widths of 3 nm (excitation and 
emission). Data were recorded at the emission peak (520nm) for DNA-bound 
picogreen and analyzed using a standard curve.  
7.2.6 In vitro Transfection  
 Cells were seeded into 96-well or 6-well plates one day prior to transfection with 
initial numbers of ~1.2×104 or ~1.0×105 cells per well, respectively.  After 24h 
growth, cells reached a 70~80% confluence when the old medium was replaced with 
fresh growth medium containing 10% FBS. Transfection was then carried out by 
adding polyplexes of various formulations to the medium with 0.6µg pGIZ-luc or 3µg 
EGFP-N1 DNA per well for 96-well or 6-well plate, respectively. Cells were allowed 
to incubate with polyplexes for 3h, followed by changing the old medium to remove 
the polyplexes. After an additional 45h post-transfection, cells in the 96-well plates 
were lysed and analyzed for luciferase activity with luciferase assay kit on an 
automated Veritas™ Microplate Luminometer. The luminescence was measured in 
arbitrary Relative Luminescence Units (RLU). Cells in 6-well plate were examined for 
GFP expression with fluorescence microscope (Nikon, Eclipse-Ti). Each transfection 
was done in triplicate. ExGen 500, a sterile solution of linear 22kDa polyethylenimine 
(PEI), was used as positive control at an N/P ratio of 6 according to the 
manufacturer’s protocol.  
7.2.7 Cytotoxicity  
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 The cytotoxicity of polyplexes was examined with LDH assay kit, based on the 
amount of cytoplasmic LDH released into the medium following cell membrane 
rupture. Samples were collected at the end of 45h post-transfection. Blank cells 
were used as a negative control to provide 0% cytotoxicity and Triton-X was used as 
a positive control to provide 100% cytotoxicity.  Cell viability was determined as 
follows: 
 
7.2.8 Drug Encapsulation  
 The paclitaxel (PTX) was encapsulated in Pluronic F127 micelles by solvent 
evaporation method. Briefly, 2mg of PTX and 100mg of F127 were dissolved in 10ml 
of acetonitrile in a 50ml flask. The solvent was then removed using a rotary 
evaporator under reduced pressure at 50°C.   A solid layer formed around the flask 
which was then placed in a vacuum oven at room temperature overnight to remove 
the residual solvent.  The flask was reheated in a water bath at 60°C, followed by 
addition of 10ml warmed water (60°C) with medium stirring. The resultant PTX 
loaded F127 micelle solution was filtered into a 0.22µm filter to remove the 
undissolved PTX and other impurities.  The filtrate was then lyophilized and stored at 
4°C for later use. The content of PTX was determined using a standard curve of 
absorbance at 227 nm, which was found to be about 1.4 wt%. The drug loading 
efficiency was found to be about 73% by dividing the weight of feed drug by the 
weight of encapsulated drug.  
                                          Abs (sample) – Abs (blank cells) 
Cell viability %  = 100   -   ―――――――――――――――   × 100 
                                          Abs (Triton-x) – Abs (blank cells) 
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7.2.9 Gene and Drug Co-delivery 
  Polyplexes were formed in a similar way as described above, but instead of using 
free Pluronic F127 alone to provide an additional shield, desired amount of PTX-
loaded F127 was mixed in at this step. In such a way, PTX and DNA could be 
delivered with a single carrier at the same time. Transfection followed the procedure 
stated above.    
7.3   Results and Discussion 
7.3.1 Effect of F127 on the Property of PEG-DA Gels  
     In the development of a barrier gel that can mimic tumor extracellular matrix to 
hinder delivery of macromolecules such as DNA vectors, we were hoping a 
reasonable diffusion rate that can be readily adjusted.  Co-dissolving Pluronic F127 
with the PEG-DA provides  a simple and inexpensive method. After gel formation by 
crosslinking in the presence of various amounts of F127, all gels looked identically 
clear(data not shown).  However, after rinsing off F127, gels appeared quite different 
in transparency though they were of the same composition(Fig. 7.2A). Compared to 
the plain PEG-DA gel that maintained the transparent appearance in the whole 
process, gels with addition of F127 experienced a change from transparent to 
opaque at different extents. The development of opaqueness, which should result 
from phase separation and/or increased number of pores/channels(17), showed a 
positive correlation with the amount of F127, indicating addition and removal of F127 
can bring a more loosely network morphology and in turn may increase the 
diffusional transport of macromolecules through the gel. Indeed, PB-PL/DNA 
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was doubled (refer to 17% F127-t), the release of DNA showed a dramatic decrease 
with more DNA entrapped in the gel, probably due to the increased volume of small 
and/or non-interconnected pores. It has been reported that the mesh size of PEG-
DA gel fluctuated with the thickness of the gel as well as the depth of cross-section, 
and the center plane exhibited significantly smaller pores than top and bottom 
planes(18). However, the initial burst release only occurred with the two 17% F127 
gels as recorded at t = 6h, implying removal of F127 at this concentration might 
generate similar micro-channels to allow fast transport across the gel. In addition to 
a desired release rate, DNA also needs to be safely packaged in the released 
sample to allow an effective transfection. The integrity of released polyplex was 
examined by dye exclusion assay using Picogreen, an ultrasensitive double-
stranded DNA dye that exhibits significant fluorescence enhancement upon 
intercalating DNA. The inaccessibility of DNA characterized by dye exclusion will 
indicate the affinity between DNA and the pentablock copolymers. As shown in 
Table 1, all released polyplexes showed an average dye exclusion of about 80%, 
similar to the case of polyplex formulated in solution. Therefore, the PB-PL/DNA 
polyplex maintained the complexed structure during transport across the gel even 
after four day release and is thus expected to have the similar transfection ability as  
that seen with the control polyplex.  
Table 7.1.  Average dye exclusion of polyplexes released by various samples within first 4 days 
 Polyplex in buffer     Polyplex in released samples (first 4 days) 
  0% F127 7% F127 17% F127 
Dye exclusion (%)       87±2    76±5   79±5    84±4 
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7.3.2 Release of DNA from Molded PEG-DA Gels   
     To make a PEG-DA gel with greater capacity for vector gel loading, we 
developed a well mold that can produce an indentation of desired shape and size on 
the top of gel (Fig. 7.1). Two factors were investigated for their influence on DNA 
release, the volume of gel solution (thickness of gel) and UV exposure time.  Fig. 7.3 
shows release profiles of DNA from three 17% F127 gels. The duration of UV 
exposure plays an important role in gel permeability, as demonstrated by 100% DNA 
released from UV-1.5 gel (red-square curve) versus 65% released from UV-2 gel   
(black-circle curve). Again, thicker gels showed greater resistance to the vector 
diffusion, and this effect seemed to be remarkably intensive in the molded gel.  With 
all the other conditions being the same, V-850 gel (blue-triangle curve) lead to only 
about 35% release of DNA as compared to 100% release from V-700 gel (red-
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-square curve). One possible reason for the thickness effect lies in the additional 
sequestration of vector molecules by the side wall around the indentation.  Besides 
diffusing straight down through the gel, the vector may also diffuse outward to the 
side wall and probably get entrapped somewhere during the subsequent transport. 
When loading twice the amount of vector on V-850 gel, the total amount of released 
DNA was found to be higher (data not shown), suggesting the entrapped vectors did 
not block the effective pores to allow additional vectors passing through. In addition 
to release into buffer, samples were also allowed to release into cell growth medium 
containing serum through medium-soaked PEG-DA gels. Similar release profiles 
were obtained as seen with the release into buffer (data not shown).  
      Thus far, we have examined the influence of various factors on the release of 
vector from PEG-DA gels and found that the V-700, UV-1.5 gels can provide a 
relatively fast and steady release within nine days, which make it appropriate for in 
vitro gene release study.  The extracellular matrix (ECM) of the tumor acts as a 
potent barrier against the transport of biopharmaceuticals such as gene vectors and 
therapeutic proteins. There are numerous influencing factors limiting the diffusion of 
macromolecules through ECM, such as the tumor type, the content of collagen(19), 
and the amount of glycosaminoglycan (GAG)(20-21). Additionally, the dynamic 
nature of ECM and vasculature(22) make it extremely difficult to predict or mimic the 
real transport in the tumor matrix using synthetic gels. What we have presented here 
is an attempt to render a more practical experimental set-up for in vitro sustained 
gene release with an inexpensive and easily implemented barrier gel.   
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7.3.3 In vitro Co-delivery of DNA and Paclitaxel  
      Besides gene delivery, we have also incorporated anti-cancer drug paclitaxel 
(PTX) in the vector to make it able to deliver gene and drug simultaneously.  Since 
PTX was encapsulated in the Pluronic F127 (PL) shield rather than the DNA 
condensing pentablock copolymers (PB), the drug loading was assumed not to 
induce any change to the interaction between DNA and PB. This assumption will be 
tested by gel electrophoresis later. One of the advantages by combined delivery of 
gene and drug lies in the positive synergistic influence of drug on gene expression, 
as it has been reported by others(12-13). Fig. 7.4 shows the influence of PTX on 
luciferase gene expression in cancerous SKOV3 and non-cancerous ARPE cells. As 
expected, the presence of PTX lead to enhancement of transfection efficiency, but to 
a different degree for each cell type with little dependence on the concentration of 
PTX studied. SKOV3 showed an up to 12-fold increase in luciferase level as 
opposed to the moderate 3-fold increase seen in APRE-19 cells at N/P of 20 with 
50% of F127 shield having PTX payload. Considering the overall low level of gene 
expression in ARPE-19, especially for the control vector at N/P of 20 which only one 
order of magnitude higher than blank cells (data now shown), the effect of PTX in 
enhancing transfection was very limited in this cell type. We have previously 
reported that the PB-PL/DNA vector presents a selective transfection in cancerous 
over non-cancerous cells due to greater lysosomal sequestration of DNA in the latter 
case(23-25). Addition of chloroquine (CLQ), a transfection enhancer, resulted in 
significant higher fold-increase in APRE-19 cells when compared to SKOV3 
cells(25), which is contrary to what was seen here with PTX.  CLQ restored the gene 
204 
 
0 20 50
103
104
105
106
107
^^ **
 
 
R
LU
/w
el
l
% PTX loaded F127
 N/P=20
 N/P=30
SKOV3
A
*
^
0 20 50
101
102
103
104
*
 
 
R
LU
/w
el
l
% PTX loaded F127
 N/P=20
 N/P=30
ARPE-19
B
*
expression in ARPE-19 cells probably by overcoming the lysosomal barrier that 
served as a primary cause of low transfection, whereas PTX failed to so. The most 
direct reason should be the fact that PTX used a different mechanism to improve 
                    
Fig. 7.4.  Effect of PTX on luciferase based transfection efficiency of SKOV3 (A) and 
ARPE (B) cells mediated by PB-PL/DNA polyplex containing various percent of PTX  
loaded F127 in the free Pluronic F127 (PL) shield.  P<0.01 
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gene expression, which is possibly related to its anti-mitotic function(13). Since PTX 
must get to microtubules in the cytosol to function through binding to the tubulin, 
entrapping in the endo/lysosomal vesicles would completely inhibit the function of 
PTX. Previous intracellular trafficking results indicate that there were a lot more 
polyplexes getting entrapped in the more acidic vesicles in non-cancerous cells 
relative to in the less acidic vesicles in cancerous cells(25). Therefore, lack of 
enhanced gene expression in PTX treated APRE-19 cells might result from the 
endo/lysosomal entrapment. The entrapped particles could then be exported out of 
the cell by exocytosis as what has been reported about colloidal silica 
nanoparaticles(26).   Besides, the non-cancerous ARPE-19 cells could be more 
resistant to PTX compared to cancerous cells. A study on K858, an anti-mitotic 
agent that can induce similar mitotic arrest as PTX, showed that ARPE-19 cells were 
slightly affected by this agent relative to other cancerous cells(27).  In this sense, 
even if PTX could be released to the cytoplasm of ARPE-19 cells, its ability to 
enhance gene expression by arresting mitosis might be quite weak. In contrast, the 
SKOV3 cells, which have been found PTX sensitive(28), could benefit from PTX 
easily to gain an enhancement in gene expression.  The similar effect of PTX on 
 
Fig. 7.5.  EGFP expression in SKOV3 cells transfected with PB-PL/DNA at N/P=20, with free 
Pluronic F127 shield composed of 0% (A), 20% (B), 50% (C) PTX-loaded F127.  
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SKOV3 cells was also observed with transfection by DNA encoding EGFP reporter 
gene as shown in Fig. 7.5.   
      Cytotoxicity measurement further confirmed the above analysis about the 
selective enhancement of gene expression by PTX in SKOV3 and ARPE-19 cells.  
As shown in Fig. 7.6, PTX brought about additional ~20% cell death compared to the 
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Fig. 7.6.  LDH based cell viability of PB-PL/DNA polyplex formulated with various percent of 
PTX loaded F127 in the free Pluronic  F127  shield on SKOV3 (A) and ARPE-19 (B) cells.  
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condition without PTX in SKOV3 cells, whereas it barely affect the viability of APRE-
19 cells. Since the cytotoxicity was determined based on Lactate dehydrogenase 
(LDH) level, which measures the cell death following loss of cell membrane integrity, 
it may not reflect all kinds of cytotoxicity induced by PTX. Other measurement 
methods will be used to in future. Taken together, co-delivery of DNA with PTX 
clearly generated a synergistic effect demonstrated by the increased gene 
expression, and the original selective transfection presented in the PB-PL type of 
vector was retained in the co-delivery method.   
7.3.4  In vitro sustained delivery of DNA and PTX to cells  
      With the above discussion about release of vector through PEG-DA barrier gel 
and enhancing effect of PTX on gene expression, sustained delivery and DNA and 
PTX will be conducted with cultured cells in future.  
7. 4   Conclusions 
    F127-treated PEG-DA gels were developed as a diffusion barrier to simulate the 
tumor matrix in an in vitro release study on injectable PB vectors. Various influencing 
factors of vector release rate were investigated and optimized. It was found that 
nearly 100% of vector could be released through the optimal PEG-DA gel, with a 
well-maintained polyplex structure. Paclitaxel (PTX) was co-packaged in the PB-PL 
type of vectors together with DNA, leading to a synergistic effect demonstrated by 
significant enhancement in gene expression in cultured human ovarian cancer 
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SKOV3 cells.  The co-delivery of drug and gene with PB based vectors will be 
further investigated for in vitro sustained release in future.  
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CHAPTER 8.   GENERAL CONCLUSIONS 
 
8.1   General Discussion 
     In recent years, more and more attention has been given to how transgene 
vectors should be designed to make the therapeutic efficacy higher while reducing 
side effects. Although low transfection efficiency has been widely known as the 
bottleneck for non-viral vectors, numerous strategies have been employed to 
overcome this hurdle, some of which showed exciting results in achieving a high 
gene expression, such as synthetic viruses that incorporate an active domain of a 
specific virus (1-4) and multifunctional polymers which can overcome multiple 
intracellular barriers (5-7). Besides high efficiency, the ideal transgene vectors 
should also provide a targeted transfection with low toxicity in the long term.  The 
novel pentablock copolymer reported here holds the promise for such a versatile 
vector with the most attractive feature being injectable for sustained release. 
Moreover, we have recently found that the pentablock copolymer vectors posses an 
ability to selectively transfect cancer cells over non-cancer cells in in vitro cultures. 
This is an interesting finding since this selectivity does not arise from any targeting 
ligands attached to the vector. Understanding the mechanism of this selectivity will 
enable us to better design polymeric vectors with inherent selectivity for specific cell 
types based on intracellular differences and not on the use of targeting ligands that 
have shown variable success.  
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      According to the results from intracellular trafficking of PB vector in cancer and 
non-cancer cells, we assumed that the selectivity was due to different intracellular 
barriers to transfection in the different cell types. Cellular uptake, endosomal escape 
and nuclear entry are commonly identified intracellular barriers that have been 
investigated for their influence on transfection efficiency. Thus, our approach 
focused on identifying the intracellular transfection barriers for this PB vector system 
and then investigating the differences in these barriers between cancer cell lines and 
non-cancer cell lines. For each barrier, a corresponding approach was employed to 
overcome that barrier; epidermal growth factor (EGF) for cellular uptake, chloroquine 
(CLQ) for endosomal escape and nuclear localization signal (NLS) for nuclear entry. 
After examining these three possible barriers, we concluded that escape from the 
endocytic pathway served as the primary intracellular barrier for PB-mediated 
transfection. This, in turn, provides insights into intracellular pH differences. PB/DNA 
vectors could have been, in large part, sequestered and degraded in acidic 
lysosomes of non-cancer cells, but survived and maintained function in less acidic 
lysosomes of cancer cells. This property could be taken advantage of to design 
vectors selectively transfecting cells with higher lysosomal pH, such as many tumor 
cells. The work highlights the importance of identifying intracellular barriers for 
different gene delivery systems involving vectors and cells, and provides a new 
paradigm for designing targeting vectors based on intracellular differences between 
cell types, rather than through the use of targeting ligands. 
      As a common lysosomotropic agent, chloroquine (CLQ) has been found to 
significantly enhance transfection efficiency in many systems(6, 8-9). Especially in 
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our study, CLQ was the only agent that increased the transfection efficiency both in 
cancer and normal cells.  To understand the function of CLQ may be helpful for 
designing high efficient vectors.  Among the multiple roles CLQ may play in assisting 
gene delivery, facilitating endosomal escape is of most importance, but recently  
facilitating dissociation of DNA from polymers has emerged as an another interesting 
possibility(10). Current methods involving DNA dyes cannot accurately assess the 
displacing effect of CLQ. In this work, we utilized cysteine-coated CdSe-ZnS core-
shell QDs in place of common DNA intercalating dyes to measure DNA released 
from PB/DNA polyplexes in the presence and absence of CLQ. We found that 
increasing concentrations of PB and DNA led to quenching of QD fluorescence while 
CLQ alone had no measurable effect. Thus, CLQ induced dissociation of the 
polyplex was sensed through changes in QD fluorescence. As expected, addition of 
CLQ to solutions containing PB/DNA polyplex and QDs resulted in significant 
quenching of QDs when compared with control samples lacking CLQ. This provides 
a strong indication that CLQ indeed facilitated polyplex dissociation. The mechanism 
of quenching was elucidated by modeling the process as the combination of static 
and dynamic quenching from the PB and DNA, as well as self-quenching due the 
bridging of QDs. 
     With the inherent transfection selectivity, PB vectors were developed further to 
deliver drug and gene simultaneously. The hydrophobic anti-cancer drug paclitaxel 
(PTX) was encapsulated in the Pluronic F127 (PL), which could self-assemble into 
the PB/DNA complexes to form a shield layer against aggregation in the presence of 
serum proteins. Separate loading of drug and DNA was believed to be able to 
214 
 
minimize the interference that may happen to the integral loading. Co-delivery of 
PTX and DNA with PB-PL/DNA vector led to enhanced gene expression and 
reduced cell viability when compared to DNA delivery.  But the synergistic effect was 
only found significant in cancer cells (SKOV3) but not in non-cancer cells (ARPE-19). 
One reason may correlate with the selective transfection discussed above. Greater 
endo/lysosomal sequestration in non-cancer cells might inhibit the interaction of PTX 
with microtubules to facilitate gene expression. Besides, the different degree of drug 
resistance or drug sensitivity between SKOV3 and APRE-19 cells could be another 
reason.   
     As the PB vector system holds a promise for sustained delivery, a convenient 
and practical method is necessary to examine the release of vector in vitro. Although 
we have studied the release in a test tube before, it cannot reflect the real 
transfecting ability of the sustained release system by making the release and 
transfection as two separate processes. Here, we reported a device that allows the 
vector to be directly released to cells, by using a poly(ethylene glycol) diacrylate 
(PEG-DA) barrier gel to mimic the role of tumor extracellular matrix in resisting 
therapeutic agents to reach tumor cells. Various factors that influence the 
permeability of PEG-DA gels were investigated and optimized. It was found that the 
released vectors maintained the integrity as a polyplex even after four day release. 
Thus we can expect the released polyplexes to have the similar transfection ability 
as regular polyplexes administered in solution.  By loading DNA and PTX together in 
the PB-PL type of vector, an instant sustained co-delivery of gene and drug to 
cultured cells could be accomplished in vitro by using PEG-DA barrier gel. 
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8.2   Recommendations for Future Research  
 With all in vitro investigations of PB based vectors, the next logical step is to 
conduct in vivo experiments to assess the performance of the vectors in animal 
models. Preliminary results have proved the effectiveness of PB vectors in delivering 
luciferase reporter gene to mice tumor by direct subcutaneous injections. Based on 
the optimized formulations and preparation protocol, a real therapeutic gene, such 
as iterleukin-12 (IL-12) a highly potent anti-tumor cytokine, should be used in place 
of the luciferase reporter gene to assess the inhibition of tumor progression by PB 
vector treatment.  Moreover, co-delivery of PTX and IL-12 could be also undertaken 
to gain a synergistic effect, with PTX delivery alone and IL-12 delivery alone as 
negative controls. However, the synergistic effect may not be accessible in cancer 
cells developing the multiple drug resistance (MDR) phenotype. MDR is known as 
one major limitation for current chemotherapy. Recent research results suggested 
that MDR is related to gene malfunction caused by chromosomal alterations in 
cancer cells(11-12). Correction of malfunctioned genes through gene delivery would 
be a promising method to solve MDR or in some extent to sensitize drug resistant 
cells towards to anticancer drugs again. Besides, small interfering RNA (siRNA) 
technology could be a promising alternative, for siRNA is chemically synthesizable 
and easy to be tailored for a special need. It has been reported that co-delivery of 
PTX and Bcl-2 targeted siRNA effectively sensitized PTX resistant MDA-M8-231 
human breast cancer cells to PTX(13). But before use of siRNA as payload, a 
detailed characterization of PB/siRNA complexes is recommended. Instead of using 
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PB vectors as a dilute solution, concentrated solution could be administered 
intratumorally as to benefit from the sustained release following body temperature 
triggered gelation. With a single injection, the therapeutic effect is expected to 
maintain at an appropriate level for a long period of time.          
     Regarding the technique using QDs to sense the dissociation of polyplexes, we 
can further its application in intracellular environments. To explore the change in 
polyplex formation in cytoplasm as well as in acidic vesicles (e.g. endosomes) would 
surely help researchers design vectors that can effectively condense and protect 
DNA payloads. We have found that QDs are capable of distributing evenly within the 
cytoplasm in large numbers. Thus, it is likely for these dispersed dots to sense 
dissociation of polyplexes as they do in solution. Furthermore, since the QDs were 
rendered water soluble though ligand exchange, various types of amino acids can 
be easily coupled to QDs as designed; for example, histidine residues can be 
coupled to the surface of QDs, leading them to readily escape endosomes. In this 
case, there could be many more QDs available in the cytoplasm. 
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